
<html lang="en"     class="pb-page"  data-request-id="b6558eec-9e51-403c-b8f5-c89161de42c6"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm501929n;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2015.58.issue-6;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Development of Novel ACK1/TNK2 Inhibitors Using a Fragment-Based Approach" /></meta><meta name="dc.Creator" content="Harshani R.  Lawrence" /></meta><meta name="dc.Creator" content="Kiran  Mahajan" /></meta><meta name="dc.Creator" content="Yunting  Luo" /></meta><meta name="dc.Creator" content="Daniel  Zhang" /></meta><meta name="dc.Creator" content="Nathan  Tindall" /></meta><meta name="dc.Creator" content="Miles  Huseyin" /></meta><meta name="dc.Creator" content="Harsukh  Gevariya" /></meta><meta name="dc.Creator" content="Sakib  Kazi" /></meta><meta name="dc.Creator" content="Sevil  Ozcan" /></meta><meta name="dc.Creator" content="Nupam P.  Mahajan" /></meta><meta name="dc.Creator" content="Nicholas J.  Lawrence" /></meta><meta name="dc.Description" content="The tyrosine kinase ACK1, a critical signal transducer regulating survival of hormone-refractory cancers, is an important therapeutic target, for which there are no selective inhibitors in clinical..." /></meta><meta name="Description" content="The tyrosine kinase ACK1, a critical signal transducer regulating survival of hormone-refractory cancers, is an important therapeutic target, for which there are no selective inhibitors in clinical..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 17, 2015" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm501929n" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2015 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm501929n" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm501929n" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm501929n" /></link>
        
    
    

<title>Development of Novel ACK1/TNK2 Inhibitors Using a Fragment-Based Approach | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm501929n" /></meta><meta property="og:title" content="Development of Novel ACK1/TNK2 Inhibitors Using a Fragment-Based Approach" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/large/jm-2014-01929n_0013.jpeg" /></meta><meta property="og:description" content="The tyrosine kinase ACK1, a critical signal transducer regulating survival of hormone-refractory cancers, is an important therapeutic target, for which there are no selective inhibitors in clinical trials to date. This work reports the discovery of novel and potent inhibitors for ACK1 tyrosine kinase (also known as TNK2) using an innovative fragment-based approach. Focused libraries were designed and synthesized by selecting fragments from reported ACK inhibitors to create hybrid structures in a mix and match process. The hybrid library was screened by enzyme-linked immunosorbent assay-based kinase inhibition and 33P HotSpot assays. Systematic structure–activity relationship studies led to the identification of compound (R)-9b, which shows potent in vitro (IC50 = 56 nM, n = 3, 33P HotSpot assay) and in vivo (IC50 &lt; 2 μM, human cancer cell lines) ACK1 inhibition. Both (R)-9b and (S)-9b were stable in human plasma and displayed a long half-life (t1/2 &gt; 6 h)." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm501929n"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm501929n">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm501929n&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm501929n&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm501929n&amp;href=/doi/10.1021/jm501929n" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2015</span><span class="cit-fg-volume">, 58</span><span class="cit-fg-issue">, 6</span><span class="cit-fg-pageRange">, 2746-2763</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/58/6" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm501908a" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm501934n" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Development of Novel ACK1/TNK2 Inhibitors Using a Fragment-Based Approach</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Harshani+R.++Lawrence">Harshani R. Lawrence</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kiran++Mahajan">Kiran Mahajan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yunting++Luo">Yunting Luo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel++Zhang">Daniel Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nathan++Tindall">Nathan Tindall</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Miles++Huseyin">Miles Huseyin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Harsukh++Gevariya">Harsukh Gevariya</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sakib++Kazi">Sakib Kazi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sevil++Ozcan">Sevil Ozcan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nupam+P.++Mahajan">Nupam P. Mahajan</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nicholas+J.++Lawrence">Nicholas J. Lawrence</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Drug Discovery Department and <sup>‡</sup>Chemical Biology Core, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, Florida 33612, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">§</span> <span class="aff-text">Department of Oncologic Sciences, University of South Florida, Tampa, Florida 33620, United States</span></div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#7f371e0d0c171e111651331e080d1a111c1a3f12101919160b0b51100d18"><span class="__cf_email__" data-cfemail="400821323328212e296e0c213732252e2325002d2f26262934346e2f3227">[email protected]</span></a>. Phone: (813) 745-6076. Fax: (813) 745-6748.</div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#c18fb4b1a0acef8ca0a9a0aba0af81acaea7a7a8b5b5efaeb3a6"><span class="__cf_email__" data-cfemail="105e6560717d3e5d7178717a717e507d7f76767964643e7f6277">[email protected]</span></a>. Phone: (813) 745-4078. Fax: (813) 745-6748.</div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#cd83a4aea5a2a1acbee381acbabfa8a3aea88da0a2ababa4b9b9e3a2bfaa"><span class="__cf_email__" data-cfemail="b2fcdbd1daddded3c19cfed3c5c0d7dcd1d7f2dfddd4d4dbc6c69cddc0d5">[email protected]</span></a>. Phone: (813) 745-6037. Fax: (813) 745-6748.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm501929n&amp;href=/doi/10.1021%2Fjm501929n" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2015</span></span><span class="cit-volume">, 58</span><span class="cit-issue">, 6</span><span class="cit-pageRange">, 2746–2763</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 20, 2015</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>12 December 2014</li><li><span class="item_label"><b>Published</b> online</span>17 March 2015</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 March 2015</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm501929n" title="DOI URL">https://doi.org/10.1021/jm501929n</a></div><div class="article_header-article-copyright"><strong>Copyright © 2015 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2746%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DHarshani%2BR.%2BLawrence%252C%2BKiran%2BMahajan%252C%2BYunting%2BLuo%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D58%26issueNum%3D6%26contentID%3Djm501929n%26title%3DDevelopment%2Bof%2BNovel%2BACK1%252FTNK2%2BInhibitors%2BUsing%2Ba%2BFragment-Based%2BApproach%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2763%26publicationDate%3DMarch%2B2015">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm501929n"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2386</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">18</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm501929n" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Development of Novel ACK1/TNK2 Inhibitors Using a Fragment-Based Approach&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Harshani&quot;,&quot;last_name&quot;:&quot;R. Lawrence&quot;},{&quot;first_name&quot;:&quot;Kiran&quot;,&quot;last_name&quot;:&quot;Mahajan&quot;},{&quot;first_name&quot;:&quot;Yunting&quot;,&quot;last_name&quot;:&quot;Luo&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Nathan&quot;,&quot;last_name&quot;:&quot;Tindall&quot;},{&quot;first_name&quot;:&quot;Miles&quot;,&quot;last_name&quot;:&quot;Huseyin&quot;},{&quot;first_name&quot;:&quot;Harsukh&quot;,&quot;last_name&quot;:&quot;Gevariya&quot;},{&quot;first_name&quot;:&quot;Sakib&quot;,&quot;last_name&quot;:&quot;Kazi&quot;},{&quot;first_name&quot;:&quot;Sevil&quot;,&quot;last_name&quot;:&quot;Ozcan&quot;},{&quot;first_name&quot;:&quot;Nupam&quot;,&quot;last_name&quot;:&quot;P. Mahajan&quot;},{&quot;first_name&quot;:&quot;Nicholas&quot;,&quot;last_name&quot;:&quot;J. Lawrence&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2015&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;17&quot;,&quot;issue&quot;:&quot;6&quot;,&quot;volume&quot;:&quot;58&quot;,&quot;pages&quot;:&quot;2746-2763&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm501929n&quot;},&quot;abstract&quot;:&quot;The tyrosine kinase ACK1, a critical signal transducer regulating survival of hormone-refractory cancers, is an important therapeutic target, for which there are no selective inhibitors in clinical trials to date. This work reports the discovery of novel and potent inhibitors for ACK1 tyrosine kinase (also known as TNK2) using an innovative fragment-based approach. Focused libraries were designed and synthesized by selecting fragments from reported ACK inhibitors to create hybrid structures in a mix and match process. The hybrid library was screened by enzyme-linked immunosorbent assay-based kinase inhibition and 33P HotSpot assays. Systematic structure–activity relationship studies led to the identification of compound (R)-9b, which shows potent in vitro (IC50 = 56 nM, n = 3, 33P HotSpot assay) and in vivo (IC50 &lt; 2 μM, human cancer cell lines) ACK1 inhibition. Both (R)-9b and (S)-9b were stable in human plasma and displayed a long half-life (t1/2 &gt; 6 h).&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm501929n&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm501929n" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm501929n&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm501929n" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm501929n&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm501929n" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm501929n&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm501929n&amp;href=/doi/10.1021/jm501929n" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm501929n" /></input><a href="/doi/pdf/10.1021/jm501929n" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm501929n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm501929n%26sid%3Dliteratum%253Aachs%26pmid%3D25699576%26genre%3Darticle%26aulast%3DLawrence%26date%3D2015%26atitle%3DDevelopment%2Bof%2BNovel%2BACK1%252FTNK2%2BInhibitors%2BUsing%2Ba%2BFragment-Based%2BApproach%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D58%26issue%3D6%26spage%3D2746%26epage%3D2763%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/58/6" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jmcmar.2015.58.issue-6/20150326/jmcmar.2015.58.issue-6.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/medium/jm-2014-01929n_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/large/jm-2014-01929n_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501929n&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The tyrosine kinase ACK1, a critical signal transducer regulating survival of hormone-refractory cancers, is an important therapeutic target, for which there are no selective inhibitors in clinical trials to date. This work reports the discovery of novel and potent inhibitors for ACK1 tyrosine kinase (also known as TNK2) using an innovative fragment-based approach. Focused libraries were designed and synthesized by selecting fragments from reported ACK inhibitors to create hybrid structures in a mix and match process. The hybrid library was screened by enzyme-linked immunosorbent assay-based kinase inhibition and <sup>33</sup>P HotSpot assays. Systematic structure–activity relationship studies led to the identification of compound (<i>R</i>)-<b>9b</b>, which shows potent in vitro (IC<sub>50</sub> = 56 nM, <i>n</i> = 3, <sup>33</sup>P HotSpot assay) and in vivo (IC<sub>50</sub> < 2 μM, human cancer cell lines) ACK1 inhibition. Both (<i>R</i>)-<b>9b</b> and (<i>S</i>)-<b>9b</b> were stable in human plasma and displayed a long half-life (<i>t</i><sub>1/2</sub> > 6 h).</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54744" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54744" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The ACK1 tyrosine kinase is aberrantly activated, amplified, or mutated in many types of human cancers, including prostate, breast, pancreatic, ovarian, and lung cancers.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> Aberrantly activated ACK1 drives cell growth via a number of molecular mechanisms, which we have recently reviewed.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Several recent discoveries underscore its tumor-promoting functions. For example, ACK1 phosphorylates the androgen receptor, at Tyr267 in its transactivation domain, in an androgen-independent manner to promote castration-resistant prostate cancer (CRPC) growth.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a> ACK1 has been shown to promote prostate tumorogenesis by phosphorylating the WW domain-containing oxidoreductase (Wwox) tumor suppressor<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> on Tyr287, leading to its polyubiquitination and subsequent degradation in prostate cancer models.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> We have also shown that ACK1 phosphorylates and activates the key signaling kinase AKT at Tyr176,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> which plays important roles in human physiology and disease.<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9-11)</a> When AKT is phosphorylated on Tyr176 by ACK1, it functionally participates in the progression of breast cancer by suppressing proapoptotic pathways.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Mechanistically, phosphorylation on AKT Tyr176 by ACK1 activates PI3K-independent AKT activation and facilitates the survival of breast cancer cells by suppressing proapoptotic pathways.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Conversely, knockdown of ACK1 expression by siRNA suppressed AKT Tyr176 phosphorylation and activation in breast, prostate, and pancreatic cancer cells and increased expression of proapoptotic genes such as Bim and Fas.<a onclick="showRef(event, 'ref8 ref12'); return false;" href="javascript:void(0);" class="ref ref8 ref12">(8, 12)</a> Recently, ACK1 has also been shown to phosphorylate histone demethylase KDM3A (JHDM2A) at Tyr1114 in breast cancer cells, conferring tamoxifen resistance.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></div><div class="NLM_p">The importance of ACK1 activation in tumor initiation in vivo first became evident when we generated transgenic mice expressing ACK1 specifically in the prostate. These ACK1 transgenic mice developed PIN, indicating that its activation is crucial in early stages of tumor initiation.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Collective evidence in preclinical models therefore validates ACK1 as an important target for anticancer drugs and has driven the development of ACK1 inhibitors.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a></div><div class="NLM_p">Selected examples of ACK1 inhibitors are shown in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>. A series of 4-amino-5,6-biarylfuro[2,3-<i>d</i>]pyrimidines (structures <b>1a</b>–<b>1c</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) were found to inhibit ACK1 and the related member of the src kinase family Lck (lymphocyte-specific kinase).<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a> For example, compound <b>1a</b> potently inhibits both ACK1 and Lck and was useful in the development of further compounds for the treatment of T cell-mediated autoimmune and inflammatory disease as a consequence of Lck inhibition. We used compound <b>1b</b> (AIM-100) as a chemical probe for ACK1 inhibition, since it was reported to inhibit Lck to a lesser extent (ACK1:Lck = 5:1) than <b>1a</b> (Lck:ACK1 = 1.8:1). We have shown that AIM-100 inhibits ACK1-dependent AKT Tyr176<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> in pancreatic cancer cells and AR Tyr267<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> phosphorylation. AIM-100 also inhibits castration and radioresistant prostate xenograft tumor growth via inhibition of AR Tyr267 phosphorylation.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> A study of further members of the 4-amino-5,6-biarylfuro[2,3-<i>d</i>]pyrimidine series showed that the dithiolane <b>1c</b> was an exceptionally potent ACK1 inhibitor (<i>K</i><sub>i</sub> = 0.3 nM). This compound inhibits the growth of an ACK1-dependent cell line with an IC<sub>50</sub> of 5 nM. However, its poor pharmacokinetic properties (attributed to oxidation of both the dithiolane ring and NMe<sub>2</sub>) precluded further development. A series of pyrazolopyrimidines of type <b>2</b> have also been developed by Amgen as ACK1 inhibitors.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> For example, compound <b>2a</b> potently inhibits ACK1 in vitro (IC<sub>50</sub> = 2 nM) and in intact cells, as measured by inhibition of ACK1 autophosphorylation (IC<sub>50</sub> = 20 nM). Gray and co-workers have identified the ACK1 inhibitor <b>3</b> by high-throughput kinase profiling of a focused library of pyrimidodiazepines.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> This compound abolishes EGF-induced ACK1 autophosphorylation (Tyr284) in HEK293 cells at concentrations of 2 μM. It also inhibits A549 lung cancer cell growth at 10 μM. A series of imidazopyrazine-based ACK1 inhibitors have been developed by Jin and co-workers at OSI/Astellas.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> For example, compound <b>4</b> is a potent and orally bioavailable ACK1 inhibitor in mouse models and possesses good experimental ADMET (absorption, distribution, metabolism, elimination, and toxicity) properties. Compound <b>4</b> inhibits ACK1-mediated phosphorylation of poly(GT) in an AlphaScreen assay with an IC<sub>50</sub> of 110 nM. Moreover, it potently inhibits ACK1 in a cellular context. In NCI-H1703 human non-small-cell lung cancer cells, its IC<sub>50</sub> for ACK1 inhibition is 35 nM as measured by an ELISA assay.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/medium/jm-2014-01929n_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/large/jm-2014-01929n_0015.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures and activities of representative ACK1 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/large/jm-2014-01929n_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501929n&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Several promiscuous kinase inhibitors have been shown to inhibit ACK1. For example, the Src/Abl kinase inhibitor bosutinib<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> inhibits ACK1 with an IC<sub>50</sub> of 2.7 nM.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Bosutinib was found to inhibit cell migration and invasion but not cell viability in a panel of non-small-cell lung cancer (NSCLC) cell lines.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> These effects were not seen when ACK1 was knocked-down specifically in K-Ras mutant cell lines. Dasatinib, another BCR/Abl and Src family tyrosine kinase inhibitor, inhibits ACK1 with a <i>K</i><sub>D</sub> of 6 nM.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Dasatinib was shown to inhibit both ACK1 autophosphorylation and AR phosphorylation of Tyr-267 in heregulin-stimulated human prostate cancer LNCaP cells with IC<sub>50</sub> values of <5 nM.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Additionally, dasatinib significantly reduced the growth of LNCaP cells expressing constitutively activated ACK1 in a mouse xenograft model.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Chemical and phosphoproteomic approaches revealed ACK1 to be a target of dasatinib in human lung cancer cells.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><div class="NLM_p">In this paper, we describe the development of novel ACK1 inhibitors by analysis of known ACK1 inhibitors, including <b>1b</b> (AIM-100, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B), the pyrazolopyrimidine derivative <b>2b</b><a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A), and the ALK inhibitor <b>5</b> (TAE684<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>C) (which strongly cross-inhibits ACK1 from published inhibitor profiling data sets; <i>K</i><sub>d</sub> = 2 nM<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> and <i>K</i><sub>i</sub> = 1 nM<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a>). The binding modes of the three inhibitors are shown in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, as derived from the X-ray structure of <b>2b</b> with ACK1<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3EQR">3EQR</a>), <b>1b</b> (AIM-100) modeled using the X-ray structure of an analogue with ACK1<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EWH">4EWH</a>), and <b>5</b> modeled using its X-ray structure with ALK<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XB7">2XB7</a>). These inhibitors bind the ACK1 hinge residue Ala208 via the pyrimidyl group, positioning groups in the hydrophobic pocket beyond the gatekeeper and in the ribose binding region.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The bisanilinopyrimidine scaffold has long been recognized as a classical kinase inhibitor motif.<a onclick="showRef(event, 'ref2 ref13 ref31'); return false;" href="javascript:void(0);" class="ref ref2 ref13 ref31">(2, 13, 31)</a> Recently, we reported our efforts in identifying novel and exceptionally potent Aurora A inhibitors using the bisanilinopyrimidine scaffold.<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32, 33)</a> In the development of novel ACK1 inhibitors, our design process incorporated an aminopyrimidine structure as the hinge binding group (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>D) and fragments of <b>1b</b>, <b>2b</b>, and <b>5</b> as R<sup>1</sup>, R<sup>2</sup>, and R<sup>3</sup> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>D) groups to create hybrid structures in a mix and match process (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/medium/jm-2014-01929n_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/large/jm-2014-01929n_0001.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A–C) Binding modes of known ACK1 inhibitors to ACK1: (A) compound <b>2b</b> taken from its crystal structure with ACK1 (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3EQP">3EQP</a>), (B) compound <b>1b</b> modeled with ACK1, based on similar compounds bound to Lck (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2OF2">2OF2</a>), and (C) compound <b>5</b> (TAE684) modeled with ACK1, based on its crystal structure with ALK (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XB7">2XB7</a>). (D) Bisanilinopyrimidine scaffold <b>6</b> for design of novel ACK1 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/large/jm-2014-01929n_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501929n&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42612" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42612" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Synthesis of (±)-<b>9a</b>–<b>t</b> as ACK1 Inhibitors</h3><div class="NLM_p">First, the synthesis of compounds (±)-<b>9a</b>–<b>t</b> with R<sup>1</sup>, R<sup>2</sup>, and R<sup>3</sup> groups was achieved from a set of 2,4-dichloropyrimidine building blocks, <b>7</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>), by sequential reactions with two amine fragments. The starting materials <b>7a</b>–<b>e</b> reacted with (±)-tetrahydrofurfurylamine using method a (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>) to obtain the intermediates (±)-<b>8a</b>–<b>e</b>, which were subsequently reacted with the requisite anilines R<sup>3</sup>NH<sub>2</sub> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>) using method b to obtain the final compounds (±)-<b>9a</b>–<b>t</b> with A- and B-rings (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). The synthesis of building block <b>7c</b> was achieved from readily available dihydroxypyrimidine-5-carboxylic acid via dichloropyrimidine-5-carbonyl chloride<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> as shown in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> in good yield.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/medium/jm-2014-01929n_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/large/jm-2014-01929n_0006.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Design and Synthesis of Bisanilinopyrimidine Derivatives <b>9a</b>–<b>t</b> with a (±)-Tetrahydrofurfurylamine A-Ring<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/large/jm-2014-01929n_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501929n&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Method a: (±)-tetrahydrofurfurylamine, Et<sub>3</sub>N, MeOH, 0 °C to rt, 2 h. Method b: cat. HCl (4 M) in dioxane, 2-methoxyethanol or ethanol or dioxane, sealed tube, 80–180 °C, 20–30 min, aq NaHCO<sub>3</sub> workup.</p></p></figure><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/medium/jm-2014-01929n_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/large/jm-2014-01929n_0007.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Design and Synthesis of Bisanilinopyrimidines with Sulfone-Substituted and Sulfide A-Rings<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/large/jm-2014-01929n_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501929n&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>See the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>. Method a: DIPEA, THF, 120 °C, 1 h, 77–90%. Method b: <i>m</i>CPBA, EtOAc, 0 °C to rt, 2 h, 70–96%. Method c: cat. HCl (4 M) in dioxane, microwave heating 180 °C, 30 min, 68–97%. Method d: POCl<sub>3</sub>, 0 °C, PCl<sub>5</sub>, 16 h, 99%. Method e: THF, 15 h, 75%.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Synthesis of the Sulfones <b>12a</b>–<b>j</b> and Sulfides <b>12k</b>–<b>r</b> as ACK1 Inhibitors</h3><div class="NLM_p last">The synthesis of sulfone-substituted derivatives <b>12a</b>–<b>j</b> was undertaken from <b>7c</b> as shown in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. Our attempts to synthesize sulfone derivatives <b>11</b> by direct reaction of <b>7c</b> with <i>o</i>-(sulfonylalkyl)aniline using microwave heating conditions (100–170 °C, 30 min, ethanol, THF, or dioxane) or conventional alkylation conditions (sodium hydride in DMF or THF at room temperature followed by heating) were unsuccessful. Therefore, we first generated the sulfide intermediates <b>10</b> by reacting building block <b>7c</b> with appropriate aniline sulfides (method a, Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>), which were then oxidized to sulfone intermediates <b>11</b> using <i>m</i>CPBA (method b, Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). The intermediates <b>10</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>) were used to prepare the final sulfide analogues <b>12k</b>–<b>r</b> with the B-ring (see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). The B-ring in these analogues was introduced using microwave heating in HCl (4 M in dioxane) (method c, Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>) to successfully obtain the final compounds in good yields with >95% purity as determined by HPLC.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Synthesis of Enantiomers of <b>9b</b></h3><div class="NLM_p">The synthesis of (<i>R</i>)-<b>9b</b> and (<i>S</i>)-<b>9b</b> stereoisomers was achieved as shown in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a> from commercially available (<i>R</i>)<i>-</i> and (<i>S</i>)<i>-</i>tetrahydrofurfurylamines. The optical rotations ([α]<sub>D</sub>) of commercially available (<i>S</i>)-(+)-tetrahydrofurfurylamine and (<i>R</i>)-(−)-tetrahydrofurfurylamine were measured as +11.85 and −11.33, respectively, and are in agreement with the reported optical rotation of the (<i>S</i>)- and (<i>R</i>)-stereoisomers, +12 and −12, respectively.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> We were able to resolve the enantiomers of (±)-<b>9b</b> using chiral HPLC (see the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>) and to determine the enantiomeric purity of (<i>R</i>)-<b>9b</b> and (<i>S</i>)-<b>9b</b> using chiral HPLC as >98%.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/medium/jm-2014-01929n_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/large/jm-2014-01929n_0008.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of (<i>R</i>)-<b>9b</b> and (<i>S</i>)-<b>9b</b> as ACK1 Inhibitors</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/large/jm-2014-01929n_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501929n&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26361" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26361" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Analogue Design and in Vitro Structure–Activity Relationship (SAR)</h3><div class="NLM_p">The ability of the pyrimidines <b>9</b> and <b>12</b> to inhibit ACK1 kinase activity was first examined using a novel ELISA (enzyme-linked immunosorbent assay) developed in our laboratory.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> This assay measured the ability of ACK1 to specifically phosphorylate a tyrosine residue in a peptide derived from AKT (of sequence ATGRY<u class="uu">Y</u>AMKIL)<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> followed by detection of phosphorylation by an antibody-based approach.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Loss of ACK1 kinase activity was directly proportional to decreased phosphorylation of AKT peptide. Subsequently, IC<sub>50</sub> values for those compounds that inhibited ACK1 activity by >80% at a concentration of 10 μM in the ELISA were determined in a <sup>33</sup>P HotSpot assay (Reaction Biology). In the present work, we performed SAR studies using the ELISA (see the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>) and dose response data obtained from the <sup>33</sup>P HotSpot assay. The (±)-tetrahydrofurfurylamine fragment (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B) from <b>1b</b> was incorporated into the design and synthesis of compounds <b>9a</b>–<b>t</b> (i.e., R<sup>2</sup> group, Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>) as a racemic mixture with >95% purity as determined by HPLC. The R<sup>1</sup> substituents at the 5-position of the pyrimidine and R<sup>3</sup> aniline fragments (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> and Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>D) in compounds <b>9a</b>–<b>t</b> were chosen from <b>2b</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A) and <b>5</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>C). The R<sup>3</sup> aniline building blocks shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> were chosen to aid inhibitor binding interactions as well as to modulate the druglike properties such as solubility, hydrophobicity (cLogP < 5), cell permeability, and polar surface area (<140 Å). We incorporated anilines possessing polar hydrophilic groups (or water-solubilizing groups such as morpholine, piperazine, and piperidine) as R<sup>3</sup>.</div><div class="NLM_p">Our initial SAR from compounds <b>9a</b>–<b>t</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>) indicated that Cl, Br, and 2-chloro-6-fluorocarboxamide groups in the 5-position of the pyrimidine ring (i.e., R<sup>1</sup>) are important for ACK1 inhibitory activities, while methyl and F groups are unfavorable. This observation is consistent with the members of the set <b>9a</b>–<b>t</b>. For example, compounds <b>13</b> (76%, entry 3, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) and <b>14</b> (66%, entry 4, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) with Br and 2-chloro-6-fluorocarboxamide, respectively, as R<sup>1</sup> and <i>m</i>-fluoro-<i>p</i>-hydroxyaniline as R<sup>3</sup> showed improved ACK1 inhibition compared to the corresponding F and Me analogues <b>9t</b> (41% at 10 μM) and <b>9u</b> (49%) (entries 1 and 2, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Similarly, compounds <b>15</b> (65%), <b>16</b> (83%), and <b>9r</b> (85%), which contain Cl, Br, and 2-chloro-6-fluorocarboxamide fragments in the 5-position (entries 5–7, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), respectively, and <i>p</i>-hydroxyaniline as R<sup>3</sup> showed 2–10-fold improvement in ACK1 inhibition compared to analogues with F (41%) and methyl (8%) as R<sup>1</sup> (not shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>; see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for synthesis). The related compounds <b>18</b> and <b>9q</b> (entries 9 and 10, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) with hydrophobic methoxyaniline as R<sup>3</sup> showed moderate ACK1 inhibition of 67% and 68%, respectively, indicating hydrophilic anilines as R<sup>3</sup> are beneficial to maintain the in vitro ACK1 inhibitory activities.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SAR and in Vitro Inhibitory Activities of Derivatives <b>9a</b>–<b>t</b> and Related Compounds<a class="ref internalNav" href="#t1-fn1" aria-label="b">b</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/medium/jm-2014-01929n_0009.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/medium/jm-2014-01929n_0010.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/medium/jm-2014-01929n_0011.gif" alt="" id="gt1a" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/medium/jm-2014-01929n_0012.gif" alt="" id="gt1b" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Inhibition (%) values are given as the average of three or more determinations.</p></div><div class="footnote" id="t1-fn1"><sup>Table b</sup><p class="last">ND = not determined. IC<sub>50</sub> values were determined for compounds that showed >80% inhibition in the ELISA assay</p></div></div><div></div></div><div class="NLM_p">The synthesis of sulfones <b>12a</b>–<b>j</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>) was also undertaken in parallel on the basis of the initial SAR information available from compounds <b>9a</b>–<b>t</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). We used the building block <b>7c</b> as the starting point, in which a 2-chloro-6-fluorocarboxamide group occupies the 5-position of the pyrimidine ring (similar to the R<sup>1</sup> group in compounds <b>9a</b>–<b>t</b>) and later introduced sulfonyl-substituted anilines as R<sup>2</sup> (A-ring, Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>), similar to the isopropylsulfonamide-containing A-ring of <b>5</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>C). Hydrophilic groups such as <i>p</i>-hydroxyaniline were introduced as the B-ring (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). However, all the analogues from the set of sulfones <b>12a</b>–<b>j</b> showed weak ACK1 inhibition (<60% at 10 μM in the ELISA), and the sulfides <b>12k</b>–<b>r</b> generated using intermediate <b>10</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>) showed very little ACK1 inhibitory activity in the ELISA (see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). Therefore, subsequent synthetic chemistry was predominantly focused on building blocks that contain Cl, Br, or 2-chloro-6-fluorocarboxamide as R<sup>1</sup> (<b>8a</b>, <b>8b</b>, and <b>8c</b>, Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>) while keeping the (±)-tetrahydrofurfurylamine group as R<sup>2</sup>.</div><div class="NLM_p">Next, we further modified the R<sup>3</sup> group of <b>9</b> using the anilines shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> while keeping R<sup>1</sup> as Cl, Br, or a 2-chloro-6-fluorocarboxamide group. Compounds <b>9c</b>, <b>9h</b>, and <b>9n</b>, which contain <i>p</i>-morpholinoaniline fragments (entries 11–13, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) as R<sup>3</sup> and Cl, Br, and 2-chloro-6-fluorocarboxamide groups as R<sup>1</sup>, showed improved ACK1 inhibitory activities with IC<sub>50</sub> values of 67.5, 106, and 48 nM, respectively, compared to earlier analogues, and this observation further suggests aniline fragments with hydrophilic/water-solubilizing moieties are well tolerated in the R<sup>3</sup> binding region. Compounds <b>9a</b>, <b>9i</b>, and <b>9m</b> with <i>p</i>-piperazinylaniline as R<sup>3</sup> also showed excellent ACK1 inhibitory activities (entries 14–16, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) with IC<sub>50</sub> values of 81, 94, and 33 nM, respectively, similar to morpholine analogues, further suggesting anilines with hydrophilic groups as R<sup>3</sup> have a positive effect on the ACK1 inhibition. As expected, compounds <b>9b</b>, <b>19</b>, and <b>20</b> with (methylpiperazinyl)aniline as R<sup>3</sup> (entries 17–19, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) showed high ACK1 inhibitory activities with IC<sub>50</sub> values of 54, 48, and 48 nM, respectively. Compound <b>9s</b> (entry 26, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) with piperidinecarboxylic acid showed a significantly improved ACK1 inhibitory activity with an IC<sub>50</sub> value of 34 nM, compared to its related Cl and Br analogues <b>9e</b> and <b>9j</b>, respectively (entries 24 and 25, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Interestingly, substitution of the <i>N</i>-methyl group of compound <b>20</b> (entry 19, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) with a succinyl amide group as in compound <b>22</b> (entry 27, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) led to >1.5-fold improvement in ACK1 inhibitory activity with an IC<sub>50</sub> of 28 nM. We noticed that compounds <b>9e</b>, <b>9s</b>, and <b>22</b> (entries 24, 26, and 27, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) with a carboxylic acid group as the H-bond donor/acceptor overall improved ACK1 inhibitory activities, indicating its potential as a handle, for example, in amide synthesis, for further SAR exploration in the ACK1 binding region.</div><div class="NLM_p">Overall, we noticed 2-chloro-6-fluorocarboxamide as the R<sup>1</sup> group significantly contributed to the ACK1 inhibitory activities in compounds <b>9n</b>, <b>9m</b>, <b>20</b>, <b>9o</b>, and <b>22</b> (entries 13, 16, 19, 23, and 27, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). <b>9o</b> (entry 23, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) with 2-chloro-6-fluorocarboxamide as R<sup>1</sup> and <i>p</i>-(4-piperidinyl)aniline as R<sup>3</sup> showed markedly improved ACK1 inhibition with an IC<sub>50</sub> of 53.3 nM, which is 3–4-fold more potent compared to the related <b>9f</b> with an IC<sub>50</sub> of 231 nM and <b>9k</b> with an IC<sub>50</sub> of 169 nM (entries 21 and 22, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), which have Cl and Br, respectively. Similarly, compound <b>9s</b> (entry 26, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) with piperidinecarboxylic acid as R<sup>3</sup> and 2-chloro-6-fluorocarboxamide as R<sup>1</sup> showed significantly improved ACK1 inhibition with an IC<sub>50</sub> of 34 nM in the enzymatic assay compared to its related Cl and Br analogues <b>9e</b> (IC<sub>50</sub> of 85 nM) and <b>9j</b> (85% inhibition at 10 μM), respectively (entries 24 and 25, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). The improved inhibitory activities of <b>9n</b>, <b>9m</b>, <b>20</b>, <b>9o</b>, and <b>9s</b> (entries 13, 16, 19, 23, and 26, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) can be attributed to the 2-chloro-6-fluorocarboxamide group in the 5-position of the pyrimidine undergoing a key H-bond contact in the gatekeeper region (see Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A). Altogether, our SAR demonstrates that Cl and Br groups are tolerated in the 5-position of the pyrimidine core, and substitution of the 5-position with hydrogen as in compound <b>21</b> (entry 20, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) considerably lowered the in vitro ACK1 affinity (16% at 10 μM, ELISA).</div><div class="NLM_p">Although compounds <b>9n</b>, <b>9m</b>, <b>20</b>, <b>9o</b>, <b>9s</b>, and <b>22</b> with a 2-chloro-6-fluorocarboxamide moiety showed higher potency for ACK1 in the enzymatic assay, these compounds did not display the expected cellular potency most probably due to lack of cell permeability. Selected compounds from the set (±)-<b>9a</b>–<b>t</b> were chosen to evaluate the effects of ACK1 inhibition in LAPC4 human prostate cancer cells with inhibition of cell growth as the readout. The piperazine-substituted chloropyrimidine (±)-<b>9b</b> (entry 17, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) showed promising ACK1 inhibitory activities in cellular assays. On the basis of the findings from cell culture data, we synthesized enantiomers of <b>9b</b> to understand the ACK1 inhibitory activities of individual stereoisomers. The difference in activities of the two enantiomers is small. The (<i>R</i>)-<b>9b</b> isomer (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>) has marginally better ACK1 inhibitory activity with an IC<sub>50</sub> of 56 nM, while (<i>S</i>)-<b>9b</b> has an IC<sub>50</sub> of 82 nM in the <sup>33</sup>P HotSpot assay. The syntheses of (<i>R</i>)-<b>9b</b> and (<i>S</i>)-<b>9b</b> are shown in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>, and other examples of enantiomerically pure compounds (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) were also synthesized using the protocols in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. Both (<i>R</i>)-<b>9b</b> and (<i>S</i>)-<b>9b</b> were able to inhibit ACK1 autophosphorylation in prostate cancer cells (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>a) and inhibit cell growth (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>b–d).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. In Vivo Inhibitory Activities of Derivatives of <b>9</b> from Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd ID</th><th class="colsep0 rowsep0" align="center" char=".">inhibition (%) of ACK1 Tyr phosphorylation at 5 μM, 16 h</th><th class="colsep0 rowsep0" align="center">compd ID</th><th class="colsep0 rowsep0" align="center" char=".">inhibition (%) of ACK1 Tyr phosphorylation at 5 μM, 16 h</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">DMSO</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="left">methyl ester of (±)-<b>9e</b></td><td class="colsep0 rowsep0" align="char" char=".">(−12.0)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(±)-<b>9b</b></td><td class="colsep0 rowsep0" align="char" char=".">65.3</td><td class="colsep0 rowsep0" align="left">(±)-<b>9e</b></td><td class="colsep0 rowsep0" align="char" char=".">1.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(±)-<b>9r</b></td><td class="colsep0 rowsep0" align="char" char=".">34.3</td><td class="colsep0 rowsep0" align="left">(<i>R</i>)-<b>9e</b></td><td class="colsep0 rowsep0" align="char" char=".">83.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(±)-<b>9m</b></td><td class="colsep0 rowsep0" align="char" char=".">36.7</td><td class="colsep0 rowsep0" align="left">(<i>S</i>)-<b>9c</b></td><td class="colsep0 rowsep0" align="char" char=".">39.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b> (Table<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>)</td><td class="colsep0 rowsep0" align="char" char=".">74.5</td><td class="colsep0 rowsep0" align="left">(<i>R</i>)-<b>9b</b></td><td class="colsep0 rowsep0" align="char" char=".">93.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(±)-<b>9i</b></td><td class="colsep0 rowsep0" align="char" char=".">58.3</td><td class="colsep0 rowsep0" align="left">(<i>S</i>)-<b>9b</b></td><td class="colsep0 rowsep0" align="char" char=".">78.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>R</i>)-<b>9c</b></td><td class="colsep0 rowsep0" align="char" char=".">(−22.1)</td><td class="colsep0 rowsep0" align="left"><b>23</b> (Table<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>)</td><td class="colsep0 rowsep0" align="char" char=".">74.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(±)-<b>9n</b></td><td class="colsep0 rowsep0" align="char" char=".">(−32.6)</td><td class="colsep0 rowsep0" align="left">(±)-<b>9l</b></td><td class="colsep0 rowsep0" align="char" char=".">8.56</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(±)-<b>9l</b></td><td class="colsep0 rowsep0" align="char" char=".">(−49.3)</td><td class="colsep0 rowsep0" align="left">TAE684 (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>)</td><td class="colsep0 rowsep0" align="char" char=".">86.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AIM-100 (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>)</td><td class="colsep0 rowsep0" align="char" char=".">70.0</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Inhibition (%) of ACK1 Tyr284 phosphorylation assessed by immunoblotting in LAPC4 cells. Negative values represent increased Tyr phosphorylation (or enhanced kinase activity).</p></div></div></div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/medium/jm-2014-01929n_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/large/jm-2014-01929n_0002.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effect of ACK1 inhibitors in prostate cancer cells: (a) inhibition of ACK1 autophosphorylation in LAPC4 cells treated with 5 μM (<i>R</i>)-<b>9b</b> and (<i>S</i>)-<b>9b</b>; inhibition of (b) LNCaP, (c) LAPC4, and (d) VCaP cell growth by AIM-100, (<i>R</i>)-<b>9b</b>, and (<i>S</i>)-<b>9b</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/large/jm-2014-01929n_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501929n&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Cell Culture Data of Selected Pyrimidines <b>9</b></h3><div class="NLM_p">ACK1 is a tyrosine kinase that autophosphorylates at Tyr284, which is indicative of its kinase activation. To determine the inhibitory potential of the representative pyrimidines <b>9</b>, the prostate cancer derived cell line LAPC4 was either treated with EGF ligand alone or added to cells pretreated with the compounds, and equal amounts of cell lysates were subjected to immunoblotting. EGF ligand causes rapid activation of EGF receptor, which in turn leads to activation of the ACK1 kinase (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>a, lane 2, top panel). In contrast, treatment of LAPC4 cells with (<i>R</i>)-<b>9b</b> and (<i>S</i>)-<b>9b</b> resulted in almost complete loss of ACK1 activation. The control ACK1 inhibitors <b>5</b> and <b>1b</b> also exhibited significant reduction in ACK1 activation. Actin was used as a control, which indicates equal loading of cell lysates (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>a, lower panel).</div><div class="NLM_p last">In addition to (<i>R</i>)-<b>9b</b> and (<i>S</i>)-<b>9b</b>, we have also assessed other examples of <b>9</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>) for their potential to suppress ACK1 kinase activity using immunoblotting, as described above. The inhibition (%) of ACK1 kinase activity is shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>.</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Effects of (<i>R</i>)-<b>9b</b> and (<i>S</i>)-<b>9b</b> in Human Cancer Cells</h3><div class="NLM_p last">Three distinct human prostate cancer derived cell lines, LNCaP, LAPC4, and VCaP, were either DMSO treated or treated with 1, 2.5, 5, 7.5, and 10 μM concentrations of inhibitors AIM-100, (<i>R</i>)-<b>9b</b>, and (<i>S</i>)-<b>9b</b> for 72 h, and the number of viable cells was counted by trypan blue exclusion assay. Both (<i>R</i>)-<b>9b</b> and (<i>S</i>)-<b>9b</b> were significantly better (IC<sub>50</sub> = 1.8 μM) than AIM-100 (IC<sub>50</sub> = 7 μM) in their ability to inhibit cell growth in LNCaP cells (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>b). However, in LAPC4 cells, all three inhibitors were comparable in their ability to suppress cell proliferation (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>c). In contrast, highly metastatic CRPC-forming VCaP cells were observed to be highly sensitive to (<i>R</i>)-<b>9b</b> (IC<sub>50</sub> = 2 μM), while AIM-100 and (<i>S</i>)-<b>9b</b> exhibited an IC<sub>50</sub> of 4 μM (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>d). Taken together, it appears that (<i>R</i>)-<b>9b</b> is a superior ACK1 inhibitor <i>in vivo</i> and most significantly exhibits an ability to suppress proliferation of androgen-independent or CRPC VCaP cells.</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Molecular Modeling of (±)-<b>9b</b></h3><div class="NLM_p">The [(tetrahydrofurfuryl)amino]pyrimidine (<i>R</i>)-<b>9b</b> was docked to the catalytic domain of ACK1 (using GOLD<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35, 36)</a> and the ACK1 crystal structure from PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EWH">4EWH</a>) (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>) to determine a representative binding mode and to study the structural features responsible for its binding to ACK1. In this pose, hydrogen bonding is predicted between the pyrimidine N1 atom and the B-ring NH to the ACK1 Ala208 residue (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A), typical of an aminopyrimidine type 1 kinase inhibitor.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> The chlorine atom is pointing toward, but not actually occupying, the hydrophobic pocket (highlighted in green in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A). This pocket is presumably occupied by the phenyl group in those derivatives that have an amide group at the pyrimidine 5-position (e.g., <b>9m</b> or <b>9s</b>). The tetrahydrofuryl group in (<i>R</i>)-<b>9b</b> orients itself closer to the ribose binding pocket of ACK1 and under the P-loop.</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/medium/jm-2014-01929n_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/large/jm-2014-01929n_0003.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Schematic representation of compound (<i>R</i>)-<b>9b</b> (blue) docked to ACK1 (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EWH">4EWH</a>), showing the ACK1 amino acid residues in the hinge (black), hydrophobic pocket (green), and ATP-ribose binding pocket (red). (B) Stick model of (<i>R</i>)-<b>9b</b> (cyan) docked to ACK1 (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EWH">4EWH</a>), showing important ACK1 amino acid residues. (C) Surface model of (<i>R</i>)-<b>9b</b> (cyan) docked to the ATP binding site of ACK1. The surface is colored according to atom type (carbon, green; hydrogen, gray; oxygen, red; nitrogen, blue). The images in panels B and C were rendered using Pymol.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/large/jm-2014-01929n_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501929n&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> SAR Overview and Further Analogue Design</h3><div class="NLM_p">For the compounds synthesized as ACK1 inhibitors, the R<sup>2</sup> group was kept constant, while the 5-positions of the pyrimidine (R<sup>1</sup>) and aniline (R<sup>3</sup>) groups were changed. The SAR changes are highlighted in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>a. Since the cell culture data indicated that (<i>R</i>)-<b>9b</b> and (<i>S</i>)-<b>9b</b> are potent in human cancer cells, we included Cl as R<sup>1</sup> in subsequent analogue synthesis. Therefore, on the basis of the cell culture data, SARs obtained for pyrimidines <b>9</b>, and inhibitory activities of compounds that contain a carboxylic acid tether such as in <b>9e</b>, <b>9j</b>, <b>9s</b>, and <b>22</b> (entries 24–27, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), the compounds shown in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>b with Cl in the 5-position of the pyrimidine as R<sup>1</sup> were synthesized to explore further SARs. Compounds <b>23</b>, <b>24</b>, <b>26</b>, and <b>28</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>b and <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>) with one- or two-carbon-tethered carboxylic acids showed moderate ACK1 inhibition. The bisamine group in compound <b>26</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>b) was introduced with the hope of facilitating cell permeability and solubility. Compound <b>29</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>b) with a piperazine amide-tethered carboxylic acid showed significant ACK1 inhibition similar to that of compounds <b>22</b> (entry 27, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). The <i>in vitro</i> activities of compounds shown in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>b demonstrate the importance of the piperazine moiety to retain potent ACK1 inhibitory activities. On the basis of the SARs obtained in this study, we will continue our medicinal/synthetic chemistry efforts to further improve this class of compounds as novel ACK1 inhibitors, and broader SAR explorations will be discussed in future publications.</div><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/medium/jm-2014-01929n_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/large/jm-2014-01929n_0004.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (a) SAR overview. (b) Compounds with an extended carboxylic acid tether as ACK1 inhibitors (inhibition (%) at 10 μM in ELISA is shown).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/large/jm-2014-01929n_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501929n&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> In Vitro PK Properties and Profiling of (<i>R</i>)-<b>9b</b></h3><div class="NLM_p">Our cell culture data showed both (<i>R</i>)-<b>9b</b> and (<i>S</i>)-<b>9b</b> can penetrate human cancer cell lines and inhibit cell growth in an ACK1-dependent manner (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). The <i>in vitro</i> human plasma stabilities of compounds (<i>R</i>)-<b>9b</b> and (<i>S</i>)-<b>9b</b> were evaluated using HPLC analysis in a time-course experiment for up to 24 h (see Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a> and the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>). Our data showed both (<i>R</i>)-<b>9b</b> and (<i>S</i>)-<b>9b</b> were stable in human plasma (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>) for up to 24 h and displayed a long half-life (<i>t</i><sub>1/2</sub> > 6 h). Procaine and procainamide were used as standards to generate the human plasma stability data of (<i>R</i>)-<b>9b</b> and (<i>S</i>)-<b>9b</b> using HPLC analysis (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>).<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> The solubilities of (<i>R</i>)-<b>9b</b> and (<i>S</i>)-<b>9b</b> were determined as 1 and 0.9 mg/mL, respectively, in PBS with 10% DMSO (clear solution). The solubility of the mesylate salt of (<i>R</i>)-<b>9b</b> in PBS with 10% DMSO was determined as >5 mg/mL, further suggesting its suitability for in vivo animal experiments. The most potent compound in the cell experiments, the [(tetrahydrofurfuryl)amino]pyrimidine (<i>R</i>)-<b>9b</b>, was subjected to limited profiling against 34 kinases using the Reaction Biology <sup>33</sup>P HotSpot kinase profiling service (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) to determine its selectivity for ACK1. At 1 μM (<i>R</i>)-<b>9b</b> ACK1 was the kinase most potently inhibited (99.8%). Of the other kinases inhibited by >80%, the most notable were the JAK family kinases JAK2 (98.6%) and Tyk2 (98.9%). Only six other kinases were inhibited by >80%; these were ABL1 (82.8%), ALK (86.0%), CHK1 (84.8%), FGFR1 (86.4%), LCK (87.7%), and ROS/ROS1 (84.2%). Dose responses were obtained for these kinases inhibited by >80% at 1 μM: JAK2 (IC<sub>50</sub> = 6 nM), Tyk2 (IC<sub>50</sub> = 5 nM), FGFR1 (IC<sub>50</sub> = 160 nM), ABL1 (IC<sub>50</sub> = 206 nM), CHK1 (IC<sub>50</sub> = 154 nM), ALK (IC<sub>50</sub> = 143 nM), LCK (IC<sub>50</sub> = 136 nM), and ROS/ROS1 (IC<sub>50</sub> = 124 nM). Interestingly we have seen that other diaminopyrimidines also give rise to potent JAK inhibition.<a onclick="showRef(event, 'ref32 ref33 ref39'); return false;" href="javascript:void(0);" class="ref ref32 ref33 ref39">(32, 33, 39)</a> To assess JAK2 activation in prostate cancer epithelial cells, LNCaP and LAPC4 were treated with heregulin or EGF ligands, respectively, followed by immunoblotting with phospho-ACK1 (Tyr284), phospho-JAK2 (Tyr1007), and phospho-STAT5 (Tyr694) antibodies. While significant ACK1 activation was observed in EGF-treated LAPC4 and LNCaP prostate cancer epithelial cells, neither JAK2 nor STAT5 activation was observed (unpublished data), suggesting that ACK1 and JAK2 kinase activations are distinct events that occur in different cellular contexts. Since several ALK inhibitors<a onclick="showRef(event, 'ref26 ref40'); return false;" href="javascript:void(0);" class="ref ref26 ref40">(26, 40)</a> also inhibit ACK1 and (<i>R</i>)-<b>9b</b> was partly designed from an ALK inhibitor, its IC<sub>50</sub> for ALK inhibition was measured using the HotSpot assay and found to be 143 nM, 3-fold less than the IC<sub>50</sub> for ACK1. The superposition of the pose of (<i>R</i>)-<b>9b</b> in ACK1 with crystal structures of both ALK and JAK2 shows a reasonable fit in each case (see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>, Figures S1 and S2). It is also known that Src kinase is a regulator of the androgen receptor.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> The IC<sub>50</sub> for (<i>R</i>)-<b>9b</b> against cSrc was 438 nM, 10-fold less than the IC<sub>50</sub> for ACK1. Overall, the selectivity of (<i>R</i>)-<b>9b</b> for ACK1 and JAK2 appears to be good.</div><figure id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/medium/jm-2014-01929n_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/large/jm-2014-01929n_0005.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Plasma stabilities of (<i>R</i>)-<b>9b</b>, (<i>S</i>)-<b>9b</b>, procainamide, and procaine using HPLC: area of the peak (<i>y</i>-axis) plotted against the time (<i>x</i>-axis). Procainamide is reported as stable and procaine unstable in human plasma.<a onclick="showRef(event, 'ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref41 ref42">(41, 42)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/large/jm-2014-01929n_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501929n&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Kinase Profiling of (<i>R</i>)-<b>9b</b> (Reaction Biology, HotSpot Assay)</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center" char=".">inhibition (%) of <b>9b</b> at 1 μM<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">std dev</th><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center" char=".">inhibition (%) of <b>9b</b> at 1 μM<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">std dev</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ABL1</td><td class="colsep0 rowsep0" align="char" char=".">82.8</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="left">IR</td><td class="colsep0 rowsep0" align="char" char=".">46.6</td><td class="colsep0 rowsep0" align="left">1.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ACK1</td><td class="colsep0 rowsep0" align="char" char=".">99.8</td><td class="colsep0 rowsep0" align="char" char=".">0.3</td><td class="colsep0 rowsep0" align="left">JAK2</td><td class="colsep0 rowsep0" align="char" char=".">98.6</td><td class="colsep0 rowsep0" align="left">0.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AKT1</td><td class="colsep0 rowsep0" align="char" char=".">4.7</td><td class="colsep0 rowsep0" align="char" char=".">2.4</td><td class="colsep0 rowsep0" align="left">KDR/VEGFR2</td><td class="colsep0 rowsep0" align="char" char=".">67.3</td><td class="colsep0 rowsep0" align="left">0.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ALK</td><td class="colsep0 rowsep0" align="char" char=".">86.0</td><td class="colsep0 rowsep0" align="char" char=".">0.1</td><td class="colsep0 rowsep0" align="left">LCK</td><td class="colsep0 rowsep0" align="char" char=".">87.7</td><td class="colsep0 rowsep0" align="left">0.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AXL</td><td class="colsep0 rowsep0" align="char" char=".">75.9</td><td class="colsep0 rowsep0" align="char" char=".">0.0</td><td class="colsep0 rowsep0" align="left">mTOR/FRAP1</td><td class="colsep0 rowsep0" align="char" char=".">–5.6</td><td class="colsep0 rowsep0" align="left">1.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BTK</td><td class="colsep0 rowsep0" align="char" char=".">45.1</td><td class="colsep0 rowsep0" align="char" char=".">0.2</td><td class="colsep0 rowsep0" align="left">p70S6K/RPS6KB1</td><td class="colsep0 rowsep0" align="char" char=".">24.1</td><td class="colsep0 rowsep0" align="left">1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">c-MET</td><td class="colsep0 rowsep0" align="char" char=".">23.1</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="left">PDGFRa</td><td class="colsep0 rowsep0" align="char" char=".">42.7</td><td class="colsep0 rowsep0" align="left">0.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CHK1</td><td class="colsep0 rowsep0" align="char" char=".">84.8</td><td class="colsep0 rowsep0" align="char" char=".">0.3</td><td class="colsep0 rowsep0" align="left">PIM1</td><td class="colsep0 rowsep0" align="char" char=".">3.6</td><td class="colsep0 rowsep0" align="left">0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">COT1/MAP3K8</td><td class="colsep0 rowsep0" align="char" char=".">–7.7</td><td class="colsep0 rowsep0" align="char" char=".">0.1</td><td class="colsep0 rowsep0" align="left">RAF1</td><td class="colsep0 rowsep0" align="char" char=".">–0.8</td><td class="colsep0 rowsep0" align="left">3.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CSK</td><td class="colsep0 rowsep0" align="char" char=".">26.3</td><td class="colsep0 rowsep0" align="char" char=".">0.1</td><td class="colsep0 rowsep0" align="left">ROS/ROS1</td><td class="colsep0 rowsep0" align="char" char=".">84.2</td><td class="colsep0 rowsep0" align="left">0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">EGFR</td><td class="colsep0 rowsep0" align="char" char=".">–2.8</td><td class="colsep0 rowsep0" align="char" char=".">3.8</td><td class="colsep0 rowsep0" align="left">c-Src</td><td class="colsep0 rowsep0" align="char" char=".">71.3</td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">EPHA2</td><td class="colsep0 rowsep0" align="char" char=".">31.9</td><td class="colsep0 rowsep0" align="char" char=".">0.1</td><td class="colsep0 rowsep0" align="left">SGK1</td><td class="colsep0 rowsep0" align="char" char=".">26.0</td><td class="colsep0 rowsep0" align="left">0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ERBB2/HER2</td><td class="colsep0 rowsep0" align="char" char=".">–1.1</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td><td class="colsep0 rowsep0" align="left">TBK1</td><td class="colsep0 rowsep0" align="char" char=".">71.8</td><td class="colsep0 rowsep0" align="left">0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ERK1</td><td class="colsep0 rowsep0" align="char" char=".">1.9</td><td class="colsep0 rowsep0" align="char" char=".">0.2</td><td class="colsep0 rowsep0" align="left">TIE2/TEK</td><td class="colsep0 rowsep0" align="char" char=".">32.0</td><td class="colsep0 rowsep0" align="left">0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FGFR1</td><td class="colsep0 rowsep0" align="char" char=".">86.4</td><td class="colsep0 rowsep0" align="char" char=".">0.1</td><td class="colsep0 rowsep0" align="left">TRKA</td><td class="colsep0 rowsep0" align="char" char=".">63.2</td><td class="colsep0 rowsep0" align="left">0.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FRK/PTK5</td><td class="colsep0 rowsep0" align="char" char=".">41.3</td><td class="colsep0 rowsep0" align="char" char=".">0.0</td><td class="colsep0 rowsep0" align="left">TYK2</td><td class="colsep0 rowsep0" align="char" char=".">98.9</td><td class="colsep0 rowsep0" align="left">0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GSK3a</td><td class="colsep0 rowsep0" align="char" char=".">5.1</td><td class="colsep0 rowsep0" align="char" char=".">0.7</td><td class="colsep0 rowsep0" align="left">WEE1</td><td class="colsep0 rowsep0" align="char" char=".">12.4</td><td class="colsep0 rowsep0" align="left">0.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IKKa/CHUK</td><td class="colsep0 rowsep0" align="char" char=".">0.4</td><td class="colsep0 rowsep0" align="char" char=".">0.8</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">ATP was used at 10 μM.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Estimated from dose response.</p></div></div></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03772" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03772" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">A combination of a fragment-based approach of creating small-molecule libraries using a bisanilinopyrimidine scaffold and a novel ELISA-based assay of screening the compound libraries for their inhibitory potential led to the identification of a novel class of ACK1 inhibitors. The SARs showed tetrahydrofurfurylamine as R<sup>2</sup> and a piperazine moiety as R<sup>3</sup> are critical for ACK1 inhibitory activities with (<i>R</i>)-<b>9b</b> and (<i>S</i>)-<b>9b</b> discovered as potent compounds using ELISA and <sup>33</sup>P HotSpot assays. Compounds (<i>R</i>)-<b>9b</b> and (<i>S</i>)-<b>9b</b> were also shown to be potent ACK1 inhibitors in vivo, suppressing the growth of the prostate cancer derived cell lines. Furthermore, (<i>R</i>)-<b>9b</b> and (<i>S</i>)-<b>9b</b> displayed selectivity toward ACK1 when compared with other related tyrosine kinases such as Src and ALK, but potently inhibited the JAK family kinases JAK2 and Tyk2. The binding mode of compound <b>9b</b> described here provides further opportunities to improve this class of compounds as ACK1 inhibitors. Overall, the availability of potent and selective ACK1 inhibitors has opened the doors for preclinical animal studies that could lead to clinical trials for hormonally regulated cancers such as prostate and breast cancers.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80138" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80138" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Assessment of ACK1 Inhibition via ELISA</h3><div class="NLM_p last">In brief, biotinylated AKT peptide (5 μM) was immobilized onto a streptavidin-coated 96-well plate, followed by blocking with 3% BSA. ACK1 enzyme purified from SF9 cells (40 ng/reaction) was resuspended in a reaction buffer (10 mM HEPES, 20 mM MgCl<sub>2</sub>, 75 mM NaCl, and 1 mM DTT) and added to the plate in the presence of the compounds (10 μM). After incubation for 1 h at 37 °C, the plates were washed, blocked, and incubated with HRP-tagged anti-pTyr antibodies (1:500) for 1 h. Alternately, anti-pY176-AKT phosphoantibodies (1:100) were used, followed by secondary anti-rabbit antibodies. The plates were developed using SigmaFast OPD substrate solution (Sigma, St. Louis, MO) and read with a spectrophotometer.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> General Chemistry Information</h3><div class="NLM_p last">All reagents were purchased from commercial suppliers and used without further purification. <sup>1</sup>H NMR spectra were recorded on an Agilent-Varian Mercury 400 MHz spectrometer with CDCl<sub>3</sub>, CD<sub>3</sub>OD, or DMSO-<i>d</i><sub>6</sub> as the solvent. <sup>13</sup>C NMR spectra were recorded at 100 MHz. All coupling constants are measured in hertz, and the chemical shifts (δ<sub>H</sub> and δ<sub>C</sub>) are quoted in parts per million relative to TMS (δ 0), which was used as the internal standard. High-resolution mass spectroscopy was carried out on an Agilent 6210 LC–MS (ESI-TOF) system. Microwave reactions were performed in CEM model 908005 and Biotage Initiator 8 machines. HPLC analysis was performed using a JASCO HPLC system equipped with a PU-2089 Plus quaternary gradient pump and a UV-2075 Plus UV–vis detector, using an Alltech Kromasil C-18 column (150 × 4.6 mm, 5 μm) and an Agilent Eclipse XDB-C18 column (150 × 4.6 mm, 5 μm). The purities of the final compounds that underwent biological assessment were >95% as measured by HPLC. Melting points were recorded on an Optimelt automated melting point system (Stanford Research Systems). Thin-layer chromatography was performed using silica gel 60 F254 plates (Fisher), with observation under UV when necessary. Anhydrous solvents (acetonitrile, dimethylformamide, ethanol, 2-propanol, methanol, and tetrahydrofuran) were used as purchased from Aldrich. Burdick and Jackson HPLC-grade solvents (methanol, acetonitrile, and water) were purchased from VWR for HPLC and high-resolution mass analysis. HPLC-grade TFA was purchased from Fisher.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 2,4-Dichloropyrimidine-5-carbonyl Chloride (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>)</h3><div class="NLM_p last">To POCl<sub>3</sub> (45 mL, 0.071 mol) in a round-bottom flask was added 2,4-dihydroxypyrimidine-5-carboxylic acid (10.00 g, 0.064 mol) portionwise at 0 °C, followed by slow addition of PCl<sub>5</sub> (46.60 g, 0.229 mol). The reaction mixture was warmed to rt and heated to reflux for 16 h. The mixture was concentrated to dryness and slurried with DCM (30 mL), and the solid precipitated was filtered and washed with DCM (2 × 20 mL). The filtrate was evaporated under reduced pressure to afford the title compound (13.90 g, 99%) as a yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.25 (s, 1H).<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 2,4-Dichloro-<i>N</i>-(2-chloro-6-fluorophenyl)pyrimidine-5-carboxamide (<b>7c</b>)</h3><div class="NLM_p last">To a solution of 2,4-dichloropyrimidine-5-carbonyl chloride (6.36 g, 0.030 mol) (obtained in the previous step) in THF (40 mL) under inert conditions was added 2-chloro-6-fluoroaniline (4.38 g, 0.03 mol) portionwise, and the reaction mixture was stirred at rt for 15 h. The resulting precipitate was filtered and washed with DCM (15 mL), and the solid obtained was sonicated in HCl (1 M, 100 mL), filtered, washed with water (20 mL) and DCM (20 mL) sequentially, and dried under high vacuum to obtain the title compound <b>7c</b> (5.53 g) as a white solid. The first filtrate (i.e., THF and DCM mixture) was concentrated, slurried with DCM (15 mL), and filtered to get a second crop of solid. This solid was again sonicated with HCl (1 M, 30 mL), filtered, washed with water (20 mL) and DCM (15 mL) sequentially, and dried under high vacuum to obtain another crop of pure product <b>7c</b> (1.70 g) also as a white solid. The combined yield of <b>7c</b> was 7.23 g (75%). Mp: 207–211 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.71 (s, 1H), 9.03 (s, 1H), 7.48–7.36 (m, 3H). <sup>19</sup>F NMR (376 MHz, DMSO-<i>d</i><sub>6</sub>): −115.25 to −115.28 (m). LC–MS (ESI+): <i>m</i>/<i>z</i> 319.96 (M + H)<sup>+</sup>. HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>11</sub>H<sub>6</sub>Cl<sub>3</sub>FN<sub>3</sub>O (M + H)<sup>+</sup> 319.9555, found 319.9562.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 2,5-Dichloro-<i>N</i>-[(tetrahydrofuran-2-yl)methyl]pyrimidin-4-amine [(±)-<b>8a</b>]</h3><div class="NLM_p last">Tetrahydrofurfurylamine (1.251 g, 12.36 mmol) in MeOH (11 mL) was added dropwise to a solution of 2,4,5-trichloropyrimidine (2.27 g, 12.36 mmol) and triethylamine (1.251 g, 12.36 mmol) in MeOH (11 mL) at 0 °C and stirred for 1.5 h under argon. The reaction mixture was warmed to room temperature, and the solvent was removed under reduced pressure. The residue obtained was dissolved in DCM. The organic layer was washed with water, dried, and concentrated to afford <b>8a</b> as a yellow solid (2.86 g, 93%). Mp: 81–84 °C. HPLC: 92.0% [<i>t</i><sub>R</sub> = 11.17 min, 30% CH<sub>3</sub>OH in 0.1% TFA/water, 20 min]. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.01 (s, 1H), 4.16–4.09 (m, 1H), 3.91–3.85 (m, 1H), 3.78–3.72 (m, 1H), 3.60–3.48 (m, 2H), 2.06–1.83 (m, 3H), 1.70–1.58 (m, 1H). LC–MS (ESI+): <i>m</i>/<i>z</i> 248.03536 (M + H)<sup>+</sup>. HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>9</sub>H<sub>11</sub>Cl<sub>2</sub>N<sub>3</sub>O<sup>+</sup> (M + H)<sup>+</sup> 248.0352, found 248.0359.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 5-Bromo-2-chloro-<i>N</i>-[(tetrahydrofuran-2-yl)methyl]pyrimidin-4-amine [(±)-<b>8b</b>]</h3><div class="NLM_p last">This compound was synthesized using the same procedure described for <b>8d</b> except using 5-bromo-2,4-dichloropyrimidine (0.500 g, 2.195 mmol) in MeOH (2 mL) and tetrahydrofurfurylamine (0.222 g, 2.195 mmol) in MeOH (2 mL) and triethylamine (0.305 mL, 2.195 mmol) to afford <b>8b</b> as a white solid (0.620 g, 97%). Mp: 85–86 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.23 (s, 1H), 7.62 (br s, 1H), 4.03–3.98 (m, 1H), 3.77–3.71 (m, 1H), 3.62–3.57 (m, 1H), 3.45–3.38 (m, 1H), 3.36–3.30 (m, 1H), 1.90–1.75 (m, 3H), 1.60–1.52 (m, 1H). HPLC–MS (ESI+): <i>m</i>/<i>z</i> 292 and 294.1 for Br isotopes (M + H)<sup>+</sup>.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 2-Chloro-<i>N</i>-(2-chloro-6-fluorophenyl)-4-[[(tetrahydrofuran-2-yl)methyl]amino]pyrimidine-5-carboxamide [(±)-<b>8c</b>]</h3><div class="NLM_p last">To a solution of tetrahydrofurfurylamine (0.121 g, 1.2 mmol) in MeOH (2 mL) was added triethylamine (0.167 mL, 1.2 mmol) at 0 °C under an inert atmosphere. After the resulting solution was stirred at 0 °C for 10 min, <b>7c</b> (0.320 g, 1.0 mmol) in DMF (0.5 mL) was added dropwise. The mixture was warmed to rt and stirred for 30 min. The solvent was removed, and the crude mixture was purified by SiO<sub>2</sub> chromatography (0–30% gradient elution, EtOAc/hexane) to afford <b>8c</b> as a pure white solid (0.283 g, 74%). Mp: 142 °C dec. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.88 (br t, 1H), 8.55 (s, 1H), 7.58 (br s, 1H), 7.30–7.23 (m, 2H), 7.15–7.12 (m, 1H), 4.12–4.06 (m, 1H), 3.91–3.85 (m, 1H), 3.80–3.72 (m, 2H), 3.54–3.48 (m, 1H), 2.07–1.99 (m, 1H), 1.94–1.86 (m, 2H), 1.64–1.56 (m, 1H). LC–MS (ESI+): <i>m</i>/<i>z</i> 385.07 (M + H)<sup>+</sup>. HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>16</sub>H<sub>16</sub>Cl<sub>2</sub>FN<sub>4</sub>O<sub>2</sub> (M + H)<sup>+</sup> 385.0629, found 385.0623.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 2-Chloro-5-fluoro-<i>N</i>-[(tetrahydrofuran-2-yl)methyl]pyrimidin-4-amine [(±)-<b>8d</b>]</h3><div class="NLM_p last">To a solution of tetrahydrofurfurylamine (0.607 g, 6 mmol) in MeOH (10 mL) was added triethylamine (836 μL) under argon at 0 °C. The mixture was stirred at 0 °C for 10 min, and then 2,4-dichloro-5-fluoropyrimidine (0.835 g, 5 mmol) in MeOH (4 mL) was added dropwise at 0 °C. The reaction mixture was warmed to room temperature and stirred for 2 h. The solvent was removed, and the resulting precipitate was dissolved in EtOAc (30 mL) and washed with water (2 × 20 mL). The organic phase was dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated. The crude material obtained was purified by SiO<sub>2</sub> chromatography (silica gel, 20 g, EtOAc/hexane, 0–25%) to afford <b>8d</b> as a white solid (0.936 g, 81%). Mp: 77–78 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.86 (d, <i>J</i> = 2.8 Hz, 1 H), 5.63 (br s, 1H), 4.08 (ddd, <i>J</i> = 14.8, 7.2, 3.2 Hz, 1 H), 3.92–3.76 (m, 3H), 3.37 (ddd, <i>J</i> = 13.6, 8.0, 4.4 Hz, 1 H), 2.10–2.02 (m, 1 H), 1.97–1.90 (m, 2H), 1.64–1.56 (m, 1H). HPLC–MS (ESI+): <i>m</i>/<i>z</i> 232.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 2-Chloro-5-methyl-<i>N</i>-[(tetrahydrofuran-2-yl)methyl]pyrimidin-4-amine [(±)-<b>8e</b>]</h3><div class="NLM_p last">This compound was synthesized according to the procedure described for <b>8d</b> except using 2,4-dichloro-5-methylpyrimidine (2.680 g, 16.440 mmol) in MeOH (20 mL) and tetrahydrofurfurylamine (1.997 g, 19.730 mmol) in MeOH (5 mL) and triethylamine (2.750 mL) to afford <b>8e</b> as a white solid (1.997 g, 53%). Mp: 86–89 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.78 (d, <i>J</i> = 0.8 Hz,1H), 5.24 (br s, 1H), 4.08–4.04 (m, 1H), 3.90–3.81 (m, 2H), 3.80–3.74 (m, 1H), 3.33 (ddd, <i>J</i> = 13.6, 8.0, 4.4 Hz, 1H), 2.08–2.01 (m, 1H), 1.99 (app d, <i>J</i> = 0.8 Hz, 3H), 1.95–1.88 (m, 2H), 1.63–1.54 (m, 1H). HPLC–MS (ESI+): <i>m</i>/<i>z</i> 228.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> (<i>R</i>)-2,5-Dichloro-<i>N</i>-[(tetrahydrofuran-2-yl)methyl]pyrimidin-4-amine [(<i>R</i>)-<b>8f</b>]</h3><div class="NLM_p last">(<i>R</i>)-(−)-Tetrahydrofurfurylamine (0.992 g, 9.81 mmol) in MeOH (10 mL) was added to a solution of 2,4,5-trichloropyrimidine (1.00 g, 5.45 mmol) in MeOH (10 mL) and triethylamine (9.81 mmol) at 0 °C for 1 h under argon. The solution was then warmed to room temperature and stirred for 2 h. The solvent was removed under reduced pressure, and the solid obtained was suspended in chloroform and washed with NaHCO<sub>3</sub>(aq). The organic layer was separated, dried (Na<sub>2</sub>SO<sub>4</sub>), concentrated, and further dried under vacuum to afford (<i>R</i>)-<b>8f</b>) as a white solid (1.354 g, 87%). Mp: 61.5–61.8 °C. HPLC: 97.3% [<i>t</i><sub>R</sub> = 3.36 min, 70% CH<sub>3</sub>OH in 0.1% TFA/water, 20 min]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.01 (s, 1H), 5.91 (s, 1H), 4.12–4.06 (m, 1H), 3.91–3.88 (m, 1H), 3.85–3.77 (m, 2H), 3.44–3.37 (m, 1H), 2.09–2.01 (m, 1H), 1.97–1.90 (m, 2H), 1.60–1.57 (m, 1H). LC–MS (ESI+): <i>m</i>/<i>z</i> 247.02792 (M + H)<sup>+</sup>. HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>9</sub>H<sub>11</sub>C<sub>l2</sub>N<sub>3</sub>O<sup>+</sup> (M + H)<sup>+</sup> 248.0352, found 248.0368.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> (<i>S</i>)-2,5-Dichloro-<i>N</i>-[(tetrahydrofuran-2-yl)methyl]pyrimidin-4-amine [(<i>S</i>)-<b>8f</b>]</h3><div class="NLM_p last">To a solution of (<i>S</i>)-(−)-tetrahydrofurfurylamine (0.992 g, 9.81 mmol) in MeOH (10 mL) was added triethylamine (1.3 mL, 9.81 mmol) at 0 °C. The solution was stirred for 10 min and added to a solution of 2,4,5-trichloropyrimidine (1.00 g, 5.45 mmol) in MeoH (4 mL) dropwise also at 0 °C. The solution was then warmed to room temperature and stirred for 2 h. The solvent was removed under reduced pressure, and the solid was dissolved in chloroform, washed with satd NaHCO<sub>3</sub>(aq). The organic layer was separated, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated to afford the chloropyrimidine (<i>S</i>)-<b>8f</b> as a white solid (1.054 g, 68%). Mp: 59.2–60.0 °C. HPLC: 95.4% [<i>t</i><sub>R</sub> = 3.36 min, 70% CH<sub>3</sub>OH in 0.1% TFA/water, 20 min]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.01 (s, 1H), 5.91 (br s, 1H), 4.09 (ddd, <i>J</i> = 7.2, 4.2, 3.2 Hz, 1H), 3.94–3.88 (m, 1H), 3.85–3.77 (m, 2H), 3.44–3.37 (m, 1H), 2.09–2.01 (m, 1H), 1.97–1.89 (m, 2H), 1.62–1.54 (m, 1H). LC–MS (ESI+): <i>m</i>/<i>z</i> 247.02792 (M + H)<sup>+</sup>. HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>9</sub>H<sub>11</sub>C<sub>l2</sub>N<sub>3</sub>O<sup>+</sup> (M + H)<sup>+</sup> 248.0352, found 248.0353.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 5-Chloro-<i>N</i><sup>2</sup>-[4-(piperazin-1-yl)phenyl]-<i>N</i><sup>4</sup>-[(tetrahydrofuran-2-yl)methyl]pyrimidine-2,4-diamine [(±)-<b>9a</b>]</h3><div class="NLM_p last">The chloropyrimidine <b>8a</b> (0.100 g, 0.403 mmol) and 1-Boc-4-(4′-aminophenyl)piperazine (0.112 g, 0.403 mmol) were mixed in EtOH (1 mL) in a 5 mL microwave vial and heated to 150 °C for 20 min in a microwave reactor, after which a drop of concentrated HCl was added before the solution was returned to the microwave for a further 20 min at 150 °C. The precipitate formed was filtered and washed with saturated NaHCO<sub>3</sub>. The white solid was dried under reduced pressure to obtain <b>9a</b> (0.074 g, 0.190 mmol, 47%). HPLC: 97.8% [<i>t</i><sub>R</sub> = 6.99 min, gradient MeOH/water, 5–95% (with 0.1% formic acid), 20 min]. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.93 (s, 1H), 7.86 (s, 1H), 7.50 (d, <i>J</i> = 9.0 Hz, 2H), 7.00 (t, <i>J</i> = 5.7 Hz, 1H), 6.79 (d, <i>J</i> = 9.1 Hz, 2H), 4.10–4.03 (m, 1H), 3.75 (dd, <i>J</i> = 13.6, 7.5 Hz, 1H), 3.60 (dd, <i>J</i> = 14.5, 7.4 Hz, 1H), 3.41 (t, <i>J</i> = 6.0 Hz, 3H), 2.91 (t, <i>J</i> = 4.0 Hz, 4H), 2.79 (t, <i>J</i> = 4.8 Hz, 4H), 1.92–1.77 (m, 3H), 1.62–1.56 (m, 1H). HPLC–MS (ESI): <i>m</i>/<i>z</i> 195.2 [(M + 2H)/2]<sup>2+</sup>. LC–MS (ESI+): <i>m</i>/<i>z</i> 389.19 (M + H)<sup>+</sup>. HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>26</sub>ClN<sub>6</sub>O<sup>+</sup> (M + H)<sup>+</sup> 389.1851, found 389.1860.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 5-Chloro-<i>N</i><sup>2</sup>-[4-(4-methylpiperazin-1-yl)phenyl]-<i>N</i><sup>4</sup>-[(tetrahydrofuran-2-yl)methyl]pyrimidine-2,4-diamine [(±)-<b>9b</b>]</h3><div class="NLM_p last">The chloropyrimidine <b>8a</b> (0.200 g, 0.806 mmol) and 4-(4-methylpiperazin-1-yl)aniline (0.170 g, 0.889 mmol) were mixed in a microwave vial with HCl (200 μL of 4 M solution in dioxane). 2-Methoxyethanol (6.50 mL) was added, the vial was sealed, and the solution was heated to 110 °C for 48 h. The resulting solution was concentrated under reduced pressure, and the product was partitioned between CHCl<sub>3</sub> and saturated aqueous NaHCO<sub>3</sub>. The organic phase was then dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The resulting product was purified (silica gel, 5:95 methanol/dichloromethane) to afford (±)-<b>9b</b> as a pure white solid (0.108 g, 33%). Mp: 133 °C dec. HPLC: 95.3% [<i>t</i><sub>R</sub> = 7.10 min, gradient MeOH/water, 5–95% (with 0.1% formic acid), 20 min]. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.77 (s, 1H), 7.46 (d, <i>J</i> = 8.8 Hz, 2H), 6.93 (d, <i>J</i> = 8.8 Hz, 2H), 4.20–4.14 (m, 1H), 3.88–3.83 (m, 1H), 3.78–3.70 (m, 1H), 3.58 (dd, <i>J</i> = 13.6, 4.8 Hz, 1H), 3.48 (dd, <i>J</i> = 13.6, 4.8 Hz, 1H), 3.14 (t, <i>J</i> = 4.8 Hz, 4H), 2.62 (t, <i>J</i> = 5.2 Hz, 4H), 2.38 (s, 3H), 2.04–1.80 (m, 3H), 1.70–1.59 (m, 1H). HPLC–MS (ESI): <i>m</i>/<i>z</i> 202.3 [(M + 2H)/2]<sup>2+</sup>. LC–MS (ESI+): <i>m</i>/<i>z</i> 403.20 (M + H)<sup>+</sup>. HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>28</sub>ClN<sub>6</sub>O<sup>+</sup> (M + H)<sup>+</sup> 403.2007, found 403.2008.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Development of Analytical Chiral HPLC Conditions for Separation of (±)-<b>9b</b></h3><div class="NLM_p last">Analytical HPLC was performed using a JASCO HPLC system equipped with a PU-2089 Plus quaternary gradient pump and a UV-2075 Plus UV–vis detector using a Chiralcel OJ column (250 × 4.6 mm). The racemic mixture (±)-<b>9b</b> was separated with 15% IPA and 85% hexane, 1.0 mL/min, and chromatography yielded a faster eluting peak, <i>t</i><sub>R</sub> = 57.7 min (<i>R</i>-isomer), and a slower eluting peak, <i>t</i><sub>R</sub> = 83.5 min (<i>S</i>-isomer).</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> (<i>R</i>)-5-Chloro-<i>N</i><sup>2</sup>-[4-(4-methylpiperazin-1-yl)phenyl]-<i>N</i><sup>4</sup>-[(tetrahydrofuran-2-yl)methyl]pyrimidine-2,4-diamine [(<i>R</i>)-<b>9b</b>]</h3><div class="NLM_p last">The chloropyrimidine (<i>R</i>)-<b>8f</b> (0.200 g, 0.806 mmol) and 4-(4-methylpiperazin-1-yl)aniline (0.170 g, 0.889 mmol) were mixed in a microwave tube with HCl (200 μL of 4 M solution in dioxane). 2-Methoxyethanol (6.50 mL) was added to the mixture, and the solution was warmed to 110 °C for 48 h. The reaction mixture was concentrated, and the product was partitioned between CHCl<sub>3</sub> and saturated aqueous NaHCO<sub>3</sub>. The organic phase was then dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The product was purified using a silica gel column with 5:95 methanol/dichloromethane to afford the pure compound (<i>R</i>)-<b>9b</b> as a white solid (0.220 g, 68%). Mp: 135 °C dec. [α]<sub>D</sub> −12 (<i>c</i> 0.25 in MeOH). HPLC: 96% [<i>t</i><sub>R</sub> = 6.11 min, 30% CH<sub>3</sub>OH in 0.1% TFA/water, 20 min]. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.82 (s, 1H), 7.50 (d, <i>J</i> = 8.8 Hz, 2H), 6.97 (d, <i>J</i> = 8.8 Hz, 2H), 4.22–4.16 (m, 1H), 3.94–3.88 (m, 1H), 3.81–3.76 (m, 1H), 3.63 (dd, <i>J</i> = 13.6, 4.8 Hz, 1H), 3.53 (dd, 13.6, 4.8 Hz, 1H), 3.18 (t, <i>J</i> = 4.8 Hz, 4H), 2.67 (t, <i>J</i> = 5.2 Hz, 4H), 2.34 (s, 3H), 2.03–1.86 (m, 3H), 1.70–1.63 (m, 1H). <sup>13</sup>C NMR (100 MHz, methanol-<i>d</i><sub>4</sub>): δ 158.38, 158.08, 152.19, 146.49, 133.46, 120.97,116.74, 103.51, 77.46, 67.61, 54.59, 49.48, 44.66, 44.18, 28.43, 25.15. LC–MS (ESI+): <i>m</i>/<i>z</i> 403.2007 (M + H)<sup>+</sup>. HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>27</sub>ClN<sub>6</sub>O<sup>+</sup> (M + H)<sup>+</sup> 403.2008, found 403.2004. Chiral HPLC: 96% [<i>t</i><sub>R</sub> = 43.18 min, 15% IPA and 85% hexane, 1.0 mL/min].</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> (<i>S</i>)-5-Chloro-<i>N</i><sup>2</sup>-[4-(4-methylpiperazin-1-yl)phenyl]-<i>N</i><sup>4</sup>-[(tetrahydrofuran-2-yl)methyl]pyrimidine-2,4-diamine [(<i>S</i>)-<b>9b</b>]</h3><div class="NLM_p last">The chloropyrimidine (<i>S</i>)-<b>8f</b> (0.372 g, 1.5 mmol) and 4-(4-methylpiperazin-1-yl)aniline (0.316 g, 1.65 mmol) were mixed in a microwave vial with HCl (0.412 mL of a 4 M solution in dioxane). The 2-methoxyethanol (8.0 mL) was added to the mixture, the vial was sealed, and the solution was heated to 110 °C for 48 h. The resulting solution was concentrated under reduced pressure, and the product was partitioned between CHCl<sub>3</sub> and saturated aqueous NaHCO<sub>3</sub>. The organic phase was separated, then dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The product obtained was purified using a silica gel column with 5:95 methanol/dichloromethane to afford the pure compound (<i>S</i>)-<b>9b</b> as a white solid (475 mg, 79%). Mp: 145 °C dec. [α]<sub>D</sub> +9.6 (<i>c</i> 0.25 in MeOH). HPLC: 98% [<i>t</i><sub>R</sub> = 6.85 min, 30% CH<sub>3</sub>OH in 0.1% TFA/water, 20 min]. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.77 (s, 1H), 7.45 (d, <i>J</i> = 8.8 Hz, 2H), 6.94 (d, <i>J</i> = 8.8 Hz, 2H), 4.17–4.14 (m, 1H), 3.89–3.84 (m, 1H), 3.77–3.71 (m, 1H), 3.63 (dd, <i>J</i> = 13.6, 4.8 Hz, 1H), 3.50 (dd, 13.6, 4.8 Hz, 1H), 3.14 (t, <i>J</i> = 4.8 Hz, 4H), 2.62 (t, <i>J</i> = 4.8 Hz, 4H), 2.34 (s, 3H), 2.02–1.88 (m, 3H), 1.70–1.63 (m, 1H). LC–MS (ESI+): <i>m</i>/<i>z</i> 403.20076 (M + H)<sup>+</sup>. HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>27</sub>ClN<sub>6</sub>O<sup>+</sup> (M + H)<sup>+</sup> 403.19349, found 403.20079. Chiral HPLC: 100% [<i>t</i><sub>R</sub> = 32.4 min, 15% IPA and 85% hexane, 1.0 mL/min].</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 5-Chloro-<i>N</i><sup>2</sup>-(4-morpholinophenyl)-<i>N</i><sup>4</sup>-[(tetrahydrofuran-2-yl)methyl]pyrimidine-2,4-diamine Hydrochloride [(±)-<b>9c</b>]</h3><div class="NLM_p last">The chloropyrimidine <b>8a</b> (0.100 g, 0.403 mmol) and 4-morpholinoaniline (0.072 g, 0.403 mmol) were mixed in EtOH (3 mL) in a 5 mL microwave vial and heated to 150 °C for 20 min in a microwave reactor. The solid obtained upon cooling was filtered, washed with ethyl acetate, and dried under vacuum to afford <b>9c</b> as an off-white solid (0.072 g, 0.185 mmol, 46%). Mp: 221.4 °C dec. HPLC: 99.0% [<i>t</i><sub>R</sub> = 9.90 min, gradient MeOH/water, 5–95% (with 0.1% formic acid), 20 min]. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>Cl3) δ 10.32 (s, 1H), 7.67 (s, 1H), 7.45 (dd, <i>J</i> = 8.8 Hz, 2H), 6.90 (d, <i>J</i> = 8.4 Hz, 2H), 6.62 (app t, <i>J</i> = 5.6 Hz, 1H), 4.13–4.06 (m, 1H), 3.92–3.86 (m, 5H), 3.82–3.77 (m, 1H), 3.46–3.40 (m, 1H), 3.15(t, <i>J</i> = 4.8 Hz, 4H), 2.08–2.00 (m, 1H), 1.981.91 (m, 2H), 1.61–1.52 (m, 1H). LC–MS (ESI+): <i>m</i>/<i>z</i> 390.17 (M-Cl)<sup>+</sup>. HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>25</sub>ClN<sub>5</sub>O<sub>2</sub><sup>+</sup> (M – Cl)<sup>+</sup> 390.1691, found 390.1694.</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 5-Chloro-<i>N</i><sup>2</sup>-[4-(piperidin-1-ylmethyl)phenyl]-<i>N</i><sup>4</sup>-[(tetrahydrofuran-2-yl)methyl]pyrimidine-2,4-diamine [(±)-<b>9d</b>]</h3><div class="NLM_p last">The chloropyrimidine <b>8a</b> (0.100 g, 0.403 mmol) and 4-(piperidinylmethyl)aniline (0.107 g, 0.564 mmol) were mixed in 2-methoxyethanol (1.5 mL), and HCl (0.05 mL of a 12 M aq solution) was added. The reaction mixture was heated in an oil bath at 120 °C with stirring for 5.5 h and then allowed to cool to room temperature. The solvent was evaporated, and saturated NaHCO<sub>3</sub> (10 mL) was added, followed by EtOAc (20 mL). The organic layer was extracted with water, dried (MgSO<sub>4)</sub>, and evaporated. The resulting solid was slurried in diethyl ether and filtered to afford the required product <b>9d</b> as a white powder (0.051 g, 31%). Mp: 120.3–121.7 °C. HPLC: 98.0% [<i>t</i><sub>R</sub> = 8.09 min, gradient MeOH/water, 5–95% (with 0.1% formic acid), 20 min]. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.82 (s, 1H), 7.57 (d, <i>J</i> = 8.6 Hz, 2H), 7.22 (d, <i>J</i> = 8.6 Hz, 2H), 4.22–4.13 (m, 1H), 3.89 (dd, <i>J</i> = 13.3, 6.6 Hz, 1H), 3.75 (dd, <i>J</i> = 14.3, 7.4 Hz, 1H), 3.58 (dd, <i>J</i> = 13.6, 4.8 Hz, 1H), 3.52 (dd, <i>J</i> = 14.0, 6.8 Hz, 1H), 3.45 (s, 2H), 2.43 (br s, 4H), 2.08–1.83 (m, 3H), 1.73–1.64 (m, 1H), 1.64–1.55 (m, 4H), 1.46 (br s, 2H). LC–MS (ESI+): <i>m</i>/<i>z</i> 317.12 (M – piperidine)<sup>+</sup>. HPLC–MS: <i>m</i>/<i>z</i> 201.7 [(M + 2H)/2]<sup>2+</sup>. HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>29</sub>ClN<sub>5</sub>O<sup>+</sup> (M + H)<sup>+</sup> 402.2055, found 402.2063.</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 5-Chloro-<i>N</i><sup>2</sup>-{4-[4-(carboxyethyl)piperidinyl]phenyl}-<i>N</i><sup>4</sup>-[(tetrahydrofuran-2-yl)methyl]pyrimidine-2,4-diamine Hydrochloride [Intermediate for (±)-<b>9e</b>]</h3><div class="NLM_p last">A suspension of <b>8a</b> (0.100 g, 0.403 mmol) and ethyl 1-(4-aminophenyl)piperidine-4-carboxylate (0.200 g, 0.806 mmol) in EtOH (4 mL) was heated in a microwave reactor at 150 °C for 20 min. The resulting mixture was concentrated, and the residue obtained was recrystallized with EtOAc/hexane (5 mL, 1:2). The mixture was filtered and the solid dried under high vacuum to afford the title compound <b>9e</b> as a gray solid (0.273 g, 68%). Mp: 113 °C dec. HPLC: 99.0% [<i>t</i><sub>R</sub> = 5.65 min, 45% CH<sub>3</sub>OH in 0.1% TFA/water, 20 min]. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.88 (s, 1H), 7.49 (br s, 2H), 7.26 (br s, 2H), 4.19–4.14 (m, 3H), 3.88–3.82 (m, 1H), 3.77–3.68 (m, 3H), 3.58 (d, <i>J</i> = 5.6 Hz, 2H), 3.21–3.12 (m, 2H), 2.61 (app t, 1H), 2.10 (app d, 2H), 2.03–1.85 (m, 5H), 1.69–1.60 (m, 1H), 1.27 (t, <i>J</i> = 6.8 Hz, 3H). LC–MS (ESI+): <i>m</i>/<i>z</i> 460.2 (M + H)<sup>+</sup>. HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>23</sub>H<sub>31</sub>ClN<sub>5</sub>O<sub>3</sub> (M + H)<sup>+</sup> 460.2110, found 460.2112.</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 5-Chloro-<i>N</i><sup>2</sup>-[4-(4-carboxypiperidinyl)phenyl]-<i>N</i><sup>4</sup>-[(tetrahydrofuran-2-yl)methyl]pyrimidine-2,4-diamine [(±)-<b>9e</b>]</h3><div class="NLM_p last">To a suspension of the compound prepared in the above step (0.272 g, 0.548 mmol) in THF (2.192 mL) was added NaOH (2 M, 1.096 mL). The reaction mixture was stirred at room temperature for 18 h. The THF was removed, water was added (2 mL), and extraction with DCM (2 mL) was performed. The aqueous solution was acidified with HCl (1 M) to pH 4–5. The resulting precipitate was filtered and washed with water (5 mL × 4), then quickly washed with MeOH (2 mL), and dried under high vacuum to afford the first crop of the required compound (0.112 g). The solid precipitated in the filtrate was filtered, washed with water (5 mL × 2), and dried under high vacuum to afford the second crop of the required compound (0.096 g). The solids were combined to afford <b>9e</b> as a pure dark gray solid (0.208 g, 81%). Mp: 93 °C dec. HPLC: 99.0% [<i>t</i><sub>R</sub> = 8.59 min, 30% CH<sub>3</sub>OH in 0.1% TFA/water, 20 min]. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.81 (s, 1H), 7.46 (d, <i>J</i> = 8.4 Hz, 2H), 7.09 (d, <i>J</i> = 8.8 Hz, 2H), 4.20–4.13 (m, 1H), 3.89–3.84 (m, 1H), 3.77–3.72 (m, 1H), 3.62–3.48 (m, 4H), 2.79 (dt, <i>J</i> = 11.2, 2.4 Hz, 2H), 2.45 (tt, <i>J</i> = 11.2, 4.0 Hz, 1H), 2.06–1.80 (m, 7H), 1.70–1.62 (m, 1H). LC–MS (ESI+): <i>m</i>/<i>z</i> 432.17; (M + H)<sup>+</sup>. HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>27</sub>ClN<sub>5</sub>O<sub>3</sub> (M + H)<sup>+</sup> 432.1796, found 432.1796.</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 4-(Piperidin-4-yl)aniline [Intermediate for (±)-<b>9f</b>]</h3><div class="NLM_p last">To a solution of 4-(4-nitrophenyl)piperidine (400 mg, 1.942 mmol) in MeOH (30 mL) was added Pd on carbon (144 mg) under argon. The argon was removed, and H<sub>2</sub> gas was introduced into the system. After 3.5 h at room temperature, the palladium catalyst was filtered, and the solvent was removed. The residue was purified by trituration with DCM to afford 4-(piperidin-4-yl)aniline as a white solid (340 mg, 99%). Mp: 162.7 °C. HPLC: 95.0% [<i>t</i><sub>R</sub> = 6.74 min, 30% CH<sub>3</sub>OH in 0.1% TFA/water, 20 min]. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 6.99 (d, <i>J</i> = 8.4 Hz, 2H), 6.69 (d, <i>J</i> = 8.4 Hz, 2H), 3.46–3.22 (m, 2H), 2.95 (td, <i>J</i> = 12.8, 3.0 Hz, 2H), 2.70–2.62 (m, 1H), 1.96–1.84 (m, 2H), 1.82–1.70 (m, 2H). LC–MS (ESI+): <i>m</i>/<i>z</i> 177.13808 (M + H)<sup>+</sup>. HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>11</sub>H<sub>16</sub>N<sub>2</sub><sup>+</sup> (M + H)<sup>+</sup> 177.1386, found 177.1382.</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 5-Chloro-<i>N</i><sup>2</sup>-[4-(piperidin-4-yl)phenyl]-<i>N</i><sup>4</sup>-[(tetrahydrofuran-2-yl)methyl]pyrimidine-2,4-diamine [(±)-<b>9f</b>]</h3><div class="NLM_p last">The chloropyrimidine <b>8a</b> (80 mg, 0.32 mmol) and 4-(piperidin-4-yl)aniline (28.4 mg, 0.32 mmol) (synthesized above) were mixed in a microwave vial with EtOH (1.5 mL). Then HCl (1 mL of a 0.1 M aq solution) was added to the tube, the tube was sealed, and the solution was heated to 150 °C for 40 min. The solvent was removed under reduced pressure and the residue washed with DCM and filtered to afford <b>9f</b> as a peach solid (90 mg, 72.0%). Mp: 160 °C dec. HPLC: 85.6% [<i>t</i><sub>R</sub> = 7.51 min, 30% CH<sub>3</sub>OH in 0.1% TFA/water, 20 min]. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 7.94 (s, 1H), 7.49 (d, <i>J</i> = 8.2 Hz, 2H), 7.35 (d, <i>J</i> = 8.4 Hz, 2H), 4.16 (p, <i>J</i> = 6.2 Hz, 1H), 3.86–3.68 (m, 2H), 3.65–3.46 (m, 4H), 3.22–3.09 (m, 2H), 3.00–2.90 (m, 1H), 2.14–1.82 (m, 8H), 1.69–1.58 (m, 1H). <sup>13</sup>C NMR (101 MHz, methanol-<i>d</i><sub>4</sub>) δ 159.20, 151.43, 141.84, 139.72, 135.04, 127.16, 122.99, 105.19, 76.74, 67.63, 45.23, 44.15, 39.15, 29.68, 28.54, 25.01. LC–MS (ESI+): <i>m</i>/<i>z</i> 388.18965 (M + H)<sup>+</sup>. HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>26</sub>ClN<sub>5</sub>O<sup>+</sup> (M + H)<sup>+</sup> 388.1899, found 388.1900.</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 5-Bromo-<i>N</i><sup>2</sup>-(4-hydroxyphenyl)-<i>N</i><sup>4</sup>-[(tetrahydrofuran-2-yl)methyl]pyrimidine-2,4-diamine Hydrochloride [(±)-<b>9g</b>]</h3><div class="NLM_p last">A suspension of (±)-<b>8b</b> (0.073 g, 0.250 mmol) and 4-amino-2-chlorophenol (0.036 g, 0.250 mmol) in EtOH (1 mL) was heated in a microwave reactor at 150 °C for 20 min. The mixture was concentrated to dryness, EtOAc (3 mL) was then added, the resulting mixture was sonicated for 5 min and filtered, and the precipitate was washed again with EtOAc (2 mL) and dried under high vacuum to afford the title compound as a gray solid (0.071 g, 65%). Mp: 193 °C dec. HPLC: 94.0% [<i>t</i><sub>R</sub> = 6.50 min, 45% CH<sub>3</sub>OH in 0.1% TFA/water, 20 min]. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.96 (s, 1H), 7.51 (s, 1H), 7.15 (dd, <i>J</i> = 8.8, 2.4 Hz, 1H), 6.96 (d, <i>J</i> = 8.4 Hz, 1H), 4.18–4.11 (m, 1H), 3.86–3.80 (m, 1H), 3.76–3.71 (m, 1H), 3.56 (app d, <i>J</i> = 6.0 Hz, 2H), 2.05–1.97 (m, 1H), 1.93–1.86 (m, 2H), 1.65–1.56 (m, 1H). LC–MS (ESI+): <i>m</i>/<i>z</i> 399.02 and 401.02 for Br isotopes (M + H)<sup>+</sup>. HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>15</sub>H<sub>17</sub>BrClN<sub>4</sub>O<sub>2</sub> (M + H)<sup>+</sup> 399.0218, found 399.0213.</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 5-Bromo-<i>N</i><sup>2</sup>-(4-morpholinophenyl)-<i>N</i><sup>4</sup>-[(tetrahydrofuran-2-yl)methyl]pyrimidine-2,4-diamine [(±)-<b>9h</b>]</h3><div class="NLM_p last">A mixture of <b>8b</b> (0.100 g, 0.342 mmol) and 4-morpholinoaniline (0.067 g, 0.376 mmol) in EtOH (1 mL) was heated in a microwave reactor at 150 °C for 20 min. The precipitate was filtered, washed with ethyl acetate, and dried under high vacuum to afford the title compound <b>9h</b> as a white solid (0.115 mg, 65%). Mp: 198 °C dec. HPLC: 94.7% [<i>t</i><sub>R</sub> = 5.84 min, 45% CH<sub>3</sub>OH in 0.1% TFA/water, 20 min]. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.98 (s, 1H), 7.46 (d, <i>J =</i> 8.4 Hz, 2H), 7.27 (d, <i>J =</i> 8.4 Hz, 2H), 4.19–4.13 (m, 1H), 3.92 (app t, <i>J</i> = 5.2 Hz, 4H), 3.86–3.80 (m, 1H), 3.76–3.71 (m, 1H), 3.61–3.56 (m, 2H), 3.35 (app t, <i>J =</i> 4.4 Hz, 4H), 2.04–1.87 (m, 3H), 1.67–1.59 (m, 1H). LC–MS (ESI+): <i>m</i>/<i>z</i> 434.13 (M + H)<sup>+</sup>. HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>25</sub>BrN<sub>5</sub>O<sub>2</sub> (M + H)<sup>+</sup> 434.1186, found 434.1182.</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> Boc Derivative of 5-Bromo-<i>N</i><sup>2</sup>-[4-(piperazin-1-yl)phenyl]-<i>N</i><sup>4</sup>-[(tetrahydrofuran-2-yl)methyl]pyrimidine-2,4-diamine Hydrochloride [Intermediate for (±)-<b>9i</b>]</h3><div class="NLM_p last">A mixture of <b>8b</b> (0.176 g, 0.6 mmol) and <i>tert</i>-butyl 4-(4-aminophenyl)piperazine-1-carboxylate (0.167 g, 0.6 mmol) in 2-propanol (3 mL) was heated at 80 °C in a sealed tube for 40 h (the reaction was monitored by HPLC–MS). The precipitate formed upon cooling the mixture was filtered, washed with 2-propanol (2 mL × 2), and dried under high vacuum to afford the title compound <b>9i</b> as a light green solid (0.300 g, 88%). Mp: 124 °C dec. HPLC: 98.5% [<i>t</i><sub>R</sub> = 7.51 min, 60% CH<sub>3</sub>OH in 0.1% TFA/water, 20 min]. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.00 (s, 1H disappeared on D<sub>2</sub>O shake), 7.94 (s, 1H), 7.53(d, <i>J</i> = 8.8 Hz, 2H), 6.84 (d, <i>J</i> = 8.8 Hz, 2H), 6.76 (br t, <i>J</i> = 5.6 Hz, 1H, disappeared on D<sub>2</sub>O shake), 4.10–4.03 (m, 1H), 3.78–3.73 (m, 1H), 3.63–3.58 (m, 1H), 3.43–3.40 (br m, 6H), 2.96 (t, <i>J</i> = 4.8 Hz, 4H), 1.90–1.77 (m, 3H), 1.62–1.56 (m, 1H), 1.40 (s, 9H). LC–MS (ESI+): <i>m</i>/<i>z</i> 533.19 and 535.19 for Br isotopes (M + H)<sup>+</sup>. HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>24</sub>H<sub>34</sub>BrN<sub>6</sub>O<sub>3</sub> (M + H)<sup>+</sup> 533.1870, found 533.1862.</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 5-Bromo-<i>N</i><sup>2</sup>-[4-(piperazin-1-yl)phenyl]-<i>N</i><sup>4</sup>-[(tetrahydrofuran-2-yl)methyl]pyrimidine-2,4-diamine Trifluoroacetate Salt [(±)-<b>9i</b>]</h3><div class="NLM_p last">To a solution of the Boc intermediate (0.291 g, 0.511 mmol) (synthesized in the above step) in DCM (2 mL) at 0 °C was added TFA (2 mL). The reaction mixture was warmed to rt and stirred for 1 h. The solvent was removed under reduced pressure. The resulting residue was slurried in DCM/EtOAc/hexane (1:1:2) and sonicated. The precipitate obtained was filtered, washed with EtOAc/hexane (1:1, 3 mL × 2), and dried under high vacuum to afford the title compound <b>9i</b> as a gray solid (0.340 g, 98%). Mp: 200 °C dec. HPLC: 100% [<i>t</i><sub>R</sub> = 4.28 min, 35% CH<sub>3</sub>OH in 0.1% TFA/water, 20 min]. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.50 (br s, 1H, disappeared on D<sub>2</sub>O shake), 8.76 (s, 1H, disappeared on D<sub>2</sub>O shake), 8.04 (s, 1H), 7.49 (d, <i>J</i> = 8.80 Hz, 2H), 6.92 (d, <i>J</i> = 8.85 Hz, 2H), 4.08–4.03 (m, 1H), 3.74–3.70 (m, 1H), 3.62–3.57 (m, 1H), 3.41 (t, <i>J</i> = 6.4 Hz, 2H), 3.24–3.22 (m, 8H), 1.91–1.74 (m, 3H), 1.61–1.54 (m, 1H). <sup>19</sup>F NMR (376 MHz, DMSO-<i>d</i><sub>6</sub>): δ −74.19 (s). LC–MS (ESI+): <i>m</i>/<i>z</i> 433.12 and 435.12 for Br isotopes (M + H)<sup>+</sup>. HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>26</sub>BrN<sub>6</sub>O (M + H)<sup>+</sup> 433.1346, found 433.1335.</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 5-Bromo-<i>N</i><sup>2</sup>-{4-[(4-carboxyethyl)piperidinyl]phenyl}-<i>N</i><sup>4</sup>-[(tetrahydrofuran-2-yl)methyl]pyrimidine-2,4-diamine [Intermediate for (±)-<b>9j</b>]</h3><div class="NLM_p last">A mixture of <b>8b</b> (0.200 g, 0.683 mmol) and ethyl 1-(4-aminophenyl)piperidine-4-carboxylate (0.186 g, 0.752 mmol) in EtOH (2 mL) was heated in a microwave reactor at 150 °C for 20 min. The precipitate obtained was filtered, washed with ethyl acetate, and dried under high vacuum to afford the title compound as a brown solid (0.070 mg, 22%). Mp: 137 °C dec. HPLC: 99.7% [<i>t</i><sub>R</sub> = 6.55 min, 45% CH<sub>3</sub>OH in water (0.1% TFA), 20 min]. <sup>1</sup>H NMR (400 MHz, DMSO) δ 8.96 (s, 1H), 7.94 (s, 1H), 7.50 (d, <i>J =</i> 8.8 Hz, 2H), 6.80 (d, <i>J =</i> 8.8 Hz, 2H), 6.74 (t, <i>J</i> = 6.4 Hz, 1H), 4.05 (q, <i>J</i> = 6.8 Hz, 2H), 3.75 (q, <i>J</i> = 7.6 Hz, 1H), 3.60 (q, <i>J</i> = 7.2 Hz, 1H), 3.49–3.88 (m, 5H), 2.64 (t, <i>J</i> = 11.2 Hz, 2H), 2.45–2.33 (m, 1H), 1.89–1.79 (m, 4H), 1.73–1.60 (m, 2H), 1.17 (t, <i>J</i> = 7.2, 3H). LC–MS (ESI+): <i>m</i>/<i>z</i> 503.2 (M + H)<sup>+</sup>. HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>23</sub>H<sub>30</sub>BrN<sub>5</sub>O<sub>3</sub> (M + H)<sup>+</sup> 504.1605, found 504.1597.</div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 5-Bromo-<i>N</i><sup>2</sup>-[4-(4-carboxypiperidinyl)phenyl]-<i>N</i><sup>4</sup>-[(tetrahydrofuran-2-yl)methyl]pyrimidine-2,4-diamine [(±)-<b>9j</b>]</h3><div class="NLM_p last">The ester intermediate (0.025 g, 0.050 mmol) (synthesized above) in THF (0.248 mL) and 2 M NaOH (0.200 mL) were stirred at room temperature for 18 h. The resulting solution was concentrated, and the product obtained was dissolved in water (2 mL). The aqueous solution was acidified with 1 M HCl to pH 4–5, and the solid mixture obtained was filtered to afford <b>9j</b> as a pure light brown solid (0.019 g, 81%). Mp: 129–133 °C. HPLC: 99.7% [<i>t</i><sub>R</sub> = 6.55 min, 45% CH<sub>3</sub>OH in water (0.1% TFA), 20 min]. <sup>1</sup>H NMR (400 MHz, DMSO) δ 12.19 (s, 1H), 8.95 (s, 1H), 7.93 (s, 1H), 7.49 (d, <i>J =</i> 9.2 Hz, 2H), 6.81 (d, <i>J =</i> 8.8 Hz, 2H), 6.74 (t, <i>J =</i> 5.6 Hz, 1H), 4.09–4.03 (m, 1H), 3.78–3.73 (m, 1H), 3.63–3.57 (m, 2H), 3.45 (dt, <i>J</i> = 12.4, 3.2 Hz, 1H), 3.42–3.39 (m, 1H), 2.61 (t, <i>J =</i> 9.2 Hz, 2H), 2.35–2.30 (m, 1H), 1.89–1.73 (m, 5H), 1.67–1.53 (m, 2H). LC–MS (ESI+): <i>m</i>/<i>z</i> 476.12 (M + H)<sup>+</sup>. HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>26</sub>BrN<sub>5</sub>O<sub>3</sub> (M + H) 476.1292, found 476.1285.</div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 5-Bromo-<i>N</i><sup>2</sup>-[4-(piperidin-4-yl)phenyl]-<i>N</i><sup>4</sup>-[(tetrahydrofuran-2-yl)methyl]pyrimidine-2,4-diamine [(±)-<b>9k</b>]</h3><div class="NLM_p last">A mixture of <b>8b</b> (0.047 g, 0.161 mmol) and 4-(piperidin-4-yl)aniline (0.028 g, 0.161 mmol) (synthesis described above) in EtOH (1 mL) and HCl (1 mL, 0.1 M aq solution) was heated in a microwave reactor at 150 °C for 40 min. The solvent was removed, and the residue was slurried with DCM, filtered, and dried under high vacuum to afford the title compound <b>9k</b> as a white solid (0.014 mg, 19%). Mp: 162 °C dec. HPLC: 98.8% [<i>t</i><sub>R</sub> = 2.50 min, 45% CH<sub>3</sub>OH in 0.1% TFA/water, 20 min]. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.01 (s, 1H), 7.47 (d, <i>J =</i> 8.0 Hz, 2H), 7.37 (d, <i>J =</i> 8.4 Hz, 2H), 4.18–4.12 (m, 1H), 3.83–3.76 (m, 1H), 3.75–3.69 (m, 1H), 3.59–3.49 (m, 4H), 3.15 (t, <i>J =</i> 12.8 Hz, 2H), 2.96 (t, <i>J =</i> 7.2 Hz, 1H), 2.10–1.87 (m, 7H), 1.66–1.58 (m, 1H). LC–MS (ESI+): <i>m</i>/<i>z</i> 432.13; (M + H)<sup>+</sup>. HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>27</sub>N<sub>5</sub>O (M + H)<sup>+</sup> 432.1394, found 432.1392.</div></div><div id="sec5_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 5-[(2-Chloro-6-fluorophenyl)carbamoyl]-<i>N</i><sup>2</sup>-{4-[(4-carboxyethyl)piperidinyl]phenyl}-<i>N</i><sup>4</sup>-[(tetrahydrofuran-2-yl)methyl]pyrimidine-2,4-diamine [Intermediate for (±)-<b>9l</b>]</h3><div class="NLM_p last">A mixture of <b>8c</b> (0.200 g, 0.519 mmol) and ethyl 1-(4-aminophenyl)piperidine-4-carboxylate (0.141 g, 0.571 mmol) in EtOH (2 mL) was heated in a microwave reactor at 150 °C for 20 min. The resulting precipitate was filtered, washed with ethyl acetate, and dried under high vacuum to afford the title compound as a gray solid (0.215 mg, 71%). Mp: 137–141 °C. HPLC: 94.1% [<i>t</i><sub>R</sub> = 12.01 min, gradient 5–95% CH<sub>3</sub>OH in water (0.1% formic acid), 20 min]. <sup>1</sup>H NMR (400 MHz, DMSO) δ 7.86 (s, 1H), 7.44 (d, <i>J =</i> 9.2 Hz, 2H), 6.95 (d, <i>J =</i> 9.2 Hz, 2H), 4.14 (q, <i>J</i> = 7.2 Hz, 3H), 3.88–3.86 (m, 1H), 3.77–3.72 (m, 1H), 3.62–3.44 (m, 4H), 2.73 (dt, <i>J</i> = 11.6, 2.4 Hz, 2H), 2.54–2.41 (m, 1H), 2.03–1.78 (m, 7H), 1.69–1.62 (m, 1H), 1.26 (t, <i>J</i> = 7.2 Hz, 3H). LC–MS (ESI+): <i>m</i>/<i>z</i> 597.21 (M + H)<sup>+</sup>. HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>30</sub>H<sub>37</sub>ClFN<sub>6</sub>O<sub>4</sub> (M + H)<sup>+</sup> 597.2388, found 597.2378.</div></div><div id="sec5_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 5-[(2-Chloro-6-fluorophenyl)carbamoyl]-<i>N</i><sup>2</sup>-[4-(4-carboxypiperidinyl)phenyl]-<i>N</i><sup>4</sup>-[(tetrahydrofuran-2-yl)methyl]pyrimidine-2,4-diamine [(±)-<b>9l</b>]</h3><div class="NLM_p last">The ester intermediate (0.100 g, 0.167 mmol) synthesized above in THF (1 mL) and 2 M NaOH (0.200 mL) were stirred at room temperature for 18 h. The resulting solution was concentrated, and the product obtained was dissolved in water (2 mL). The aqueous solution was acidified with HCl (1 M aq solution) to pH 4–5, and the solid mixture obtained was filtered to afford <b>9j</b> as a white solid (0.75 mg, 78%). Mp: 145.1 °C. HPLC: 99.3% [<i>t</i><sub>R</sub> = 4.20 min, 55% CH<sub>3</sub>OH in 0.1% TFA/water, 20 min]. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.23 (s, 1H), 9.84 (s, 1H), 9.49 (br s, 1H), 8.85 (br s, 1H), 8.73 (s, 1H), 7.57 (d, <i>J</i> = 7.6 Hz, 2H), 7.43–7.30 (m, 3H), 6.87 (d, <i>J</i> = 7.6 Hz, 2H), 4.01–3.98 (m, 1H), 3.76–3.71 (m, 1H), 3.62–3.50 (m, 4H), 3.43–3.38 (m, 1H), 2.66 (app t, 2H), 2.34 (app t, 1H), 1.94–1.77 (m, 5H), 1.67–1.48 (m, 3H). LC–MS (ESI+): <i>m</i>/<i>z</i> 569.2 (M + H)<sup>+</sup>. HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>28</sub>H<sub>31</sub>ClFN<sub>6</sub>O<sub>4</sub> (M + H)<sup>+</sup> 569.2074, found 569.2063.</div></div><div id="sec5_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> Boc Derivative of 5-[(2-Chloro-6-fluorophenyl)carbamoyl]-<i>N</i><sup>2</sup>-[4-(piperazin-1-yl]phenyl]-<i>N</i><sup>4</sup>-[(tetrahydrofuran-2-yl)methyl]pyrimidine-2,4-diamine [Intermediate for (±)-<b>9m</b>]</h3><div class="NLM_p last">A mixture of <b>8c</b> (0.308 g, 0.8 mmol) and <i>tert</i>-butyl 4-(4-aminophenyl)piperazine-1-carboxylate (0.222 g, 0.8 mmol) in 2-propanol (4 mL) was heated at 80 °C in a sealed tube for 5 h. The resulting precipitate was filtered upon cooling, washed with 2-propanol (2 mL × 3), and then dried under vacuum to afford the title compound as a light green solid (0.440 g, 83%). Mp: 184–186 °C. HPLC: 99.8% [<i>t</i><sub>R</sub> = 5.23 min, 70% CH<sub>3</sub>OH in 0.1% TFA/water, 20 min]. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.26 (br s, 1H, disappeared on D<sub>2</sub>O shake), 10.12 (br s, 1H, disappeared on D<sub>2</sub>O shake), 9.31 (br s, 1H, disappeared on D<sub>2</sub>O shake), 8.71 (s, 1H), 7.51–7.33 (m, 4H), 7.02 (app d, <i>J</i> = 6.0 Hz, 2H), 4.05–3.98 (m, 1H), 3.75–3.70 (m, 1H, overlapping with water peak), 3.63–3.57 (m, 1H, overlapping with water peak), 3.47–3.42 (m, 6H), 3.10 (br s, 4H), 1.93–1.88 (m, 1H), 1.83–1.76 (m, 2H), 1.56–1.48 (m, 1H), 1.40 (s, 9H). <sup>19</sup>F NMR (376 MHz, DMSO-<i>d</i><sub>6</sub>): δ −116.16 to −116.20 (m). LC–MS (ESI+): <i>m</i>/<i>z</i> 626.25 (M + H)<sup>+</sup>. HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>31</sub>H<sub>38</sub>ClFN<sub>7</sub>O<sub>4</sub> (M + H)<sup>+</sup> 626.2652, found 626.2651.</div></div><div id="sec5_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 5-[(2-Chloro-6-fluorophenyl)carbamoyl]-<i>N</i><sup>2</sup>-[(4-piperazin-1-yl]phenyl]-<i>N</i><sup>4</sup>-[(tetrahydrofuran-2-yl)methyl]pyrimidine-2,4-diamine Trifluoroacetate Salt [(±)-<b>9m</b>]</h3><div class="NLM_p last">To a solution of the Boc intermediate synthesized above (0.408 g, 0.616 mmol) in DCM (4 mL) at 0 °C was added TFA (4 mL). The reaction mixture was warmed to rt and stirred for 1 h. The solvent was removed under reduced pressure. The resulting residue was slurried in EtOAc/hexane (1:2) and sonicated. The precipitate was filtered, washed with EtOAc/hexane (1:1) (3 mL × 2), and dried under high vacuum to afford the title compound as a gray solid (0.400 g, 102%). Mp: 205 °C dec. HPLC: 99.5% [<i>t</i><sub>R</sub> = 4.44 min, 50% CH<sub>3</sub>OH in 0.1% TFA/water, 20 min]. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.99 (s, 1H, disappeared on D<sub>2</sub>O shake), 9.80 (br s, 1H, disappeared on D<sub>2</sub>O shake), 9.04 (br s, 1H, disappeared on D<sub>2</sub>O shake) 8.73 (s, 1H), 7.60 (d, <i>J</i> = 8.8 Hz, 2H), 7.44–7.31 (m, 3H), 6.96 (d, <i>J</i> = 8.8 Hz, 2H), 4.04–3.98 (m, 1H), 3.74–3.72 (m, 1H), 3.63–3.58 (m, 2H), 3.44–3.39 (m, 1H), 3.27–3.23 (m, 8H), 1.94–1.88 (m, 1H), 1.83–1.77 (m, 2H), 1.57–1.49 (m, 1H). <sup>19</sup>F NMR (376 MHz, DMSO-<i>d</i><sub>6</sub>): δ −74.24 (s, 3H), −116.17 to −116.21 (m, 1H). LC–MS (ESI+): <i>m</i>/<i>z</i> 526.22 (M + H)<sup>+</sup>. HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>30</sub>ClFN<sub>7</sub>O<sub>2</sub> (M + H)<sup>+</sup> 526.2128, found 526.2123.</div></div><div id="sec5_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 5-[(2-Chloro-6-fluorophenyl)carbamoyl]-<i>N</i><sup>2</sup>-[(4-morpholinophenyl]-<i>N</i><sup>4</sup>-[(tetrahydrofuran-2-yl)methyl]pyrimidine-2,4-diamine [(±)-<b>9n</b>]</h3><div class="NLM_p last">The chloropyrimidine <b>8c</b> (100 mg, 0.26 mmol) and 4-morpholinoaniline (0.069 g, 0.38 mmol) were mixed in a microwave tube with HCl (110 μL of a 4 M solution in dioxane). 2-Methoxyethanol (4.00 mL) was added to the mixture and the resulting mixture heated at 110 °C for 16 h. The resulting solution was concentrated, and the product was partitioned between CHCl<sub>3</sub> and saturated aqueous NaHCO<sub>3</sub>. The organic phase was then dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The resulting solid was slurried twice with dichloromethane and hexane, filtered, and dried under reduced pressure to yield <b>9n</b> as a light green solid (0.080 g). Mp: 231 °C dec. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): 8.50 (s, 1H), 7.38–7.37 (m, 4H), 7.24–7.19 (m, 1H), 7.08 (d, <i>J =</i> 8.8 Hz, 2H), 4.16–4.10 (m, 1H), 3.85 (t, <i>J =</i> 4.8 Hz, 4H), 3.76–3.59 (m, 3H), 3.20 (t, <i>J =</i> 4.8 Hz, 5H), 2.01–1.91 (m, 3H), 1.66–1.58 (m, 1H). HPLC–MS (ESI+): <i>m</i>/<i>z</i> 527.2 (100%). HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>27</sub>H<sub>31</sub>ClFN<sub>6</sub>O<sub>3</sub> (M + H) 527.1968, found 527.1962.</div></div><div id="sec5_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 5-[(2-Chloro-6-fluorophenyl)carbamoyl]-<i>N</i><sup>2</sup>-[(4-(piperidin-4-yl)phenyl]-<i>N</i><sup>4</sup>-[(tetrahydrofuran-2-yl)methyl]pyrimidine-2,4-diamine [(±)-<b>9o</b>]</h3><div class="NLM_p last">A mixture of chloropyrimidine <b>8c</b> (0.062 g, 0.161 mmol) and 4-piperidinylaniline (0.028 g, 0.161 mmol) in EtOH (1 mL) and HCl (1 mL of a 0.1 M aq solution) was heated in a microwave reactor at 150 °C for 40 min. The solvent was removed, and the resulting residue was slurried with DCM, filtered, and dried under high vacuum to afford the title compound <b>9o</b> as a solid (0.032 mg, 36%). Mp: 186 °C dec. HPLC: 89.4% [<i>t</i><sub>R</sub> = 10.37 min, 45% CH<sub>3</sub>OH in 0.1% TFA/water, 20 min]. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.60 (d, <i>J =</i> 4.0 Hz, 1H), 7.55 (d, <i>J =</i> 7.6 Hz, 2H), 7.40–7.38 (m, 3H),), 7.25–7.19 (m, 1H), 4.19–4.10 (m, 1H), 3.93–3.80 (m, 1H), 3.75–3.60 (m, 3H), 3.53–3.50 (d, <i>J =</i> 12.0 Hz, 2H), 3.16 (t, <i>J =</i> 10.4 Hz, 2H), 2.97 (t, <i>J =</i> 12.0 Hz, 1H), 2.11–1.89 (m, 6H), 1.67–1.60 (m, 1H). LC–MS (ESI+): <i>m</i>/<i>z</i> 525.2; (M + H)<sup>+</sup>. HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>27</sub>H<sub>31</sub>ClFN<sub>6</sub>O<sub>2</sub> (M + H)<sup>+</sup> 525.2176, found 525.2175.</div></div><div id="sec5_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 5-[(2-Chloro-6-fluorophenyl)carbamoyl]-<i>N</i><sup>2</sup>-[(3-fluoro-4-hydroxyphenyl)amino]-<i>N</i><sup>4</sup>-[(tetrahydrofuran-2-yl)methyl]pyrimidine-2,4-diamine [(±)-<b>9p</b>]</h3><div class="NLM_p last">This compound was synthesized according to the procedure described for <b>9o</b> using <b>8c</b> (0.050 g, 0.130 mmol), 4-amino-2-fluorophenol (0.017 g, 0.130 mmol), and EtOH (1 mL). A mixture of EtOAc/hexane was used for recrystallization to afford the title compound as a brown solid (0.051 g, 76%). Mp: 183 °C dec. HPLC: 99.4% [<i>t</i><sub>R</sub> = 6.53 min, 55% CH<sub>3</sub>OH in 0.1% TFA/water, 20 min]. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.54 (s, 1H), 7.43–7.38 (m, 3H), 7.24–7.19 (m, 1H), 7.10 (d, <i>J</i> = 8.4 Hz, 1H), 6.96 (t, <i>J</i> = 8.4 Hz, 1H), 4.15–4.09 (m, 1H), 3.90–3.85 (m, 1H), 3.77–3.59 (m, 3H), 2.05–1.99 (m, 1H), 1.96–1.88 (m, 1H), 1.67–1.58 (m, 1H). <sup>19</sup>F NMR (376 MHz, CD<sub>3</sub>OD): δ −118.25 (d). LC–MS (ESI+): <i>m</i>/<i>z</i> 476.12 (M + H)<sup>+</sup>. HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>21</sub>F<sub>2</sub>N<sub>5</sub>O<sub>3</sub> (M + H)<sup>+</sup> 476.1296, found 476.1290.</div></div><div id="sec5_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 5-[(2-Chloro-6-fluorophenyl)carbamoyl]-<i>N</i><sup>2</sup>-[(4-methoxyphenyl)amino]-<i>N</i><sup>4</sup>-[(tetrahydrofuran-2-yl)methyl]pyrimidine-2,4-diamine [(±)-<b>9q</b>]</h3><div class="NLM_p last">A mixture of <b>8c</b> (0.050 g, 0.130 mmol), 4-methoxyaniline (0.016 g, 0.132 mmol), and HCl (0.033 mL of a 4 M solution in dioxane, 0.132 mmol) in dioxane (1 mL) was heated in a microwave reactor at 180 °C for 30 min. The mixture was evaporated to dryness, EtOAc was added (5 mL), and the resulting mixture was sonicated. The resulting solid was filtered, washed with satd NaHCO<sub>3</sub> (5 mL × 2) and water (5 mL × 2), and dried under vacuum to afford the title compound <b>9q</b> as a pure white solid (0.051 g, 84%). Mp: 201 °C dec. HPLC: 99.5% [<i>t</i><sub>R</sub> = 4.37 min, 65% CH<sub>3</sub>OH in 0.1% TFA/water, 20 min]. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.22 (s, 1H), 10.06 (br s, 1H), 9.27 (br s, 1H), 8.72 (s, 1H), 7.54 (app d, <i>J</i> = 7.6 Hz, 2H), 7.45–7.32 (m, 3H), 6.93 (d, <i>J</i> = 8.8 Hz, 2H), 4.04–3.98 (m, 1H), 3.75–3.70 (m, 4H), 3.61–3.55 (m, 3H), 1.95–1.87 (m, 1H), 1.82–1.76 (m, 2H), 1.56–1.48 (m, 1H). <sup>19</sup>F NMR (376 MHz, DMSO-<i>d</i><sub>6</sub>): δ −116.16 to −116.19 (m). LC–MS (ESI+): <i>m</i>/<i>z</i> 472.14 (M + H)<sup>+</sup>. HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>23</sub>H<sub>24</sub>ClFN<sub>5</sub>O<sub>3</sub> (M + H)<sup>+</sup> 472.1546, found 472.1548.</div></div><div id="sec5_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 5-[(2-Chloro-6-fluorophenyl)carbamoyl]-<i>N</i><sup>2</sup>-[(4-hydroxyphenyl)amino]-<i>N</i><sup>4</sup>-[(tetrahydrofuran-2-yl)methyl]pyrimidine-2,4-diamine [(±)-<b>9r</b>]</h3><div class="NLM_p last">This compound was synthesized using the procedure described for <b>9q</b> using pyrimidine <b>8c</b> (0.050 g, 0.130 mmol) and 4-aminophenol (0.017 g, 0.156 mmol) to obtain the title compound <b>9r</b> as a beige solid (0.046 g, 78%). Mp: 263 °C dec. HPLC: 99.4% [<i>t</i><sub>R</sub> = 6.77 min, 55% CH<sub>3</sub>OH in 0.1% TFA/water, 20 min]. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.82 (s, 1H), 9.41 (br s, 1H), 9.09 (s, 1H), 8.83 (br s, 1H), 8.72 (s, 1H), 7.49 (d, <i>J</i> = 8.4 Hz, 2H), 7.43–7.30 (m, 3H), 6.67 (d, <i>J</i> = 8.8 Hz, 2H), 4.02–3.98 (m, 1H), 3.76–3.71 (m, 1H), 3.62–3.57 (m, 2H), 3.42–3.37 (m, 1H), 1.93–1.87 (m, 1H), 1.84–1.75 (m, 2H), 1.56–1.47 (m, 1H). <sup>19</sup>F NMR (376 MHz, DMSO-<i>d</i><sub>6</sub>): δ −116.15 to −116.19 (m). LC–MS (ESI+): <i>m</i>/<i>z</i> 458.13 (M + H)<sup>+</sup>. HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>22</sub>ClFN<sub>5</sub>O<sub>3</sub> (M + H)<sup>+</sup> 458.1390, found 458.1390.</div></div><div id="sec5_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 5-Fluoro-<i>N</i><sup>2</sup>-[(4-hydroxy-3-fluorophenyl)amino]-<i>N</i><sup>4</sup>-[(tetrahydrofuran-2-yl)methyl]pyrimidine-2,4-diamine Hydrochloride [(±)-<b>9s</b>]</h3><div class="NLM_p last">A mixture of pyrimidine <b>8d</b> (0.116 g, 0.5 mmol) and 4-amino-2-fluorophenol (0.064 g, 0.5 mmol) in EtOH (2 mL) was heated in a microwave reactor at 150 °C for 20 min. The solvent was removed, and the resulting residue was slurried and sonicated with EtOAc (3 mL). The mixture was filtered, and the precipitate was washed with EtOAc (2 mL) and then dried under high vacuum to afford the title compound as a dark brown solid (0.152 g, 84%). Mp: 201 °C dec. HPLC: 98.5% [<i>t</i><sub>R</sub> = 7.72 min, 35% CH<sub>3</sub>OH in 0.1% TFA/water, 20 min]. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.23 (s, 1H), 9.87 (br s, 1H), 10.18 (s, 1H), 9.19 (br s, 1H), 8.08 (d, <i>J</i> = 5.2 Hz, 1H), 7.43 (dd, <i>J</i> = 13.2, 2.0 Hz, 1H), 7.01 (dd, <i>J</i> = 8.8, 1.6 Hz, 1 H), 6.94 (t, <i>J</i> = 9.6 Hz, 1H), 4.07–4.01 (m, 1H), 3.75–3.69 (m, 1H), 3.63–3.58 (m, 1H), 1.93–1.85 (m, 1H), 1.83–1.75 (m, 2H), 1.59–1.51 (m, 1H). <sup>19</sup>F NMR (376 MHz, DMSO-<i>d</i><sub>6</sub>): δ −134.70 (s), −163.23 (s). LC–MS (ESI+): <i>m</i>/<i>z</i> 323.14 (M + H)<sup>+</sup>. HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>15</sub>H<sub>17</sub>F<sub>2</sub>N<sub>4</sub>O<sub>2</sub> (M + H)<sup>+</sup> 323.1314, found 323.1314.</div></div><div id="sec5_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> 5-Methyl-<i>N</i><sup>2</sup>-[(4-hydroxy-3-fluorophenyl)amino]-<i>N</i><sup>4</sup>-[(tetrahydrofuran-2-yl)methyl]pyrimidine-2,4-diamine Hydrochloride [(±)-<b>9t</b>]</h3><div class="NLM_p last">A suspension of pyrimidine <b>8e</b> (0.114 g, 0.5 mmol) and 4-amino-2-fluorophenol (0.064 g, 0.5 mmol) in EtOH (1 mL) was heated in a microwave reactor at 150 °C for 20 min. The mixture was concentrated, and the residue obtained was recrystallized with MeOH/EtOAc, filtered, and washed with EtOAc (2 mL) to afford the title compound <b>9t</b> as a dark brown solid. The filtrate was concentrated and recrystallized again with MeOH/EtOAc to afford a second crop of solid. The solids were combined to afford the title compound <b>9t</b> as a dark brown solid (0.163 g, 92%). Mp: 199 °C dec. HPLC: 98.8% [<i>t</i><sub>R</sub> = 12.26 min, 35% CH<sub>3</sub>OH in 0.1% TFA/water, 20 min]. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.45 (s, 1H), 7.29 (dd, <i>J</i> = 12.0, 1.6 Hz, 1H), 7.03–6.93 (m, 2H), 4.20–4.13 (m, 1H), 3.88–3.83 (m, 1H), 3.78–3.72 (m, 1H), 3.64–3.51 (m, 2H), 2.04 (s, 3H), 1.96–1.87 (m, 2H), 1.66–1.57 (m, 1H). <sup>19</sup>F NMR (376 MHz, CD<sub>3</sub>OD): δ −136.94 (s). LC–MS (ESI+): <i>m</i>/<i>z</i> 319.16 (M + H)<sup>+</sup>. HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>16</sub>H<sub>20</sub>FN<sub>4</sub>O<sub>2</sub> (M + H)<sup>+</sup> 319.1565, found 319.1566.</div></div><div id="sec5_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> 5-Bromo-<i>N</i><sup>2</sup>-[(4-hydroxy-3-fluorophenyl)amino]-<i>N</i><sup>4</sup>-[(tetrahydrofuran-2-yl)methyl]pyrimidine-2,4-diamine [(±)-<b>13</b>]</h3><div class="NLM_p last">A mixture of pyrimidine <b>8b</b> (0.400 g, 1.4 mmol) and 4-amino-2-fluorophenol (0.174 g, 1.4 mmol) in EtOH (3 mL) in a microwave vial was heated to 150 °C for 20 min in a microwave reactor. The solvent was evaporated, and the residue obtained was washed with ethyl acetate, slurried with dichloromethane and hexane, and filtered to afford <b>13</b> as a pure beige solid (0.580 g, 98%). Mp: 205–207 °C. HPLC: 94% [<i>t</i><sub>R</sub> = 6.33 min, 40% CH<sub>3</sub>OH in 0.1% TFA/water, 20 min]. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.20 (s, 1H), 9.83 (br s, 1H), 8.34 (br s, 1H), 8.16 (s, 1H), 7.44 (dd, <i>J</i> = 12.8, 2.0 Hz, 1H), 7.02 (dd, <i>J</i> = 8.4, 1.2 Hz, 1H), 6.91 (t, <i>J</i> = 8.4 Hz, 1H), 4.07–4.01 (m, 1H), 3.72–3.67 (m, 1H), 3.60–3.55 (m, 1H), 3.42–3.37 (m, 2H), 1.88–1.71 (m, 3H), 1.56–1.48 (m, 1H). HPLC–MS (ESI+): <i>m</i>/<i>z</i> 383 and 385 for Br isotopes (M + H)<sup>+</sup>. HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>15</sub>H<sub>17</sub>BrFN<sub>4</sub>O<sub>2</sub> (M + H)<sup>+</sup> 383.0513, found 383.0513.</div></div><div id="sec5_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> 5-[(2-Chloro-6-fluorophenyl)carbamoyl]-<i>N</i><sup>2</sup>-(3-fluoro-4-hydroxyphenyl)-<i>N</i><sup>4</sup>-[(tetrahydrofuran-2-yl)methyl]pyrimidine-2,4-diamine Hydrochloride [(±)-<b>14</b>]</h3><div class="NLM_p last">This compound was synthesized using the procedure described for <b>9t</b> except using <b>8c</b> (0.050 g, 0.130 mmol), 4-amino-2-fluorophenol (0.017 g, 0.130 mmol), and EtOH (1 mL). EtOAc/hexane was used for recrystallization to afford the title compound as a brown solid (0.051 g, 76%). Mp: 183 °C dec. HPLC: 99.4% [<i>t</i><sub>R</sub> = 6.53 min, 55% CH<sub>3</sub>OH in 0.1% TFA/water, 20 min]. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.54 (s, 1H), 7.43–7.38 (m, 3H), 7.24–7.19 (m, 1H), 7.10 (d, <i>J</i> = 8.4 Hz, 1H), 6.96 (t, <i>J</i> = 8.4 Hz, 1H), 4.15–4.09 (m, 1H), 3.90–3.85 (m, 1H), 3.77–3.59 (m, 3H), 2.05–1.99 (m, 1H), 1.96–1.88 (m, 2H), 1.67–1.58 (m, 1H). <sup>19</sup>F NMR (376 MHz, CD<sub>3</sub>OD): δ −118.25 (d). LC–MS (ESI+): <i>m</i>/<i>z</i> 476.12 (M + H)<sup>+</sup>. HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>21</sub>F<sub>2</sub>N<sub>5</sub>O<sub>3</sub> (M + H)<sup>+</sup> 476.1296, found 476.1290.</div></div><div id="sec5_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> 5-Chloro-<i>N</i><sup>2</sup>-(4-hydroxyphenyl)-<i>N</i><sup>4</sup>-[(tetrahydrofuran-2-yl)methyl]pyrimidine-2,4-diamine Hydrochloride [(±)-<b>15</b>]</h3><div class="NLM_p last">A mixture of <b>8a</b> (0.050 g, 0.20 mmol) and 4-aminophenol (0.024 g, 0.22 mmol) in EtOH (0.500 mL) in a microwave vial was heated to 150 °C for 20 min in a microwave reactor. The precipitate formed upon cooling the mixture was filtered, washed with ethyl acetate, slurried with dichloromethane and hexane, and filtered to afford <b>15</b> as a brown solid (0.027 g, 42%). Mp: 214.0 °C dec. HPLC: 100% [<i>t</i><sub>R</sub> = 8.90 min, gradient 5–95% CH<sub>3</sub>OH in water (0.1% formic acid), 20 min]. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.85 (s, 1H), 9.43 (s, 1H), 8.45 (s, 1H), 8.03 (s, 1H) 7.27 (d, <i>J =</i> 8.8 Hz, 2H), 6.74 (d, <i>J =</i> 8.8 Hz, 2H), 4.08–4.01 (m, 1H), 3.73–3.68 (m, 1H), 3.62–3.57 (m, 2H), 1.90–1.74 (m, 3H), 1.58–1.50 (m, 1H). LC–MS (ESI+): <i>m</i>/<i>z</i> 320.10400 (M + H)<sup>+</sup>. HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>15</sub>H<sub>17</sub>ClN<sub>4</sub>O<sub>2</sub> (M + H) 321.11128, found 321.11161.</div></div><div id="sec5_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> 5-Bromo-<i>N</i><sup>2</sup>-(4-hydroxyphenyl)-<i>N</i><sup>4</sup>-[(tetrahydrofuran-2-yl)methyl]pyrimidine-2,4-diamine Hydrochloride [(±)-<b>16</b>]</h3><div class="NLM_p last">A mixture of <b>8b</b> (0.500 g, 1.7 mmol) and 4-aminophenol (0.186 g, 1.7 mmol) in EtOH (5 mL) in a microwave vial was heated to 150 °C for 20 min in a microwave reactor. The solvent was evaporated, and the residue obtained was filtered, washed with ethyl acetate, slurried with dichloromethane and hexane, and filtered to afford <b>16</b> as a gray solid (0.70 g, 99%). Mp: 188 °C dec. HPLC: 95.7% [<i>t</i><sub>R</sub> = 5.83 min, 40% CH<sub>3</sub>OH in water (0.1% TFA), 20 min]. <sup>1</sup>H NMR (400 MHz, CD3OD): δ 7.90 (s, 1H), 7.22 (d, <i>J</i> = 8.4 Hz, 2H), 6.85 (d, <i>J</i> = 8.4 Hz, 2H), 4.16–4.13 (m, 1H), 3.84–3.82 (m, 1H), 3.76–3.71 (m, 1H), 3.56 (d, <i>J</i> = 5.6 Hz, 2H), 2.01–1.89 (m, 3H), 1.63–1.58 (m, 1H). LC–MS (ESI+): <i>m</i>/<i>z</i> 367 (M + H)<sup>+</sup>. HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>15</sub>H<sub>17</sub>BrN<sub>4</sub>O<sub>2</sub> (M + H) 365.0607, found 365.0586.</div></div><div id="sec5_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> 5-Bromo-<i>N</i><sup>2</sup>-(4-hydroxy-3-methylphenyl)-<i>N</i><sup>4</sup>-[(tetrahydrofuran-2-yl)methyl]pyrimidine-2,4-diamine Hydrochloride [(±)-<b>17</b>]</h3><div class="NLM_p last">A mixture of <b>8b</b> (0.400 g, 1.4 mmol) and 4-aminophenol (0.168 g, 1.4 mmol) in EtOH (3 mL) in a microwave vial was heated to 150 °C for 20 min in a microwave reactor. The solvent was evaporated, and the residue obtained was washed with ethyl acetate, slurried with dichloromethane and hexane, and filtered to afford <b>17</b> as a pure gray solid (0.60 g, 99%). Mp: 206–209 °C. HPLC: 96% [<i>t</i><sub>R</sub> = 5.64 min, 45% CH<sub>3</sub>OH in 0.1% TFA/water, 20 min] <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.86 (s, 1H), 7.11 (s, 1H), 7.03(d, <i>J</i> = 8.0 Hz, 1H), 6.80 (d, <i>J</i> = 8.4 Hz, 1H), 4.18–4.13 (m, 1H), 3.86–3.82 (m, 1H), 3.76–3.71 (m, 1H), 3.57 (d, <i>J</i> = 5.6 Hz, 2H), 2.20 (s, 3H), 2.01–1.90 (m, 3H), 1.65–1.57 (m, 1H). LC–MS (ESI+): <i>m</i>/<i>z</i> 367 (M + H)<sup>+</sup>. HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>16</sub>H<sub>20</sub>BrN<sub>4</sub>O<sub>2</sub> (M + H) 379.0764, found 379.0760.</div></div><div id="sec5_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> 5-Bromo-<i>N</i><sup>2</sup>-(4-methoxyphenyl)-<i>N</i><sup>4</sup>-[(tetrahydrofuran-2-yl)methyl]pyrimidine-2,4-diamine Hydrochloride [(±)-<b>18</b>]</h3><div class="NLM_p last">A mixture of <b>8b</b> (0.100 g, 0.34 mmol) and 4-methoxyaniline (0.040 g, 0.34 mmol) in EtOH (2 mL) in a microwave vial was heated to 150 °C for 20 min in a microwave reactor. The solvent was evaporated, and the residue obtained was washed with ethyl acetate, slurried with dichloromethane and hexane, and filtered to afford <b>18</b> as a brown solid (0.134 g, 93%). Mp: 192 °C dec. HPLC: 95.6% [<i>t</i><sub>R</sub> = 9.89 min, 45% CH<sub>3</sub>OH in water (0.1% TFA), 20 min]. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.91 (s, 1H), 7.34 (d, <i>J</i> = 8.8 Hz, 2H), 6.99 (d, <i>J</i> = 8.8 Hz, 2H), 4.16–4.13 (m, 1H), 3.87–3.79 (m, 4H), 3.82 (s, 3H), 3.56 (d, <i>J</i> = 5.6 Hz, 2H), 2.00–1.88 (m, 3H), 1.65–1.59 (m, 1H). LC–MS (ESI+): <i>m</i>/<i>z</i> 379 and 381 for Br isotopes (M + H)<sup>+</sup>. HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>16</sub>H<sub>19</sub>BrN<sub>4</sub>O<sub>2</sub> (M + H) 379.0764, found 379.0766.</div></div><div id="sec5_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> 5-Bromo-<i>N</i><sup>2</sup>-[4-(4-methylpiperazin-1-yl)phenyl]-<i>N</i><sup>4</sup>-[(tetrahydrofuran-2-yl)methyl]pyrimidine-2,4-diamine [(±)-<b>19</b>]</h3><div class="NLM_p last">The piperazine <b>9i</b> (0.055 g, 0.10 mmol), iodomethane (0.014 g, 0.10 mmol), and potassium carbonate (0.55 g, 0.40 mmol) were mixed in MeOH (2 mL) and stirred at room temperature for 8 h. The mixture was then concentrated under reduce pressure, and the solid was purified by flash chromatography (5 g of silica gel, 0–5% MeOH) to afford <b>19</b> as a yellow solid (0.012 g, 27%). Mp: 123 °C dec. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.97 (s, 1H), 7.94 (s, 1H), 7.54 (d, <i>J =</i> 8.8 Hz, 2H), 6.83 (d, <i>J =</i> 8.8 Hz, 2H), 6.75 (t, <i>J =</i> 5.6 Hz, 1H), 4.08–4.03 (m, 1H), 3.78–3.73 (m, 1H), 3.63–3.58 (m, 1H), 3.43–3.40 (m, 2H), 3.05 (br s, 4H), 2.54 (br s, 4H, partially overlapped with DMSO signal), 2.29 (s, 3H), 1.91–1.56 (m, 3H), 1.63–1.56 (m, 1H). LC–MS (ESI+): <i>m</i>/<i>z</i> 446.14297 (M + H)<sup>+</sup>. HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>15</sub>H<sub>17</sub>ClN<sub>4</sub>O<sub>2</sub> (M + H) 447.1502, found 447.1493.</div></div><div id="sec5_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> 5-[(2-Chloro-6-fluorophenyl)carbamoyl]-<i>N</i><sup>2</sup>-[4-(4-methylpiperazin-1-yl)phenyl]-<i>N</i><sup>4</sup>-[(tetrahydrofuran-2-yl)methyl]pyrimidine-2,4-diamine [(±)-<b>20</b>]</h3><div class="NLM_p last">The chloropyrimidine <b>8c</b> (0.150 g, 0.390 mmol) and 4-(4-methylpiperazin-1-yl)aniline (0.082 g, 0.430 mmol) were mixed in a microwave vial with HCl (110 μL of 4 M solution in dioxane). 2-Methoxyethanol (4.00 mL) was added to the mixture, and the resulting solution was heated at 110 °C for 16 h. The resulting solution was concentrated under reduced pressure, and the product was partitioned between CHCl<sub>3</sub> and saturated aqueous NaHCO<sub>3</sub>. The organic phase was then dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure. The resulting solid was slurried twice with dichloromethane and hexane, filtered, and dried under reduced pressure to yield <b>20</b> as a dark gray solid (0.097 g, 47%). Mp: 210.4 °C dec. HPLC: 90.8% [<i>t</i><sub>R</sub> = 10.2 min, gradient 5–95% CH<sub>3</sub>OH in water (0.1% formic acid), 20 min]. <sup>1</sup>H NMR (400 MHz, DMSO) δ 9.83 (s, 1H), 9.46 (s, 1H), 8.85 (s, 1H), 8.73 (s, 1H), 7.598 (d, <i>J =</i> 8.8 Hz, 2H), 7.43–7.30 (m, 3H), 6.86 (d, <i>J =</i> 8.8 Hz, 2H), 4.01–3.90 (m, 1H), 3.77–3.72 (m, 1H), 3.61–3.59 (m, 2H), 3.44–3.39 (m, 2H), 3.04 (app t, <i>J =</i> 4.0 Hz, 4H), 2.42 (app t, <i>J =</i> 4.4 Hz, 4H), 2.20 (s, 3H), 1.96–1.78 (m, 3H), 1.57–1.49 (m, 1H). LC–MS (ESI+): <i>m</i>/<i>z</i> 539.22118 (M + H)<sup>+</sup>. HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>27</sub>H<sub>31</sub>ClN<sub>7</sub>O<sub>2</sub> (M + H) 540.2284, found 540.2283.</div></div><div id="sec5_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> <i>N</i><sup>2</sup>-[4-(4-Methylpiperazin-1-yl)phenyl]-<i>N</i><sup>4</sup>-[(tetrahydrofuran-2-yl)methyl]pyrimidine-2,4-diamine [(±)-<b>21</b>]</h3><div class="NLM_p last">2-Chloro-<i>N</i>-((tetrahydrofuran-2-yl)methyl)pyrimidin-4-amine (0.150 g, 0.0.70 mmol) and 4-(4-methylpiperazin-1-yl)aniline (0.148 g, 0.0.77 mmol) were mixed in a microwave vial with HCl (140 μL of a 4 M solution in dioxane). The solvent 2-methoxyethanol (4.00 mL) was added to the mixture, and the resulting solution was heated at 110 °C for 16 h. The resulting solution was concentrated, and the product was partitioned between CHCl<sub>3</sub> and saturated aqueous NaHCO<sub>3</sub>. The organic phase was then dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure. The resulting solid was slurried twice with dichloromethane and hexane, filtered, and dried under reduced pressure to yield <b>21</b> as a dark brown solid (0.108 g, 58%). Mp: 212 °C dec. HPLC: 99.9% [<i>t</i><sub>R</sub> = 9.36 min, 55% CH<sub>3</sub>OH in water (0.1% TFA), 20 min]. <sup>1</sup>H NMR (400 MHz, DMSO) δ 8.64 (s, 1H), 7.71 (br s, 1H), 7.56 (d, <i>J =</i> 9.2 Hz, 2H), 7.16 (br s, 1H), 6.79 (d, <i>J =</i> 9.2, 2H), 5.88 (d, <i>J =</i> 5.6 Hz, 1H), 3.99–3.93 (m, 1H), 3.77–3.74 (m, 1H), 3.64–3.58 (m, 2H), 3.00 (t, <i>J =</i> 5.2 Hz, 4H), 2.42 (t, <i>J =</i> 4.8 Hz, 4H), 2.19 (s, 3H), 1.92–1.77 (m, 3H), 1.57–1.50 (m, 1H). LC–MS (ESI+): <i>m</i>/<i>z</i> 369.23246 (M + H)<sup>+</sup>. HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>28</sub>N<sub>6</sub>O (M + H) 369.2397, found 369.2407.</div></div><div id="sec5_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> 4-(4-{4-[[5-((2-Chloro-6-fluorophenyl)carbamoyl)-4-(((tetrahydrofuran-2-yl)methyl)amino)pyrimidin-2-yl]amino]phenyl}piperazin-1-yl)-4-oxobutanoic Acid [(±)-<b>22</b>]</h3><div class="NLM_p last">To a suspension of <b>9m</b> (0.096 g, 0.15 mmol) in chloroform (2 mL) under an inert atmosphere was added DIPEA (0.194 g, 1.5 mmol). The mixture became a clear solution and was cooled to 0 °C. Succinic anhydride (0.015 g, 0.15 mmol) was added slowly, and the reaction mixture was warmed to rt and stirred for 1 h. The solvent was removed under reduced pressure. The resulting residue was sonicated in water (5 mL), filtered, washed with water (3 mL), and dried under vacuum to afford the title compound <b>22</b> as a light green solid (0.084 g, 89%). Mp: 189 °C dec. HPLC: 99.0% [<i>t</i><sub>R</sub> = 3.71 min, 60% CH<sub>3</sub>OH in 0.1% TFA/water, 20 min]. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.03 (s, 1H, disappeared on D<sub>2</sub>O shake), 9.84 (s, 1H, disappeared on D<sub>2</sub>O shake), 9.51 (s, 1H, disappeared on D<sub>2</sub>O shake), 8.85 (s, 1H, disappeared on D<sub>2</sub>O shake), 8.73 (s, 1H), 7.61 (d, <i>J</i> = 8.8 Hz, 2H), 7.43–7.30 (m, 3H), 6.90 (d, <i>J</i> = 8.8 Hz, 2H), 4.03–3.97 (m, 1H), 3.75–3.71 (m, 1H), 3.62–3.57 (m, 6H), 3.44–3.39 (m, 1H), 3.07 (br t, 2H), 3.00 (br t, 2H), 2.56 (t, <i>J</i> = 6.4 Hz, 2H), 2.42 (t, <i>J</i> = 5.6 Hz, 2H), 1.96–1.89 (m, 1H), 1.85–1.78 (m, 2H), 1.57–1.49 (m, 1H). <sup>19</sup>F NMR (376 MHz, DMSO-<i>d</i><sub>6</sub>): δ −116.16 to −116.19 (m). LC–MS (ESI+): <i>m</i>/<i>z</i> 626.22; (M + H)<sup>+</sup>. HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>30</sub>H<sub>34</sub>ClFN<sub>7</sub>O<sub>5</sub> (M + H)<sup>+</sup> 626.2289, found 626.2289.</div></div><div id="sec5_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> Plasma Stabilities of (<i>R</i>)-<b>9b</b> and (<i>S</i>)-<b>9b</b></h3><div class="NLM_p">The in vitro human plasma stabilities of compounds (<i>R</i>)-<b>9b</b> and (<i>S</i>)-<b>9b</b> were evaluated using HPLC analysis in a time-course experiment for up to 24 h.</div><div class="NLM_p last">A compound [(<i>R</i>)-<b>9a</b>, (<i>S</i>)-<b>9a</b>, procaine, and procainamide, 5 μL of 10 mM stock solutions in DMSO] was added to human plasma (195 μL), and a clear solution was obtained. This mixture was incubated at 37 °C for 0 min, 15 min, 30 min, 1 h, 2 h, 4 h, 8 h, and 24 h. After the incubation time MeOH (400 μL) was added to the sample vial. A white precipitate was observed, and the mixture was centrifuged for 15 min. An aliquot (400 μL) of the supernatant was removed from the mixture, and 60 μL was injected for analysis by HPLC. The percentage of the compound remaining vs time showed the stability of each compound in human plasma. Procaine and procainamide were run as unstable and stable standards, respectively.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i72"><a href="/doi/suppl/10.1021/jm501929n">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13476" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13476" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Synthetic protocols for preparation of sulfides <b>10a</b>–<b>d</b>, sulfones <b>11a</b>–<b>d</b>, sulfides and sulfones <b>12a</b>–<b>r</b>, and compounds <b>23</b>–<b>42</b> and Figures S1 and S2 showing (<i>R</i>)-<b>9b</b> superposed in JAK2 and ALK. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm501929n/suppl_file/jm501929n_si_001.pdf">jm501929n_si_001.pdf (617.22 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm501929n" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31463" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31463" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Harshani R. Lawrence</span> - <span class="hlFld-Affiliation affiliation">Department
of Oncologic Sciences, University of South
Florida, Tampa, Florida 33620, United
States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#7e361f0c0d161f101750321f090c1b101d1b3e13111818170a0a50110c19"><span class="__cf_email__" data-cfemail="2e664f5c5d464f404700624f595c4b404d4b6e43414848475a5a00415c49">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nupam P. Mahajan</span> - <span class="hlFld-Affiliation affiliation">Department
of Oncologic Sciences, University of South
Florida, Tampa, Florida 33620, United
States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#703e0500111d5e3d1118111a111e301d1f16161904045e1f0217"><span class="__cf_email__" data-cfemail="e2ac9792838fccaf838a8388838ca28f8d84848b9696cc8d9085">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nicholas J. Lawrence</span> - <span class="hlFld-Affiliation affiliation">Department
of Oncologic Sciences, University of South
Florida, Tampa, Florida 33620, United
States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#9cd2f5fff4f3f0fdefb2d0fdebeef9f2fff9dcf1f3fafaf5e8e8b2f3eefb"><span class="__cf_email__" data-cfemail="a0eec9c3c8cfccc1d38eecc1d7d2c5cec3c5e0cdcfc6c6c9d4d48ecfd2c7">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kiran Mahajan</span> - <span class="hlFld-Affiliation affiliation">Department
of Oncologic Sciences, University of South
Florida, Tampa, Florida 33620, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yunting Luo</span> - <span class="hlFld-Affiliation affiliation">†Drug Discovery Department and ‡Chemical Biology
Core, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, Florida 33612, United
States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Oncologic Sciences, University of South
Florida, Tampa, Florida 33620, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel Zhang</span> - <span class="hlFld-Affiliation affiliation">†Drug Discovery Department and ‡Chemical Biology
Core, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, Florida 33612, United
States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Oncologic Sciences, University of South
Florida, Tampa, Florida 33620, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nathan Tindall</span> - <span class="hlFld-Affiliation affiliation">†Drug Discovery Department and ‡Chemical Biology
Core, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, Florida 33612, United
States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Oncologic Sciences, University of South
Florida, Tampa, Florida 33620, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Miles Huseyin</span> - <span class="hlFld-Affiliation affiliation">†Drug Discovery Department and ‡Chemical Biology
Core, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, Florida 33612, United
States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Oncologic Sciences, University of South
Florida, Tampa, Florida 33620, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Harsukh Gevariya</span> - <span class="hlFld-Affiliation affiliation">†Drug Discovery Department and ‡Chemical Biology
Core, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, Florida 33612, United
States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Oncologic Sciences, University of South
Florida, Tampa, Florida 33620, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sakib Kazi</span> - <span class="hlFld-Affiliation affiliation">†Drug Discovery Department and ‡Chemical Biology
Core, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, Florida 33612, United
States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Oncologic Sciences, University of South
Florida, Tampa, Florida 33620, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sevil Ozcan</span> - <span class="hlFld-Affiliation affiliation">†Drug Discovery Department and ‡Chemical Biology
Core, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, Florida 33612, United
States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Oncologic Sciences, University of South
Florida, Tampa, Florida 33620, United
States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">H.R.L., K.M., N.P.M. and N.J.L. are named as inventors on US patent application 60/862,763 titled “Inhibitors of ACK1/TNK2 Tyrosine Kinase.”<br /></br></div></li></ul></div><div class="ack" id="ACK-d3323e6671-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i73">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83802" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83802" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work is supported in part by a Department of Defense grant (W81XWH-12-1-0248) to K.M. and by a National Cancer Institute, NIH/NCI, grant (1R01CA135328) and Department of Defense grants (W81XWH-14-1-0002 and W81XWH-14-1-0003) to N.P.M. This work has been supported in part by the Chemical Biology Core Facility (Chemistry Unit for synthesis and analytical chemistry support and Structural Biology Unit for production and purification of ACK1) at the H. Lee Moffitt Cancer Center & Research Institute, an NCI-designated Comprehensive Cancer Center (Grant P30-CA076292).</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i74" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i74"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i75" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i75"> Abbreviations Used</h2><tr><td class="NLM_term">ACK1</td><td class="NLM_def"><p class="first last">activated CDC42-associated kinase 1</p></td></tr><tr><td class="NLM_term">AR</td><td class="NLM_def"><p class="first last">androgen receptor</p></td></tr><tr><td class="NLM_term">CRPC</td><td class="NLM_def"><p class="first last">castration-resistant prostate cancer</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i76">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17538" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17538" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 42 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Mahajan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahajan, N. P.</span><span> </span><span class="NLM_article-title">ACK1 tyrosine kinase: targeted inhibition to block cancer cell proliferation</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">338</span><span class="NLM_x">, </span> <span class="NLM_fpage">185</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm501929n&amp;key=10.1016%2Fj.canlet.2013.04.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm501929n&amp;key=23597703" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm501929n&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmvF2itr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=338&publication_year=2013&pages=185-192&author=K.+Mahajanauthor=N.+P.+Mahajan&title=ACK1+tyrosine+kinase%3A+targeted+inhibition+to+block+cancer+cell+proliferation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">ACK1 tyrosine kinase: Targeted inhibition to block cancer cell proliferation</span></div><div class="casAuthors">Mahajan, Kiran; Mahajan, Nupam P.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">338</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">185-192</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  ACK1 tyrosine kinase, located on chromosome 3q29, is aberrantly activated, amplified or mutated in a wide variety of human cancers.  While the deregulated kinase is oncogenic and its activation correlates with progression to metastatic stage, its inhibition causes cell cycle arrest, sensitizes cells to ionizing radiation and induces apoptosis.  Oncogenicity of ACK1 is not only due to its ability to promote activation of crit. pro-survival kinases and harmone receptors by phosphorylating at distinct tyrosine residues, but also by employing a similar mechanism to eliminate a tumor suppressor from cancer cells.  Despite the substantial data supporting the oncogenic role of ACK1, and the potential clin. benefit of blocking ACK1 in metastatic disease, to date ACK1-specific small mol. inhibitors have not been exploited for cancer therapy.  This review highlights recent advances that elucidate how cancer cells employ ACK1 kinase to their advantage and discusses some of the novel ACK1 inhibitors that have shown promise in pre-clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXKiLC1fojfbVg90H21EOLACvtfcHk0ljg294Hhy5Ilw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmvF2itr0%253D&md5=aa2b5b4bb43e73cb00e4c6bad50c869d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2013.04.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2013.04.004%26sid%3Dliteratum%253Aachs%26aulast%3DMahajan%26aufirst%3DK.%26aulast%3DMahajan%26aufirst%3DN.%2BP.%26atitle%3DACK1%2520tyrosine%2520kinase%253A%2520targeted%2520inhibition%2520to%2520block%2520cancer%2520cell%2520proliferation%26jtitle%3DCancer%2520Lett.%26date%3D2013%26volume%3D338%26spage%3D185%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Mahajan, K.; Mahajan, N. P.</span><span> </span><span class="NLM_article-title">ACK1/TNK2 tyrosine kinase: molecular signaling and evolving role in cancers</span>.  <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span>DOI: <span class="refDoi"> DOI: 10.1038/onc.2014.350</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm501929n&amp;key=10.1038%2Fonc.2014.350" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=K.+Mahajan&author=N.+P.+Mahajan&title=ACK1%2FTNK2+tyrosine+kinase%3A+molecular+signaling+and+evolving+role+in+cancers&doi=10.1038%2Fonc.2014.350"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fonc.2014.350&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2014.350%26sid%3Dliteratum%253Aachs%26aulast%3DMahajan%26aufirst%3DK.%26atitle%3DACK1%252FTNK2%2520tyrosine%2520kinase%253A%2520molecular%2520signaling%2520and%2520evolving%2520role%2520in%2520cancers%26jtitle%3DOncogene%26date%3D2014%26doi%3D10.1038%2Fonc.2014.350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Mahajan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahajan, N. P.</span><span> </span><span class="NLM_article-title">Shepherding AKT and androgen receptor by Ack1 tyrosine kinase</span> <span class="citation_source-journal">J. Cell. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">224</span><span class="NLM_x">, </span> <span class="NLM_fpage">327</span><span class="NLM_x">–</span> <span class="NLM_lpage">333</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm501929n&amp;key=10.1002%2Fjcp.22162" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm501929n&amp;key=20432460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm501929n&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmslWiu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=224&publication_year=2010&pages=327-333&author=K.+Mahajanauthor=N.+P.+Mahajan&title=Shepherding+AKT+and+androgen+receptor+by+Ack1+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Shepherding AKT and androgen receptor by Ack1 tyrosine kinase</span></div><div class="casAuthors">Mahajan, Kiran; Mahajan, Nupam P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Physiology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">224</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">327-333</span>CODEN:
                <span class="NLM_cas:coden">JCLLAX</span>;
        ISSN:<span class="NLM_cas:issn">0021-9541</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  Ack1 (also known as ACK, TNK2, or activated Cdc42 kinase) is a structurally unique non-receptor tyrosine kinase that is expressed in diverse cell types.  It integrates signals from plethora of ligand-activated receptor tyrosine kinases (RTKs), for example, MERTK, EGFR, HER2, PDGFR and insulin receptor to initiate intracellular signaling cascades.  Ack1 transduces extracellular signals to cytosolic and nuclear effectors such as the protein kinase AKT/PKB and androgen receptor (AR), to promote cell survival and growth.  While tyrosine phosphorylation of AR at Tyr267 regulates androgen-independent recruitment of AR to the androgen-responsive enhancers and transcription of AR target genes to drive prostate cancer progression, phosphorylation of an evolutionarily conserved Tyrosine 176 in the kinase domain of AKT is essential for mitotic progression and pos. correlates with breast cancer progression.  In contrast to AR and AKT, Ack1-mediated phosphorylation of the tumor suppressor Wwox at Tyr287 lead to rapid Wwox polyubiquitination followed by degrdn.  Thus, by its ability to promote tumor growth by neg. regulating tumor suppressor such as Wwox and pos. regulating pro-survival factors such as AKT and AR, Ack1 is emerging as a crit. player in cancer biol.  In this review, we discuss recent advances in understanding the physiol. functions of Ack1 signaling in normal cells and the consequences of its hyperactivation in various cancers.  J. Cell. Physiol. 224: 327-333, 2010. © 2010 Wiley-Liss, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotDJqD0S9vr7Vg90H21EOLACvtfcHk0ljKg8G2IaUULw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmslWiu7k%253D&md5=520ad1c81b0dc5e6d35a2efdc36af2e9</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1002%2Fjcp.22162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcp.22162%26sid%3Dliteratum%253Aachs%26aulast%3DMahajan%26aufirst%3DK.%26aulast%3DMahajan%26aufirst%3DN.%2BP.%26atitle%3DShepherding%2520AKT%2520and%2520androgen%2520receptor%2520by%2520Ack1%2520tyrosine%2520kinase%26jtitle%3DJ.%2520Cell.%2520Physiol.%26date%3D2010%26volume%3D224%26spage%3D327%26epage%3D333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Mahajan, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majumder, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warren, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohler, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Earp, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whang, Y. E.</span><span> </span><span class="NLM_article-title">Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">8438</span><span class="NLM_x">–</span> <span class="NLM_lpage">8443</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=8438-8443&author=N.+P.+Mahajanauthor=Y.+Liuauthor=S.+Majumderauthor=M.+R.+Warrenauthor=C.+E.+Parkerauthor=J.+L.+Mohlerauthor=H.+S.+Earpauthor=Y.+E.+Whang&title=Activated+Cdc42-associated+kinase+Ack1+promotes+prostate+cancer+progression+via+androgen+receptor+tyrosine+phosphorylation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMahajan%26aufirst%3DN.%2BP.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DMajumder%26aufirst%3DS.%26aulast%3DWarren%26aufirst%3DM.%2BR.%26aulast%3DParker%26aufirst%3DC.%2BE.%26aulast%3DMohler%26aufirst%3DJ.%2BL.%26aulast%3DEarp%26aufirst%3DH.%2BS.%26aulast%3DWhang%26aufirst%3DY.%2BE.%26atitle%3DActivated%2520Cdc42-associated%2520kinase%2520Ack1%2520promotes%2520prostate%2520cancer%2520progression%2520via%2520androgen%2520receptor%2520tyrosine%2520phosphorylation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2007%26volume%3D104%26spage%3D8438%26epage%3D8443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Mahajan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coppola, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rawal, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engelman, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahajan, N. P.</span><span> </span><span class="NLM_article-title">Ack1-mediated androgen receptor phosphorylation modulates radiation resistance in castration-resistant prostate cancer</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">22112</span><span class="NLM_x">–</span> <span class="NLM_lpage">22122</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=22112-22122&author=K.+Mahajanauthor=D.+Coppolaauthor=B.+Rawalauthor=Y.+A.+Chenauthor=H.+R.+Lawrenceauthor=R.+W.+Engelmanauthor=N.+J.+Lawrenceauthor=N.+P.+Mahajan&title=Ack1-mediated+androgen+receptor+phosphorylation+modulates+radiation+resistance+in+castration-resistant+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMahajan%26aufirst%3DK.%26aulast%3DCoppola%26aufirst%3DD.%26aulast%3DRawal%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DY.%2BA.%26aulast%3DLawrence%26aufirst%3DH.%2BR.%26aulast%3DEngelman%26aufirst%3DR.%2BW.%26aulast%3DLawrence%26aufirst%3DN.%2BJ.%26aulast%3DMahajan%26aufirst%3DN.%2BP.%26atitle%3DAck1-mediated%2520androgen%2520receptor%2520phosphorylation%2520modulates%2520radiation%2520resistance%2520in%2520castration-resistant%2520prostate%2520cancer%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D22112%26epage%3D22122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Aqeilan, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croce, C. M.</span><span> </span><span class="NLM_article-title">WWOX in biological control and tumorigenesis</span> <span class="citation_source-journal">J. Cell. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">212</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">310</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm501929n&amp;key=10.1002%2Fjcp.21099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm501929n&amp;key=17458891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm501929n&amp;key=1%3ACAS%3A528%3ADC%252BD2sXntlyqtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=212&publication_year=2007&pages=307-310&author=R.+I.+Aqeilanauthor=C.+M.+Croce&title=WWOX+in+biological+control+and+tumorigenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">WWOX in biological control and tumorigenesis</span></div><div class="casAuthors">Aqeilan, Rami I.; Croce, Carlo M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Physiology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">212</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">307-310</span>CODEN:
                <span class="NLM_cas:coden">JCLLAX</span>;
        ISSN:<span class="NLM_cas:issn">0021-9541</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  The WW domain-contg. oxidoreductase (WWOX) gene is located at 16q23.1-16q23.2, a region that spans the second most common human fragile site, FRA16D.  The WWOX protein contains two N-terminal WW domains and a central short chain oxidoreductase-like domain.  In the last few years, considerable amt. of data have shown inactivation of WWOX in a variety of human malignancies.  Moreover, interacting partners have been identified biochem. that define, at least in part, the mol. mechanism of WWOX action.  Recently, we demonstrated that targeted deletion of the Wwox gene in the mouse led to increased incidence of spontaneous and chem. induced tumor formation, thereby providing the first in vivo evidence that WWOX is a bona fide tumor suppressor.  This review focuses on the most recent progress in understanding WWOX function as a tumor suppressor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlyPpK62RPErVg90H21EOLACvtfcHk0ljKg8G2IaUULw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXntlyqtr8%253D&md5=ba1947484f42c8c2d9b0a60359c6984d</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1002%2Fjcp.21099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcp.21099%26sid%3Dliteratum%253Aachs%26aulast%3DAqeilan%26aufirst%3DR.%2BI.%26aulast%3DCroce%26aufirst%3DC.%2BM.%26atitle%3DWWOX%2520in%2520biological%2520control%2520and%2520tumorigenesis%26jtitle%3DJ.%2520Cell.%2520Physiol.%26date%3D2007%26volume%3D212%26spage%3D307%26epage%3D310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Mahajan, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whang, Y. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohler, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Earp, H. S.</span><span> </span><span class="NLM_article-title">Activated tyrosine kinase Ack1 promotes prostate tumorigenesis: role of Ack1 in polyubiquitination of tumor suppressor Wwox</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">10514</span><span class="NLM_x">–</span> <span class="NLM_lpage">10523</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=10514-10523&author=N.+P.+Mahajanauthor=Y.+E.+Whangauthor=J.+L.+Mohlerauthor=H.+S.+Earp&title=Activated+tyrosine+kinase+Ack1+promotes+prostate+tumorigenesis%3A+role+of+Ack1+in+polyubiquitination+of+tumor+suppressor+Wwox"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMahajan%26aufirst%3DN.%2BP.%26aulast%3DWhang%26aufirst%3DY.%2BE.%26aulast%3DMohler%26aufirst%3DJ.%2BL.%26aulast%3DEarp%26aufirst%3DH.%2BS.%26atitle%3DActivated%2520tyrosine%2520kinase%2520Ack1%2520promotes%2520prostate%2520tumorigenesis%253A%2520role%2520of%2520Ack1%2520in%2520polyubiquitination%2520of%2520tumor%2520suppressor%2520Wwox%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D10514%26epage%3D10523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Mahajan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coppola, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Challa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koomen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engelman, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivera, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muraoka-Cook, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schonbrunn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebti, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Earp, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahajan, N. P.</span><span> </span><span class="NLM_article-title">Ack1 mediated AKT/PKB tyrosine 176 phosphorylation regulates its activation</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">e9646</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=e9646&author=K.+Mahajanauthor=D.+Coppolaauthor=S.+Challaauthor=B.+Fangauthor=Y.+A.+Chenauthor=W.+Zhuauthor=A.+S.+Lopezauthor=J.+Koomenauthor=R.+W.+Engelmanauthor=C.+Riveraauthor=R.+S.+Muraoka-Cookauthor=J.+Q.+Chengauthor=E.+Schonbrunnauthor=S.+M.+Sebtiauthor=H.+S.+Earpauthor=N.+P.+Mahajan&title=Ack1+mediated+AKT%2FPKB+tyrosine+176+phosphorylation+regulates+its+activation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMahajan%26aufirst%3DK.%26aulast%3DCoppola%26aufirst%3DD.%26aulast%3DChalla%26aufirst%3DS.%26aulast%3DFang%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DY.%2BA.%26aulast%3DZhu%26aufirst%3DW.%26aulast%3DLopez%26aufirst%3DA.%2BS.%26aulast%3DKoomen%26aufirst%3DJ.%26aulast%3DEngelman%26aufirst%3DR.%2BW.%26aulast%3DRivera%26aufirst%3DC.%26aulast%3DMuraoka-Cook%26aufirst%3DR.%2BS.%26aulast%3DCheng%26aufirst%3DJ.%2BQ.%26aulast%3DSchonbrunn%26aufirst%3DE.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26aulast%3DEarp%26aufirst%3DH.%2BS.%26aulast%3DMahajan%26aufirst%3DN.%2BP.%26atitle%3DAck1%2520mediated%2520AKT%252FPKB%2520tyrosine%2520176%2520phosphorylation%2520regulates%2520its%2520activation%26jtitle%3DPLoS%2520One%26date%3D2010%26volume%3D5%26spage%3De9646" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Franke, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, T. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Datta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazlauskas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsichlis, P. N.</span><span> </span><span class="NLM_article-title">The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">727</span><span class="NLM_x">–</span> <span class="NLM_lpage">736</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1995&pages=727-736&author=T.+F.+Frankeauthor=S.+I.+Yangauthor=T.+O.+Chanauthor=K.+Dattaauthor=A.+Kazlauskasauthor=D.+K.+Morrisonauthor=D.+R.+Kaplanauthor=P.+N.+Tsichlis&title=The+protein+kinase+encoded+by+the+Akt+proto-oncogene+is+a+target+of+the+PDGF-activated+phosphatidylinositol+3-kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFranke%26aufirst%3DT.%2BF.%26aulast%3DYang%26aufirst%3DS.%2BI.%26aulast%3DChan%26aufirst%3DT.%2BO.%26aulast%3DDatta%26aufirst%3DK.%26aulast%3DKazlauskas%26aufirst%3DA.%26aulast%3DMorrison%26aufirst%3DD.%2BK.%26aulast%3DKaplan%26aufirst%3DD.%2BR.%26aulast%3DTsichlis%26aufirst%3DP.%2BN.%26atitle%3DThe%2520protein%2520kinase%2520encoded%2520by%2520the%2520Akt%2520proto-oncogene%2520is%2520a%2520target%2520of%2520the%2520PDGF-activated%2520phosphatidylinositol%25203-kinase%26jtitle%3DCell%26date%3D1995%26volume%3D81%26spage%3D727%26epage%3D736" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Burgering, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coffer, P. J.</span><span> </span><span class="NLM_article-title">Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">376</span><span class="NLM_x">, </span> <span class="NLM_fpage">599</span><span class="NLM_x">–</span> <span class="NLM_lpage">602</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=376&publication_year=1995&pages=599-602&author=B.+M.+Burgeringauthor=P.+J.+Coffer&title=Protein+kinase+B+%28c-Akt%29+in+phosphatidylinositol-3-OH+kinase+signal+transduction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurgering%26aufirst%3DB.%2BM.%26aulast%3DCoffer%26aufirst%3DP.%2BJ.%26atitle%3DProtein%2520kinase%2520B%2520%2528c-Akt%2529%2520in%2520phosphatidylinositol-3-OH%2520kinase%2520signal%2520transduction%26jtitle%3DNature%26date%3D1995%26volume%3D376%26spage%3D599%26epage%3D602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Manning, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span> </span><span class="NLM_article-title">AKT/PKB signaling: navigating downstream</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">1261</span><span class="NLM_x">–</span> <span class="NLM_lpage">1274</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2007&pages=1261-1274&author=B.+D.+Manningauthor=L.+C.+Cantley&title=AKT%2FPKB+signaling%3A+navigating+downstream"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DB.%2BD.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26atitle%3DAKT%252FPKB%2520signaling%253A%2520navigating%2520downstream%26jtitle%3DCell%26date%3D2007%26volume%3D129%26spage%3D1261%26epage%3D1274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Mahajan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coppola, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahajan, N. P.</span><span> </span><span class="NLM_article-title">Ack1 tyrosine kinase activation correlates with pancreatic cancer progression</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">180</span><span class="NLM_x">, </span> <span class="NLM_fpage">1386</span><span class="NLM_x">–</span> <span class="NLM_lpage">1393</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm501929n&amp;key=10.1016%2Fj.ajpath.2011.12.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm501929n&amp;key=22322295" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm501929n&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsFCju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2012&pages=1386-1393&author=K.+Mahajanauthor=D.+Coppolaauthor=Y.+A.+Chenauthor=W.+Zhuauthor=H.+R.+Lawrenceauthor=N.+J.+Lawrenceauthor=N.+P.+Mahajan&title=Ack1+tyrosine+kinase+activation+correlates+with+pancreatic+cancer+progression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Ack1 tyrosine kinase activation correlates with pancreatic cancer progression</span></div><div class="casAuthors">Mahajan, Kiran; Coppola, Domenico; Chen, Y. Ann; Zhu, Weiwei; Lawrence, Harshani R.; Lawrence, Nicholas J.; Mahajan, Nupam P.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">180</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1386-1393</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Pancreatic cancer is a significant cause of cancer mortality worldwide as the disease has advanced significantly in patients before symptoms are evident.  The signal transduction pathways that promote this rapid progression are not well understood.  Ack1 or TNK2, an ubiquitously expressed oncogenic non-receptor tyrosine kinase, integrates signals from ligand-activated receptor tyrosine kinases to modulate intracellular signaling cascades.  In the present study, we investigated the Ack1 activation profile in a pancreatic cancer tumor microarray, and obsd. that expression levels of activated Ack1 and pTyr284-Ack1 pos. correlated with the severity of disease progression and inversely correlated with the survival of patients with pancreatic cancer.  To explore the mechanisms by which Ack1 promotes tumor progression, we investigated the role of AKT/PKB, an oncogene and Ack1-interacting protein.  Ack1 activates AKT directly in pancreatic and other cancer cell lines by phosphorylating AKT at Tyr176 to promote cell survival.  In addn., the Ack1 inhibitor AIM-100 not only inhibited Ack1 activation but also suppressed AKT tyrosine phosphorylation, leading to cell cycle arrest in the G1 phase.  This effect resulted in a significant decrease in the proliferation of pancreatic cancer cells and induction of apoptosis.  Collectively, our data indicate that activated Ack1 could be a prognostic marker for ascertaining early or advanced pancreatic cancer.  Thus, Ack1 inhibitors hold promise for therapeutic intervention to inhibit pancreatic tumor growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_olTwaj3DErVg90H21EOLACvtfcHk0lg33LabsX8SCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsFCju7c%253D&md5=de887ab01db229a4d6f6b38d4c6a987a</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.ajpath.2011.12.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajpath.2011.12.028%26sid%3Dliteratum%253Aachs%26aulast%3DMahajan%26aufirst%3DK.%26aulast%3DCoppola%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DY.%2BA.%26aulast%3DZhu%26aufirst%3DW.%26aulast%3DLawrence%26aufirst%3DH.%2BR.%26aulast%3DLawrence%26aufirst%3DN.%2BJ.%26aulast%3DMahajan%26aufirst%3DN.%2BP.%26atitle%3DAck1%2520tyrosine%2520kinase%2520activation%2520correlates%2520with%2520pancreatic%2520cancer%2520progression%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2012%26volume%3D180%26spage%3D1386%26epage%3D1393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Mahajan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahajan, N. P.</span><span> </span><span class="NLM_article-title">ACK1 tyrosine kinase interacts with histone demethylase KDM3A to regulate the mammary tumor oncogene HOXA1</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">28179</span><span class="NLM_x">–</span> <span class="NLM_lpage">28191</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=28179-28191&author=K.+Mahajanauthor=H.+R.+Lawrenceauthor=N.+J.+Lawrenceauthor=N.+P.+Mahajan&title=ACK1+tyrosine+kinase+interacts+with+histone+demethylase+KDM3A+to+regulate+the+mammary+tumor+oncogene+HOXA1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMahajan%26aufirst%3DK.%26aulast%3DLawrence%26aufirst%3DH.%2BR.%26aulast%3DLawrence%26aufirst%3DN.%2BJ.%26aulast%3DMahajan%26aufirst%3DN.%2BP.%26atitle%3DACK1%2520tyrosine%2520kinase%2520interacts%2520with%2520histone%2520demethylase%2520KDM3A%2520to%2520regulate%2520the%2520mammary%2520tumor%2520oncogene%2520HOXA1%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D28179%26epage%3D28191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">DiMauro, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcomb, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunes, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bemis, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boucher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchanan, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckner, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faust, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turci, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span> </span><span class="NLM_article-title">Discovery of 4-amino-5,6-biaryl-furo[2,3-d]pyrimidines as inhibitors of Lck: development of an expedient and divergent synthetic route and preliminary SAR</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2305</span><span class="NLM_x">–</span> <span class="NLM_lpage">2309</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=2305-2309&author=E.+F.+DiMauroauthor=J.+Newcombauthor=J.+J.+Nunesauthor=J.+E.+Bemisauthor=C.+Boucherauthor=J.+L.+Buchananauthor=W.+H.+Bucknerauthor=A.+Chengauthor=T.+Faustauthor=F.+Hsiehauthor=X.+Huangauthor=J.+H.+Leeauthor=T.+L.+Marshallauthor=M.+W.+Martinauthor=D.+C.+McGowanauthor=S.+Schneiderauthor=S.+M.+Turciauthor=R.+D.+Whiteauthor=X.+Zhu&title=Discovery+of+4-amino-5%2C6-biaryl-furo%5B2%2C3-d%5Dpyrimidines+as+inhibitors+of+Lck%3A+development+of+an+expedient+and+divergent+synthetic+route+and+preliminary+SAR"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DNewcomb%26aufirst%3DJ.%26aulast%3DNunes%26aufirst%3DJ.%2BJ.%26aulast%3DBemis%26aufirst%3DJ.%2BE.%26aulast%3DBoucher%26aufirst%3DC.%26aulast%3DBuchanan%26aufirst%3DJ.%2BL.%26aulast%3DBuckner%26aufirst%3DW.%2BH.%26aulast%3DCheng%26aufirst%3DA.%26aulast%3DFaust%26aufirst%3DT.%26aulast%3DHsieh%26aufirst%3DF.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DMarshall%26aufirst%3DT.%2BL.%26aulast%3DMartin%26aufirst%3DM.%2BW.%26aulast%3DMcGowan%26aufirst%3DD.%2BC.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DTurci%26aufirst%3DS.%2BM.%26aulast%3DWhite%26aufirst%3DR.%2BD.%26aulast%3DZhu%26aufirst%3DX.%26atitle%3DDiscovery%2520of%25204-amino-5%252C6-biaryl-furo%255B2%252C3-d%255Dpyrimidines%2520as%2520inhibitors%2520of%2520Lck%253A%2520development%2520of%2520an%2520expedient%2520and%2520divergent%2520synthetic%2520route%2520and%2520preliminary%2520SAR%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D2305%26epage%3D2309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Martin, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcomb, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunes, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bemis, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchanan, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMauro, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boucher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faust, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turci, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span> </span><span class="NLM_article-title">Discovery of novel 2,3-diarylfuro[2,3-<i>b</i>]pyridin-4-amines as potent and selective inhibitors of Lck: synthesis, SAR, and pharmacokinetic properties</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2299</span><span class="NLM_x">–</span> <span class="NLM_lpage">3304</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=2299-3304&author=M.+W.+Martinauthor=J.+Newcombauthor=J.+J.+Nunesauthor=J.+E.+Bemisauthor=D.+C.+McGowanauthor=R.+D.+Whiteauthor=J.+L.+Buchananauthor=E.+F.+DiMauroauthor=C.+Boucherauthor=T.+Faustauthor=F.+Hsiehauthor=X.+Huangauthor=J.+H.+Leeauthor=S.+Schneiderauthor=S.+M.+Turciauthor=X.+Zhu&title=Discovery+of+novel+2%2C3-diarylfuro%5B2%2C3-b%5Dpyridin-4-amines+as+potent+and+selective+inhibitors+of+Lck%3A+synthesis%2C+SAR%2C+and+pharmacokinetic+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DM.%2BW.%26aulast%3DNewcomb%26aufirst%3DJ.%26aulast%3DNunes%26aufirst%3DJ.%2BJ.%26aulast%3DBemis%26aufirst%3DJ.%2BE.%26aulast%3DMcGowan%26aufirst%3DD.%2BC.%26aulast%3DWhite%26aufirst%3DR.%2BD.%26aulast%3DBuchanan%26aufirst%3DJ.%2BL.%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DBoucher%26aufirst%3DC.%26aulast%3DFaust%26aufirst%3DT.%26aulast%3DHsieh%26aufirst%3DF.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DTurci%26aufirst%3DS.%2BM.%26aulast%3DZhu%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520novel%25202%252C3-diarylfuro%255B2%252C3-b%255Dpyridin-4-amines%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520Lck%253A%2520synthesis%252C%2520SAR%252C%2520and%2520pharmacokinetic%2520properties%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D2299%26epage%3D3304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Mahajan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Challa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coppola, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gevariya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahajan, N. P.</span><span> </span><span class="NLM_article-title">Effect of Ack1 tyrosine kinase inhibitor on ligand-independent androgen receptor activity</span> <span class="citation_source-journal">Prostate</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">1274</span><span class="NLM_x">–</span> <span class="NLM_lpage">1285</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=1274-1285&author=K.+Mahajanauthor=S.+Challaauthor=D.+Coppolaauthor=H.+Lawrenceauthor=Y.+Luoauthor=H.+Gevariyaauthor=W.+Zhuauthor=Y.+A.+Chenauthor=N.+J.+Lawrenceauthor=N.+P.+Mahajan&title=Effect+of+Ack1+tyrosine+kinase+inhibitor+on+ligand-independent+androgen+receptor+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMahajan%26aufirst%3DK.%26aulast%3DChalla%26aufirst%3DS.%26aulast%3DCoppola%26aufirst%3DD.%26aulast%3DLawrence%26aufirst%3DH.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DGevariya%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DY.%2BA.%26aulast%3DLawrence%26aufirst%3DN.%2BJ.%26aulast%3DMahajan%26aufirst%3DN.%2BP.%26atitle%3DEffect%2520of%2520Ack1%2520tyrosine%2520kinase%2520inhibitor%2520on%2520ligand-independent%2520androgen%2520receptor%2520activity%26jtitle%3DProstate%26date%3D2010%26volume%3D70%26spage%3D1274%26epage%3D1285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Kopecky, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaen, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardozo, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesche, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrelly, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayser, F.</span><span> </span><span class="NLM_article-title">Identification and optimization of N3,N6-diaryl-1H-pyrazolo[3,4-<i>d</i>]pyrimidine-3,6-diamines as a novel class of ACK1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">6352</span><span class="NLM_x">–</span> <span class="NLM_lpage">6356</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=6352-6356&author=D.+J.+Kopeckyauthor=X.+Haoauthor=Y.+Chenauthor=J.+Fuauthor=X.+Jiaoauthor=J.+C.+Jaenauthor=M.+G.+Cardozoauthor=J.+Liuauthor=Z.+Wangauthor=N.+P.+Walkerauthor=H.+Wescheauthor=S.+Liauthor=E.+Farrellyauthor=S.+H.+Xiaoauthor=F.+Kayser&title=Identification+and+optimization+of+N3%2CN6-diaryl-1H-pyrazolo%5B3%2C4-d%5Dpyrimidine-3%2C6-diamines+as+a+novel+class+of+ACK1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKopecky%26aufirst%3DD.%2BJ.%26aulast%3DHao%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DJiao%26aufirst%3DX.%26aulast%3DJaen%26aufirst%3DJ.%2BC.%26aulast%3DCardozo%26aufirst%3DM.%2BG.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DWalker%26aufirst%3DN.%2BP.%26aulast%3DWesche%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DFarrelly%26aufirst%3DE.%26aulast%3DXiao%26aufirst%3DS.%2BH.%26aulast%3DKayser%26aufirst%3DF.%26atitle%3DIdentification%2520and%2520optimization%2520of%2520N3%252CN6-diaryl-1H-pyrazolo%255B3%252C4-d%255Dpyrimidine-3%252C6-diamines%2520as%2520a%2520novel%2520class%2520of%2520ACK1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D6352%26epage%3D6356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Miduturu, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwiatkowski, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brault, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwaller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">High-throughput kinase profiling: a more efficient approach toward the discovery of new kinase inhibitors</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">868</span><span class="NLM_x">–</span> <span class="NLM_lpage">879</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm501929n&amp;key=10.1016%2Fj.chembiol.2011.05.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm501929n&amp;key=21802008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm501929n&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpsFarurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=868-879&author=C.+V.+Miduturuauthor=X.+Dengauthor=N.+Kwiatkowskiauthor=W.+Yangauthor=L.+Braultauthor=P.+Filippakopoulosauthor=E.+Chungauthor=Q.+Yangauthor=J.+Schwallerauthor=S.+Knappauthor=R.+W.+Kingauthor=J.+D.+Leeauthor=S.+Herrgardauthor=P.+Zarrinkarauthor=N.+S.+Gray&title=High-throughput+kinase+profiling%3A+a+more+efficient+approach+toward+the+discovery+of+new+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">High-Throughput Kinase Profiling: A More Efficient Approach toward the Discovery of New Kinase Inhibitors</span></div><div class="casAuthors">Miduturu, Chandrasekhar V.; Deng, Xianming; Kwiatkowski, Nicholas; Yang, Wannian; Brault, Laurent; Filippakopoulos, Panagis; Chung, Eunah; Yang, Qingkai; Schwaller, Juerg; Knapp, Stefan; King, Randall W.; Lee, Jiing-Dwan; Herrgard, Sanna; Zarrinkar, Patrick; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">868-879</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Selective protein kinase inhibitors have only been developed against a small no. of kinase targets.  Here we demonstrate that "high-throughput kinase profiling" is an efficient method for the discovery of lead compds. for established as well as unexplored kinase targets.  We screened a library of 118 compds. constituting two distinct scaffolds (furan-thiazolidinediones and pyrimido-diazepines) against a panel of 353 kinases.  A distinct kinase selectivity profile was obsd. for each scaffold.  Selective inhibitors were identified with submicromolar cellular activity against PIM1, ERK5, ACK1, MPS1, PLK1-3, and Aurora A,B kinases.  In addn., we identified potent inhibitors for so far unexplored kinases such as DRAK1, HIPK2, and DCAMKL1 that await further evaluation.  This inhibitor-centric approach permits comprehensive assessment of a scaffold of interest and represents an efficient and general strategy for identifying new selective kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKLvN9eLNvybVg90H21EOLACvtfcHk0lhLx-H9sUS2iQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpsFarurw%253D&md5=d62a4771b1215551f3913b93d6eca7ee</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2011.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2011.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DMiduturu%26aufirst%3DC.%2BV.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DKwiatkowski%26aufirst%3DN.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DBrault%26aufirst%3DL.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DChung%26aufirst%3DE.%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DSchwaller%26aufirst%3DJ.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DKing%26aufirst%3DR.%2BW.%26aulast%3DLee%26aufirst%3DJ.%2BD.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DZarrinkar%26aufirst%3DP.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DHigh-throughput%2520kinase%2520profiling%253A%2520a%2520more%2520efficient%2520approach%2520toward%2520the%2520discovery%2520of%2520new%2520kinase%2520inhibitors%26jtitle%3DChem.%2520Biol.%26date%3D2011%26volume%3D18%26spage%3D868%26epage%3D879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Jin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleinberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadalbajoo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siu, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bittner, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thelemann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhagwat, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulvihill, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rechka, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pachter, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crew, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulvihill, M. J.</span><span> </span><span class="NLM_article-title">Discovery of potent, selective and orally bioavailable imidazo[1,5-<i>a</i>]pyrazine derived ACK1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">979</span><span class="NLM_x">–</span> <span class="NLM_lpage">984</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=979-984&author=M.+Jinauthor=J.+Wangauthor=A.+Kleinbergauthor=M.+Kadalbajooauthor=K.+W.+Siuauthor=A.+Cookeauthor=M.+A.+Bittnerauthor=Y.+Yaoauthor=A.+Thelemannauthor=Q.+Jiauthor=S.+Bhagwatauthor=K.+M.+Mulvihillauthor=J.+A.+Rechkaauthor=J.+A.+Pachterauthor=A.+P.+Crewauthor=D.+Epsteinauthor=M.+J.+Mulvihill&title=Discovery+of+potent%2C+selective+and+orally+bioavailable+imidazo%5B1%2C5-a%5Dpyrazine+derived+ACK1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DKleinberg%26aufirst%3DA.%26aulast%3DKadalbajoo%26aufirst%3DM.%26aulast%3DSiu%26aufirst%3DK.%2BW.%26aulast%3DCooke%26aufirst%3DA.%26aulast%3DBittner%26aufirst%3DM.%2BA.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DThelemann%26aufirst%3DA.%26aulast%3DJi%26aufirst%3DQ.%26aulast%3DBhagwat%26aufirst%3DS.%26aulast%3DMulvihill%26aufirst%3DK.%2BM.%26aulast%3DRechka%26aufirst%3DJ.%2BA.%26aulast%3DPachter%26aufirst%3DJ.%2BA.%26aulast%3DCrew%26aufirst%3DA.%2BP.%26aulast%3DEpstein%26aufirst%3DD.%26aulast%3DMulvihill%26aufirst%3DM.%2BJ.%26atitle%3DDiscovery%2520of%2520potent%252C%2520selective%2520and%2520orally%2520bioavailable%2520imidazo%255B1%252C5-a%255Dpyrazine%2520derived%2520ACK1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D979%26epage%3D984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Golas, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arndt, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Etienne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nardin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frost, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boschelli, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boschelli, F.</span><span> </span><span class="NLM_article-title">SKI-606, a 4-anilino-3-quinolinecarbonitrile dual inhibitor of Src and Abl kinases, is a potent antiproliferative agent against chronic myelogenous leukemia cells in culture and causes regression of K562 xenografts in nude mice</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">375</span><span class="NLM_x">–</span> <span class="NLM_lpage">381</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm501929n&amp;key=12543790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm501929n&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnt1Krsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=375-381&author=J.+M.+Golasauthor=K.+Arndtauthor=C.+Etienneauthor=J.+Lucasauthor=D.+Nardinauthor=J.+Gibbonsauthor=P.+Frostauthor=F.+Yeauthor=D.+H.+Boschelliauthor=F.+Boschelli&title=SKI-606%2C+a+4-anilino-3-quinolinecarbonitrile+dual+inhibitor+of+Src+and+Abl+kinases%2C+is+a+potent+antiproliferative+agent+against+chronic+myelogenous+leukemia+cells+in+culture+and+causes+regression+of+K562+xenografts+in+nude+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">SKI-606, a 4-Anilino-3-quinolinecarbonitrile Dual Inhibitor of Src and Abl Kinases, Is a Potent Antiproliferative Agent against Chronic Myelogenous Leukemia Cells in Culture and Causes Regression of K562 Xenografts in Nude Mice</span></div><div class="casAuthors">Golas, Jennifer M.; Arndt, Kim; Etienne, Carlo; Lucas, Judy; Nardin, Danielle; Gibbons, James; Frost, Philip; Ye, Fei; Boschelli, Diane H.; Boschelli, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">375-381</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Constitutive tyrosine kinase activity of Bcr-Abl promotes proliferation and survival of chronic myelogenous leukemia (CML) cells.  Inhibition of Bcr-Abl tyrosine kinase activity or signaling proteins activated by Bcr-Abl in CML cells blocks proliferation and causes apoptotic cell death.  The selective Abl kinase inhibitor, STI-571 (marketed as Gleevec), is toxic to CML cells in culture, causes regression of CML tumors in nude mice, and is currently used to treat CML patients.  Here we describe a p.o. active, dual Src/Abl kinase inhibitor with potent antiproliferative activity against CML cells in culture.  This 4-anilino-3-quinolinecarbonitrile (SKI-606) ablates tyrosine phosphorylation of Bcr-Abl in CML cells and of v-Abl expressed in fibroblasts.  SKI-606 inhibits phosphorylation of cellular proteins, including STAT5, at concns. that inhibit proliferation in CML cells.  Phosphorylation of the autoactivation site of the Src family kinases Lyn and/or Hck is also reduced by treatment with SKI-606.  Once daily oral administration of this compd. at 100 mg/kg for 5 days causes complete regression of large K562 xenografts in nude mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJ0DM9Z0QjjLVg90H21EOLACvtfcHk0ljN4ldsLnH0-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnt1Krsg%253D%253D&md5=e7b5e5ffee0238543dc9c31b7e86b3d2</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGolas%26aufirst%3DJ.%2BM.%26aulast%3DArndt%26aufirst%3DK.%26aulast%3DEtienne%26aufirst%3DC.%26aulast%3DLucas%26aufirst%3DJ.%26aulast%3DNardin%26aufirst%3DD.%26aulast%3DGibbons%26aufirst%3DJ.%26aulast%3DFrost%26aufirst%3DP.%26aulast%3DYe%26aufirst%3DF.%26aulast%3DBoschelli%26aufirst%3DD.%2BH.%26aulast%3DBoschelli%26aufirst%3DF.%26atitle%3DSKI-606%252C%2520a%25204-anilino-3-quinolinecarbonitrile%2520dual%2520inhibitor%2520of%2520Src%2520and%2520Abl%2520kinases%252C%2520is%2520a%2520potent%2520antiproliferative%2520agent%2520against%2520chronic%2520myelogenous%2520leukemia%2520cells%2520in%2520culture%2520and%2520causes%2520regression%2520of%2520K562%2520xenografts%2520in%2520nude%2520mice%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D375%26epage%3D381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Remsing Rix, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rix, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colinge, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hantschel, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stranzl, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumgartner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valent, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augustin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Till, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Superti-Furga, G.</span><span> </span><span class="NLM_article-title">Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">477</span><span class="NLM_x">–</span> <span class="NLM_lpage">485</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm501929n&amp;key=10.1038%2Fleu.2008.334" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm501929n&amp;key=19039322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm501929n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXivVKhu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2009&pages=477-485&author=L.+L.+Remsing+Rixauthor=U.+Rixauthor=J.+Colingeauthor=O.+Hantschelauthor=K.+L.+Bennettauthor=T.+Stranzlauthor=A.+Mullerauthor=C.+Baumgartnerauthor=P.+Valentauthor=M.+Augustinauthor=J.+H.+Tillauthor=G.+Superti-Furga&title=Global+target+profile+of+the+kinase+inhibitor+bosutinib+in+primary+chronic+myeloid+leukemia+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells</span></div><div class="casAuthors">Remsing Rix, L. L.; Rix, U.; Colinge, J.; Hantschel, O.; Bennett, K. L.; Stranzl, T.; Mueller, A.; Baumgartner, C.; Valent, P.; Augustin, M.; Till, J. H.; Superti-Furga, G.</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">477-485</span>CODEN:
                <span class="NLM_cas:coden">LEUKED</span>;
        ISSN:<span class="NLM_cas:issn">0887-6924</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The detailed mol. mechanism of action of second-generation BCR-ABL tyrosine kinase inhibitors, including perturbed targets and pathways, should contribute to rationalized therapy in chronic myeloid leukemia (CML) or in other affected diseases.  Here, we characterized the target profile of the dual SRC/ABL inhibitor bosutinib employing a two-tiered approach using chem. proteomics to identify natural binders in whole cell lysates of primary CML and K562 cells in parallel to in vitro kinase assays against a large recombinant kinase panel.  The combined strategy resulted in a global survey of bosutinib targets comprised of over 45 novel tyrosine and serine/threonine kinases.  We have found clear differences in the target patterns of bosutinib in primary CML cells vs. the K562 cell line.  A comparison of bosutinib with dasatinib across the whole kinase panel revealed overlapping, but distinct, inhibition profiles.  Common among those were the SRC, ABL and TEC family kinases.  Bosutinib did not inhibit KIT or platelet-derived growth factor receptor, but prominently targeted the apoptosis-linked STE20 kinases.  Although in vivo bosutinib is inactive against ABL T315I, we found this clin. important mutant to be enzymically inhibited in the mid-nanomolar range.  Finally, bosutinib is the first kinase inhibitor shown to target CAMK2G, recently implicated in myeloid leukemia cell proliferation.  Leukemia (2009) 23, 477-485; doi:10.1038/leu.2008.334; published online 27 Nov. 2008.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8u0ixFotIMLVg90H21EOLACvtfcHk0ljN4ldsLnH0-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXivVKhu7w%253D&md5=b0d56d468ef66ddc2a6f012d08f8c1a4</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fleu.2008.334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fleu.2008.334%26sid%3Dliteratum%253Aachs%26aulast%3DRemsing%2BRix%26aufirst%3DL.%2BL.%26aulast%3DRix%26aufirst%3DU.%26aulast%3DColinge%26aufirst%3DJ.%26aulast%3DHantschel%26aufirst%3DO.%26aulast%3DBennett%26aufirst%3DK.%2BL.%26aulast%3DStranzl%26aufirst%3DT.%26aulast%3DMuller%26aufirst%3DA.%26aulast%3DBaumgartner%26aufirst%3DC.%26aulast%3DValent%26aufirst%3DP.%26aulast%3DAugustin%26aufirst%3DM.%26aulast%3DTill%26aufirst%3DJ.%2BH.%26aulast%3DSuperti-Furga%26aufirst%3DG.%26atitle%3DGlobal%2520target%2520profile%2520of%2520the%2520kinase%2520inhibitor%2520bosutinib%2520in%2520primary%2520chronic%2520myeloid%2520leukemia%2520cells%26jtitle%3DLeukemia%26date%3D2009%26volume%3D23%26spage%3D477%26epage%3D485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Tan, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haaland, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gan, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tham, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krisna, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thu, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liew, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ullrich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chua, B. T.</span><span> </span><span class="NLM_article-title">Bosutinib inhibits migration and invasion via ACK1 in KRAS mutant non-small cell lung cancer</span> <span class="citation_source-journal">Mol. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm501929n&amp;key=10.1186%2F1476-4598-13-13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm501929n&amp;key=24461128" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm501929n&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivFaksLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=13&author=D.+S.+Tanauthor=B.+Haalandauthor=J.+M.+Ganauthor=S.+C.+Thamauthor=I.+Sinhaauthor=E.+H.+Tanauthor=K.+H.+Limauthor=A.+Takanoauthor=S.+S.+Krisnaauthor=M.+M.+Thuauthor=H.+P.+Liewauthor=A.+Ullrichauthor=W.+T.+Limauthor=B.+T.+Chua&title=Bosutinib+inhibits+migration+and+invasion+via+ACK1+in+KRAS+mutant+non-small+cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Bosutinib inhibits migration and invasion via ack1 in kras mutant non-small cell lung cancer</span></div><div class="casAuthors">Tan, Daniel S. W.; Haaland, Benjamin; Gan, Jia Min; Tham, Su Chin; Sinha, Indrajit; Tan, Eng Huat; Lim, Kiat Hon; Takano, Angela; Krisna, Sai Sakktee; Thu, Minn Minn Myint; Liew, Hoe Peng; Ullrich, Axel; Lim, Wan-Teck; Chua, Boon Tin</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">13/1-13/10, 10 pp.</span>CODEN:
                <span class="NLM_cas:coden">MCOACG</span>;
        ISSN:<span class="NLM_cas:issn">1476-4598</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">The advent of effective targeted therapeutics has led to increasing emphasis on precise biomarkers for accurate patient stratification.  Here, we describe the role of ACK1, a non-receptor tyrosine kinase in abrogating migration and invasion in KRAS mutant lung adenocarcinoma.  Bosutinib, which inhibits ACK1 at 2.7 nM IC50, was found to inhibit cell migration and invasion but not viability in a panel of non-small cell lung cancer (NSCLC) cell lines.  Knockdown of ACK1 abrogated bosutinib-induced inhibition of cell migration and invasion specifically in KRAS mutant cells.  This finding was further confirmed in an in vivo zebrafish metastatic model.  Tissue microarray data on 210 Singaporean lung adenocarcinomas indicate that cytoplasmic ACK1 was significantly over-expressed relative to paired adjacent non-tumor tissue.  Interestingly, ACK1 expression in "normal" tissue adjacent to tumor, but not tumor, was independently assocd. with poor overall and relapse-free survival.  In conclusion, inhibition of ACK1 with bosutinib attenuates migration and invasion in the context of KRAS mutant NSCLC and may fulfil a therapeutic niche through combinatorial treatment approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcHXBxLnO8B7Vg90H21EOLACvtfcHk0lgUvDfFiwA1NA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivFaksLc%253D&md5=400cc32d1d67eb1f6c75c197ebebc14e</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1186%2F1476-4598-13-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1476-4598-13-13%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DD.%2BS.%26aulast%3DHaaland%26aufirst%3DB.%26aulast%3DGan%26aufirst%3DJ.%2BM.%26aulast%3DTham%26aufirst%3DS.%2BC.%26aulast%3DSinha%26aufirst%3DI.%26aulast%3DTan%26aufirst%3DE.%2BH.%26aulast%3DLim%26aufirst%3DK.%2BH.%26aulast%3DTakano%26aufirst%3DA.%26aulast%3DKrisna%26aufirst%3DS.%2BS.%26aulast%3DThu%26aufirst%3DM.%2BM.%26aulast%3DLiew%26aufirst%3DH.%2BP.%26aulast%3DUllrich%26aufirst%3DA.%26aulast%3DLim%26aufirst%3DW.%2BT.%26aulast%3DChua%26aufirst%3DB.%2BT.%26atitle%3DBosutinib%2520inhibits%2520migration%2520and%2520invasion%2520via%2520ACK1%2520in%2520KRAS%2520mutant%2520non-small%2520cell%2520lung%2520cancer%26jtitle%3DMol.%2520Cancer%26date%3D2014%26volume%3D13%26spage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Carter, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velasco, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabian, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milanov, Z. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atteridge, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biggs, W. H.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edeen, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grotzfeld, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insko, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyers, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varmus, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, D. J.</span><span> </span><span class="NLM_article-title">Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinases</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">11011</span><span class="NLM_x">–</span> <span class="NLM_lpage">11016</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm501929n&amp;key=10.1073%2Fpnas.0504952102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm501929n&amp;key=16046538" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm501929n&amp;key=1%3ACAS%3A528%3ADC%252BD2MXnvVWjurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=11011-11016&author=T.+A.+Carterauthor=L.+M.+Wodickaauthor=N.+P.+Shahauthor=A.+M.+Velascoauthor=M.+A.+Fabianauthor=D.+K.+Treiberauthor=Z.+V.+Milanovauthor=C.+E.+Atteridgeauthor=W.+H.+Biggsauthor=P.+T.+Edeenauthor=M.+Floydauthor=J.+M.+Fordauthor=R.+M.+Grotzfeldauthor=S.+Herrgardauthor=D.+E.+Inskoauthor=S.+A.+Mehtaauthor=H.+K.+Patelauthor=W.+Paoauthor=C.+L.+Sawyersauthor=H.+Varmusauthor=P.+P.+Zarrinkarauthor=D.+J.+Lockhart&title=Inhibition+of+drug-resistant+mutants+of+ABL%2C+KIT%2C+and+EGF+receptor+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinases</span></div><div class="casAuthors">Carter, Todd A.; Wodicka, Lisa M.; Shah, Neil P.; Velasco, Anne Marie; Fabian, Miles A.; Treiber, Daniel K.; Milanov, Zdravko V.; Atteridge, Corey E.; Biggs, William H., III; Edeen, Philip T.; Floyd, Mark; Ford, Julia M.; Grotzfeld, Robert M.; Herrgard, Sanna; Insko, Darren E.; Mehta, Shamal A.; Patel, Hitesh K.; Pao, William; Sawyers, Charles L.; Varmus, Harold; Zarrinkar, Patrick P.; Lockhart, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">11011-11016</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">To realize the full potential of targeted protein kinase inhibitors for the treatment of cancer, it is important to address the emergence of drug resistance in treated patients.  Mutant forms of BCR-ABL, KIT, and the EGF receptor (EGFR) have been found that confer resistance to the drugs imatinib, gefitinib, and erlotinib.  The mutations weaken or prevent drug binding, and interestingly, one of the most common sites of mutation in all three kinases is a highly conserved "gatekeeper" threonine residue near the kinase active site.  We have identified existing clin. compds. that bind and inhibit drug-resistant mutant variants of ABL, KIT, and EGFR.  We found that the Aurora kinase inhibitor VX-680 and the p38 inhibitor BIRB-796 inhibit the imatinib- and BMS-354825-resistant ABL(T315I) kinase.  The KIT/FLT3 inhibitor SU-11248 potently inhibits the imatinib-resistant KIT(V559D/T670I) kinase, consistent with the clin. efficacy of SU-11248 against imatinib-resistant gastrointestinal tumors, and the EGFR inhibitors EKB-569 and Cl-1033, but not GW-572016 and ZD-6474, potently inhibit the gefitinib- and erlotinib-resistant EGFR(L858R/T790M) kinase.  EKB-569 and Cl-1033 are already in clin. trials, and our results suggest that they should be considered for testing in the treatment of gefitinib/erlotinib-resistant non-small cell lung cancer.  The results highlight the strategy of screening existing clin. compds. against newly identified drug-resistant mutant variants to find compds. that may serve as starting points for the development of next-generation drugs, or that could be used directly to treat patients that have acquired resistance to first-generation targeted therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdgFgcC03tybVg90H21EOLACvtfcHk0lgUvDfFiwA1NA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXnvVWjurg%253D&md5=448c95c51b0cf9b5035df4065cd8f62c</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0504952102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0504952102%26sid%3Dliteratum%253Aachs%26aulast%3DCarter%26aufirst%3DT.%2BA.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DShah%26aufirst%3DN.%2BP.%26aulast%3DVelasco%26aufirst%3DA.%2BM.%26aulast%3DFabian%26aufirst%3DM.%2BA.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DBiggs%26aufirst%3DW.%2BH.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DFord%26aufirst%3DJ.%2BM.%26aulast%3DGrotzfeld%26aufirst%3DR.%2BM.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DInsko%26aufirst%3DD.%2BE.%26aulast%3DMehta%26aufirst%3DS.%2BA.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DPao%26aufirst%3DW.%26aulast%3DSawyers%26aufirst%3DC.%2BL.%26aulast%3DVarmus%26aufirst%3DH.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26atitle%3DInhibition%2520of%2520drug-resistant%2520mutants%2520of%2520ABL%252C%2520KIT%252C%2520and%2520EGF%2520receptor%2520kinases%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D11011%26epage%3D11016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karaca, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gioeli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Earp, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whang, Y. E.</span><span> </span><span class="NLM_article-title">Dasatinib inhibits site-specific tyrosine phosphorylation of androgen receptor by Ack1 and Src kinases</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">3208</span><span class="NLM_x">–</span> <span class="NLM_lpage">3216</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2010&pages=3208-3216&author=Y.+Liuauthor=M.+Karacaauthor=Z.+Zhangauthor=D.+Gioeliauthor=H.+S.+Earpauthor=Y.+E.+Whang&title=Dasatinib+inhibits+site-specific+tyrosine+phosphorylation+of+androgen+receptor+by+Ack1+and+Src+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DKaraca%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DGioeli%26aufirst%3DD.%26aulast%3DEarp%26aufirst%3DH.%2BS.%26aulast%3DWhang%26aufirst%3DY.%2BE.%26atitle%3DDasatinib%2520inhibits%2520site-specific%2520tyrosine%2520phosphorylation%2520of%2520androgen%2520receptor%2520by%2520Ack1%2520and%2520Src%2520kinases%26jtitle%3DOncogene%26date%3D2010%26volume%3D29%26spage%3D3208%26epage%3D3216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rix, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colinge, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eschrich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Superti-Furga, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koomen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haura, E. B.</span><span> </span><span class="NLM_article-title">A chemical and phosphoproteomic characterization of dasatinib action in lung cancer</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="NLM_x">–</span> <span class="NLM_lpage">299</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm501929n&amp;key=10.1038%2Fnchembio.332" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm501929n&amp;key=20190765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm501929n&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFeksbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=291-299&author=J.+Liauthor=U.+Rixauthor=B.+Fangauthor=Y.+Baiauthor=A.+Edwardsauthor=J.+Colingeauthor=K.+L.+Bennettauthor=J.+Gaoauthor=L.+Songauthor=S.+Eschrichauthor=G.+Superti-Furgaauthor=J.+Koomenauthor=E.+B.+Haura&title=A+chemical+and+phosphoproteomic+characterization+of+dasatinib+action+in+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">A chemical and phosphoproteomic characterization of dasatinib action in lung cancer</span></div><div class="casAuthors">Li, Jiannong; Rix, Uwe; Fang, Bin; Bai, Yun; Edwards, Arthur; Colinge, Jacques; Bennett, Keiryn L.; Gao, Jingchun; Song, Lanxi; Eschrich, Steven; Superti-Furga, Giulio; Koomen, John; Haura, Eric B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">291-299</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We describe a strategy for comprehending signaling pathways that are active in lung cancer cells and that are targeted by dasatinib using chem. proteomics to identify direct interacting proteins combined with immunoaffinity purifn. of tyrosine-phosphorylated peptides corresponding to activated tyrosine kinases.  We identified nearly 40 different kinase targets of dasatinib.  These include SRC-family kinase (SFK) members (LYN, SRC, FYN, LCK and YES), nonreceptor tyrosine kinases (FRK, BRK and ACK) and receptor tyrosine kinases (Ephrin receptors, DDR1 and EGFR).  Using quant. phosphoproteomics, we identified peptides corresponding to autophosphorylation sites of these tyrosine kinases that are inhibited in a concn.-dependent manner by dasatinib.  Using drug-resistant gatekeeper mutants, we show that SFKs (particularly SRC and FYN), as well as EGFR, are relevant targets for dasatinib action.  The combined mass spectrometry-based approach described here provides a system-level view of dasatinib action in cancer cells and suggests both functional targets and a rationale for combinatorial therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqww7cetmkYebVg90H21EOLACvtfcHk0lhpzEtk6XB5vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFeksbw%253D&md5=6118751b40473b407f1cb45b785c7028</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.332%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DRix%26aufirst%3DU.%26aulast%3DFang%26aufirst%3DB.%26aulast%3DBai%26aufirst%3DY.%26aulast%3DEdwards%26aufirst%3DA.%26aulast%3DColinge%26aufirst%3DJ.%26aulast%3DBennett%26aufirst%3DK.%2BL.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DSong%26aufirst%3DL.%26aulast%3DEschrich%26aufirst%3DS.%26aulast%3DSuperti-Furga%26aufirst%3DG.%26aulast%3DKoomen%26aufirst%3DJ.%26aulast%3DHaura%26aufirst%3DE.%2BB.%26atitle%3DA%2520chemical%2520and%2520phosphoproteomic%2520characterization%2520of%2520dasatinib%2520action%2520in%2520lung%2520cancer%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D6%26spage%3D291%26epage%3D299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Galkin, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melnick, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steensma, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopiuk, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warmuth, M.</span><span> </span><span class="NLM_article-title">Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">270</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=270-275&author=A.+V.+Galkinauthor=J.+S.+Melnickauthor=S.+Kimauthor=T.+L.+Hoodauthor=N.+Liauthor=L.+Liauthor=G.+Xiaauthor=R.+Steensmaauthor=G.+Chopiukauthor=J.+Jiangauthor=Y.+Wanauthor=P.+Dingauthor=Y.+Liuauthor=F.+Sunauthor=P.+G.+Schultzauthor=N.+S.+Grayauthor=M.+Warmuth&title=Identification+of+NVP-TAE684%2C+a+potent%2C+selective%2C+and+efficacious+inhibitor+of+NPM-ALK"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGalkin%26aufirst%3DA.%2BV.%26aulast%3DMelnick%26aufirst%3DJ.%2BS.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DHood%26aufirst%3DT.%2BL.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DXia%26aufirst%3DG.%26aulast%3DSteensma%26aufirst%3DR.%26aulast%3DChopiuk%26aufirst%3DG.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DWan%26aufirst%3DY.%26aulast%3DDing%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DF.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DWarmuth%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520NVP-TAE684%252C%2520a%2520potent%252C%2520selective%252C%2520and%2520efficacious%2520inhibitor%2520of%2520NPM-ALK%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2007%26volume%3D104%26spage%3D270%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Davis, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallares, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hocker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span> </span><span class="NLM_article-title">Comprehensive analysis of kinase inhibitor selectivity</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1046</span><span class="NLM_x">–</span> <span class="NLM_lpage">1051</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm501929n&amp;key=10.1038%2Fnbt.1990" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm501929n&amp;key=22037378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm501929n&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyisrrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=1046-1051&author=M.+I.+Davisauthor=J.+P.+Huntauthor=S.+Herrgardauthor=P.+Ciceriauthor=L.+M.+Wodickaauthor=G.+Pallaresauthor=M.+Hockerauthor=D.+K.+Treiberauthor=P.+P.+Zarrinkar&title=Comprehensive+analysis+of+kinase+inhibitor+selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive analysis of kinase inhibitor selectivity</span></div><div class="casAuthors">Davis, Mindy I.; Hunt, Jeremy P.; Herrgard, Sanna; Ciceri, Pietro; Wodicka, Lisa M.; Pallares, Gabriel; Hocker, Michael; Treiber, Daniel K.; Zarrinkar, Patrick P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1046-1051</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We tested the interaction of 72 kinase inhibitors with 442 kinases covering >80% of the human catalytic protein kinome.  Our data show that, as a class, type II inhibitors are more selective than type I inhibitors, but that there are important exceptions to this trend.  The data further illustrate that selective inhibitors have been developed against the majority of kinases targeted by the compds. tested.  Anal. of the interaction patterns reveals a class of 'group-selective' inhibitors broadly active against a single subfamily of kinases, but selective outside that subfamily.  The data set suggests compds. to use as tools to study kinases for which no dedicated inhibitors exist.  It also provides a foundation for further exploring kinase inhibitor biol. and toxicity, as well as for studying the structural basis of the obsd. interaction patterns.  Our findings will help to realize the direct enabling potential of genomics for drug development and basic research about cellular signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEZnKVs6Xt5rVg90H21EOLACvtfcHk0lhpzEtk6XB5vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyisrrK&md5=67639f702cb48ffb2c60e9a250f0df5e</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fnbt.1990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.1990%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DM.%2BI.%26aulast%3DHunt%26aufirst%3DJ.%2BP.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DPallares%26aufirst%3DG.%26aulast%3DHocker%26aufirst%3DM.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26atitle%3DComprehensive%2520analysis%2520of%2520kinase%2520inhibitor%2520selectivity%26jtitle%3DNat.%2520Biotechnol.%26date%3D2011%26volume%3D29%26spage%3D1046%26epage%3D1051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Metz, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soni, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merta, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kifle, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajduk, P. J.</span><span> </span><span class="NLM_article-title">Navigating the kinome</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">200</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm501929n&amp;key=10.1038%2Fnchembio.530" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm501929n&amp;key=21336281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm501929n&amp;key=1%3ACAS%3A528%3ADC%252BC3MXit1aitrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=200-202&author=J.+T.+Metzauthor=E.+F.+Johnsonauthor=N.+B.+Soniauthor=P.+J.+Mertaauthor=L.+Kifleauthor=P.+J.+Hajduk&title=Navigating+the+kinome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Navigating the kinome</span></div><div class="casAuthors">Metz, James T.; Johnson, Eric F.; Soni, Niru B.; Merta, Philip J.; Kifle, Lemma; Hajduk, Philip J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">200-202</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Although it is increasingly being recognized that drug-target interaction networks can be powerful tools for the interrogation of systems biol. and the rational design of multitargeted drugs, there is no generalized, statistically validated approach to harmonizing sequence-dependent and pharmacol.-dependent networks.  Here we demonstrate the creation of a comprehensive kinome interaction network based not only on sequence comparisons but also on multiple pharmacol. parameters derived from activity profiling data.  The framework described for statistical interpretation of these network connections also enables rigorous investigation of chemotype-specific interaction networks, which is crit. for multitargeted drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOgzF9Q0eH87Vg90H21EOLACvtfcHk0lj9uZJf1hTzxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXit1aitrc%253D&md5=09234ec451a4918e5aca6d65e0b65aee</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.530&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.530%26sid%3Dliteratum%253Aachs%26aulast%3DMetz%26aufirst%3DJ.%2BT.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DSoni%26aufirst%3DN.%2BB.%26aulast%3DMerta%26aufirst%3DP.%2BJ.%26aulast%3DKifle%26aufirst%3DL.%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26atitle%3DNavigating%2520the%2520kinome%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2011%26volume%3D7%26spage%3D200%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Jiao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopecky, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaen, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardozo, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesche, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrelly, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayser, F.</span><span> </span><span class="NLM_article-title">Synthesis and optimization of substituted furo[2,3-<i>d</i>]-pyrimidin-4-amines and 7H-pyrrolo[2,3-<i>d</i>]pyrimidin-4-amines as ACK1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">6212</span><span class="NLM_x">–</span> <span class="NLM_lpage">6217</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=6212-6217&author=X.+Jiaoauthor=D.+J.+Kopeckyauthor=J.+Liuauthor=J.+C.+Jaenauthor=M.+G.+Cardozoauthor=R.+Sharmaauthor=N.+Walkerauthor=H.+Wescheauthor=S.+Liauthor=E.+Farrellyauthor=S.+H.+Xiaoauthor=Z.+Wangauthor=F.+Kayser&title=Synthesis+and+optimization+of+substituted+furo%5B2%2C3-d%5D-pyrimidin-4-amines+and+7H-pyrrolo%5B2%2C3-d%5Dpyrimidin-4-amines+as+ACK1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJiao%26aufirst%3DX.%26aulast%3DKopecky%26aufirst%3DD.%2BJ.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DJaen%26aufirst%3DJ.%2BC.%26aulast%3DCardozo%26aufirst%3DM.%2BG.%26aulast%3DSharma%26aufirst%3DR.%26aulast%3DWalker%26aufirst%3DN.%26aulast%3DWesche%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DFarrelly%26aufirst%3DE.%26aulast%3DXiao%26aufirst%3DS.%2BH.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DKayser%26aufirst%3DF.%26atitle%3DSynthesis%2520and%2520optimization%2520of%2520substituted%2520furo%255B2%252C3-d%255D-pyrimidin-4-amines%2520and%25207H-pyrrolo%255B2%252C3-d%255Dpyrimidin-4-amines%2520as%2520ACK1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D6212%26epage%3D6217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Bossi, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saccardo, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ardini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menichincheri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusconi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnaghi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orsini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avanzi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgia, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nesi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bandiera, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogliatto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, J. A.</span><span> </span><span class="NLM_article-title">Crystal structures of anaplastic lymphoma kinase in complex with ATP competitive inhibitors</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6813</span><span class="NLM_x">–</span> <span class="NLM_lpage">6825</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi1005514" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm501929n&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpt1Clsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=6813-6825&author=R.+T.+Bossiauthor=M.+B.+Saccardoauthor=E.+Ardiniauthor=M.+Menichincheriauthor=L.+Rusconiauthor=P.+Magnaghiauthor=P.+Orsiniauthor=N.+Avanziauthor=A.+L.+Borgiaauthor=M.+Nesiauthor=T.+Bandieraauthor=G.+Fogliattoauthor=J.+A.+Bertrand&title=Crystal+structures+of+anaplastic+lymphoma+kinase+in+complex+with+ATP+competitive+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structures of Anaplastic Lymphoma Kinase in Complex with ATP Competitive Inhibitors</span></div><div class="casAuthors">Bossi, Roberto T.; Saccardo, M. Beatrice; Ardini, Elena; Menichincheri, Maria; Rusconi, Luisa; Magnaghi, Paola; Orsini, Paolo; Avanzi, Nilla; Borgia, Andrea Lombardi; Nesi, Marcella; Bandiera, Tiziano; Fogliatto, Gianpaolo; Bertrand, Jay A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">6813-6825</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase involved in the development of several human cancers and, as a result, is a recognized target for the development of small-mol. inhibitors for the treatment of ALK-pos. malignancies.  Here, the crystal structures of the unphosphorylated human ALK kinase domain in complex with the ATP competitive ligands PHA-E429 and NVP-TAE684 are presented.  Anal. of these structures provides valuable information concerning the specific characteristics of the ALK active site as well as giving indications about how to obtain selective ALK inhibitors.  In addn., the ALK-KD-PHA-E429 structure led to the identification of a potential regulatory mechanism involving a link made between a short helical segment immediately following the DFG motif and an N-terminal two-stranded β-sheet.  Finally, mapping of the activating mutations assocd. with neuroblastoma onto the structures may explain the roles these residues have in the activation process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2b8yuzTuAYbVg90H21EOLACvtfcHk0lj9uZJf1hTzxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpt1Clsbs%253D&md5=e8e9e3fde63a196a15c874300c995342</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fbi1005514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi1005514%26sid%3Dliteratum%253Aachs%26aulast%3DBossi%26aufirst%3DR.%2BT.%26aulast%3DSaccardo%26aufirst%3DM.%2BB.%26aulast%3DArdini%26aufirst%3DE.%26aulast%3DMenichincheri%26aufirst%3DM.%26aulast%3DRusconi%26aufirst%3DL.%26aulast%3DMagnaghi%26aufirst%3DP.%26aulast%3DOrsini%26aufirst%3DP.%26aulast%3DAvanzi%26aufirst%3DN.%26aulast%3DBorgia%26aufirst%3DA.%2BL.%26aulast%3DNesi%26aufirst%3DM.%26aulast%3DBandiera%26aufirst%3DT.%26aulast%3DFogliatto%26aufirst%3DG.%26aulast%3DBertrand%26aufirst%3DJ.%2BA.%26atitle%3DCrystal%2520structures%2520of%2520anaplastic%2520lymphoma%2520kinase%2520in%2520complex%2520with%2520ATP%2520competitive%2520inhibitors%26jtitle%3DBiochemistry%26date%3D2010%26volume%3D49%26spage%3D6813%26epage%3D6825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Bernhart, C.; Bouaboula, M.; Casellas, P.; Jegham, S.; Arigon, J.; Combet, R.; Hilairet, S.; Fraisse, P.</span><span> </span><span class="NLM_article-title">Nicotinamide derivatives, preparation thereof and therapeutic use thereof</span>. US20100222319A1,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=C.+Bernhart&author=M.+Bouaboula&author=P.+Casellas&author=S.+Jegham&author=J.+Arigon&author=R.+Combet&author=S.+Hilairet&author=P.+Fraisse&title=Nicotinamide+derivatives%2C+preparation+thereof+and+therapeutic+use+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBernhart%26aufirst%3DC.%26atitle%3DNicotinamide%2520derivatives%252C%2520preparation%2520thereof%2520and%2520therapeutic%2520use%2520thereof%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Martin, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pireddu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alam, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozcan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebti, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schonbrunn, E.</span><span> </span><span class="NLM_article-title">A novel mechanism by which small molecule inhibitors induce the DFG flip in Aurora A</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">698</span><span class="NLM_x">–</span> <span class="NLM_lpage">706</span></span><div class="citationLinks">[<a href="/doi/10.1021/cb200508b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=698-706&author=M.+P.+Martinauthor=J.+Y.+Zhuauthor=H.+R.+Lawrenceauthor=R.+Piredduauthor=Y.+Luoauthor=R.+Alamauthor=S.+Ozcanauthor=S.+M.+Sebtiauthor=N.+J.+Lawrenceauthor=E.+Schonbrunn&title=A+novel+mechanism+by+which+small+molecule+inhibitors+induce+the+DFG+flip+in+Aurora+A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fcb200508b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb200508b%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DM.%2BP.%26aulast%3DZhu%26aufirst%3DJ.%2BY.%26aulast%3DLawrence%26aufirst%3DH.%2BR.%26aulast%3DPireddu%26aufirst%3DR.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DAlam%26aufirst%3DR.%26aulast%3DOzcan%26aufirst%3DS.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26aulast%3DLawrence%26aufirst%3DN.%2BJ.%26aulast%3DSchonbrunn%26aufirst%3DE.%26atitle%3DA%2520novel%2520mechanism%2520by%2520which%2520small%2520molecule%2520inhibitors%2520induce%2520the%2520DFG%2520flip%2520in%2520Aurora%2520A%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2012%26volume%3D7%26spage%3D698%26epage%3D706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gevariya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rix, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schonbrunn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebti, S. M.</span><span> </span><span class="NLM_article-title">Dual Aurora A and JAK2 kinase blockade effectively suppresses malignant transformation</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">2947</span><span class="NLM_x">–</span> <span class="NLM_lpage">2961</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=2947-2961&author=H.+Yangauthor=H.+R.+Lawrenceauthor=A.+Kaziauthor=H.+Gevariyaauthor=R.+Patelauthor=Y.+Luoauthor=U.+Rixauthor=E.+Schonbrunnauthor=N.+J.+Lawrenceauthor=S.+M.+Sebti&title=Dual+Aurora+A+and+JAK2+kinase+blockade+effectively+suppresses+malignant+transformation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DH.%26aulast%3DLawrence%26aufirst%3DH.%2BR.%26aulast%3DKazi%26aufirst%3DA.%26aulast%3DGevariya%26aufirst%3DH.%26aulast%3DPatel%26aufirst%3DR.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DRix%26aufirst%3DU.%26aulast%3DSchonbrunn%26aufirst%3DE.%26aulast%3DLawrence%26aufirst%3DN.%2BJ.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26atitle%3DDual%2520Aurora%2520A%2520and%2520JAK2%2520kinase%2520blockade%2520effectively%2520suppresses%2520malignant%2520transformation%26jtitle%3DOncotarget%26date%3D2014%26volume%3D5%26spage%3D2947%26epage%3D2961" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Cooper, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walborsky, H. M.</span><span> </span><span class="NLM_article-title">Alkali metals dissolved in optically active solvents</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">2110</span><span class="NLM_x">–</span> <span class="NLM_lpage">2116</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00323a026" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1981&pages=2110-2116&author=K.+D.+Cooperauthor=H.+M.+Walborsky&title=Alkali+metals+dissolved+in+optically+active+solvents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjo00323a026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00323a026%26sid%3Dliteratum%253Aachs%26aulast%3DCooper%26aufirst%3DK.%2BD.%26aulast%3DWalborsky%26aufirst%3DH.%2BM.%26atitle%3DAlkali%2520metals%2520dissolved%2520in%2520optically%2520active%2520solvents%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1981%26volume%3D46%26spage%3D2110%26epage%3D2116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Jones, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willett, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glen, R. C.</span><span> </span><span class="NLM_article-title">Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">245</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm501929n&amp;key=10.1016%2FS0022-2836%2895%2980037-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm501929n&amp;key=7823319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm501929n&amp;key=1%3ACAS%3A528%3ADyaK2MXjtVKlsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=245&publication_year=1995&pages=43-53&author=G.+Jonesauthor=P.+Willettauthor=R.+C.+Glen&title=Molecular+recognition+of+receptor+sites+using+a+genetic+algorithm+with+a+description+of+desolvation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular recognition of a receptor sites using a genetic algorithm with a description of desolvation</span></div><div class="casAuthors">Jones, Gareth; Willett, Peter; Glen, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">245</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-53</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Understanding the principles whereby macromol. biol. receptors can recognize small mol. substrates or inhibitors is the subject of a major effort.  This is of paramount importance in rational drug design where the receptor structure is known (the "docking" problem).  Current theor. approaches utilize models of the steric and electrostatic interaction of bound ligands and recently conformational flexibility has been incorporated.  The authors report results based on software using a genetic algorithm that uses an evolutionary strategy in exploring the full conformational flexibility of the ligand with partial flexibility of the protein, and which satisfies the fundamental requirement that the ligand must displace loosely bound water on binding.  Results are reported on five test systems showing excellent agreement with exptl. data.  The design of the algorithm offers insight into the mol. recognition mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7Xcn7nQyVRLVg90H21EOLACvtfcHk0lg8in5QE-_cBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjtVKlsbc%253D&md5=bf45edafb986a73c7c1d0ac55e070f28</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2FS0022-2836%2895%2980037-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-2836%252895%252980037-9%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DG.%26aulast%3DWillett%26aufirst%3DP.%26aulast%3DGlen%26aufirst%3DR.%2BC.%26atitle%3DMolecular%2520recognition%2520of%2520receptor%2520sites%2520using%2520a%2520genetic%2520algorithm%2520with%2520a%2520description%2520of%2520desolvation%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1995%26volume%3D245%26spage%3D43%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Verdonk, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartshorn, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, R. D.</span><span> </span><span class="NLM_article-title">Improved protein–ligand docking using GOLD</span> <span class="citation_source-journal">Proteins: Struct., Funct., Bioinf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">609</span><span class="NLM_x">–</span> <span class="NLM_lpage">623</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2003&pages=609-623&author=M.+L.+Verdonkauthor=J.+C.+Coleauthor=M.+J.+Hartshornauthor=C.+W.+Murrayauthor=R.+D.+Taylor&title=Improved+protein%E2%80%93ligand+docking+using+GOLD"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVerdonk%26aufirst%3DM.%2BL.%26aulast%3DCole%26aufirst%3DJ.%2BC.%26aulast%3DHartshorn%26aufirst%3DM.%2BJ.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DTaylor%26aufirst%3DR.%2BD.%26atitle%3DImproved%2520protein%25E2%2580%2593ligand%2520docking%2520using%2520GOLD%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Bioinf.%26date%3D2003%26volume%3D52%26spage%3D609%26epage%3D623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Targeting cancer with small molecule kinase inhibitors</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm501929n&amp;key=10.1038%2Fnrc2559" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm501929n&amp;key=19104514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm501929n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1yg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=28-39&author=J.+Zhangauthor=P.+L.+Yangauthor=N.+S.+Gray&title=Targeting+cancer+with+small+molecule+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting cancer with small molecule kinase inhibitors</span></div><div class="casAuthors">Zhang, Jianming; Yang, Priscilla L.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">28-39</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Deregulation of kinase activity has emerged as a major mechanism by which cancer cells evade normal physiol. constraints on growth and survival.  To date, 11 kinase inhibitors have received US Food and Drug Administration approval as cancer treatments, and there are considerable efforts to develop selective small mol. inhibitors for a host of other kinases that are implicated in cancer and other diseases.  Herein we discuss the current challenges in the field, such as designing selective inhibitors and developing strategies to overcome resistance mutations.  This Review provides a broad overview of some of the approaches currently used to discover and characterize new kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriSM3BN_uEz7Vg90H21EOLACvtfcHk0lg8in5QE-_cBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1yg&md5=35bc38f414cd21eef5e61ce181b580fb</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1038%2Fnrc2559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2559%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DP.%2BL.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DTargeting%2520cancer%2520with%2520small%2520molecule%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2009%26volume%3D9%26spage%3D28%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Hartman, D. A.</span><span> </span><span class="NLM_article-title">Determination of the stability of drugs in plasma</span>.  <span class="citation_source-book">Current Protocols in Pharmacology</span>; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2003</span><span class="NLM_x">; </span>Chapter 7, Unit 7.6.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm501929n&amp;key=10.1002%2F0471141755.ph0706s19" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=D.+A.+Hartman&title=Current+Protocols+in+Pharmacology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1002%2F0471141755.ph0706s19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F0471141755.ph0706s19%26sid%3Dliteratum%253Aachs%26aulast%3DHartman%26aufirst%3DD.%2BA.%26atitle%3DDetermination%2520of%2520the%2520stability%2520of%2520drugs%2520in%2520plasma%26btitle%3DCurrent%2520Protocols%2520in%2520Pharmacology%26pub%3DWiley%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Lawrence, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pireddu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gevariya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozcan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kendig, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elias, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebti, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schonbrunn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, N. J.</span><span> </span><span class="NLM_article-title">Development of <i>o</i>-chlorophenyl substituted pyrimidines as exceptionally potent aurora kinase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">7392</span><span class="NLM_x">–</span> <span class="NLM_lpage">7416</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300334d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm501929n&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVGhsrfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7392-7416&author=H.+R.+Lawrenceauthor=M.+P.+Martinauthor=Y.+Luoauthor=R.+Piredduauthor=H.+Yangauthor=H.+Gevariyaauthor=S.+Ozcanauthor=J.+Y.+Zhuauthor=R.+Kendigauthor=M.+Rodriguezauthor=R.+Eliasauthor=J.+Q.+Chengauthor=S.+M.+Sebtiauthor=E.+Schonbrunnauthor=N.+J.+Lawrence&title=Development+of+o-chlorophenyl+substituted+pyrimidines+as+exceptionally+potent+aurora+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Development of o-Chlorophenyl Substituted Pyrimidines as Exceptionally Potent Aurora Kinase Inhibitors</span></div><div class="casAuthors">Lawrence, Harshani R.; Martin, Mathew P.; Luo, Yunting; Pireddu, Roberta; Yang, Hua; Gevariya, Harsukh; Ozcan, Sevil; Zhu, Jin-Yi; Kendig, Robert; Rodriguez, Mercedes; Elias, Roy; Cheng, Jin Q.; Sebti, Said M.; Schonbrunn, Ernst; Lawrence, Nicholas J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7392-7416</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The o-carboxylic acid substituted bisanilinopyrimidine I was identified as a potent hit (Aurora A IC50 = 6.1 ± 1.0 nM) from inhouse screening.  Detailed structure-activity relationship (SAR) studies indicated that polar substituents at the para position of the B-ring are crit. for potent activity.  X-ray crystallog. studies revealed that compd. I is a type I inhibitor that binds the Aurora kinase active site in a DFG-in conformation.  Structure-activity guided replacement of the A-ring carboxylic acid with halogens and incorporation of fluorine at the pyrimidine 5-position led to highly potent inhibitors of Aurora A that bind in a DFG-out conformation.  B-Ring modifications were undertaken to improve the soly. and cell permeability.  Compds. such as II with water-solubilizing moieties at the para position of the B-ring inhibited the autophosphorylation of Aurora A in MDA-MB-468 breast cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeJbI5uTT-4bVg90H21EOLACvtfcHk0ljrLTrS3PQTmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVGhsrfN&md5=8158e18d9d2a26dfce7a831a353f333c</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm300334d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300334d%26sid%3Dliteratum%253Aachs%26aulast%3DLawrence%26aufirst%3DH.%2BR.%26aulast%3DMartin%26aufirst%3DM.%2BP.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DPireddu%26aufirst%3DR.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DGevariya%26aufirst%3DH.%26aulast%3DOzcan%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DJ.%2BY.%26aulast%3DKendig%26aufirst%3DR.%26aulast%3DRodriguez%26aufirst%3DM.%26aulast%3DElias%26aufirst%3DR.%26aulast%3DCheng%26aufirst%3DJ.%2BQ.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26aulast%3DSchonbrunn%26aufirst%3DE.%26aulast%3DLawrence%26aufirst%3DN.%2BJ.%26atitle%3DDevelopment%2520of%2520o-chlorophenyl%2520substituted%2520pyrimidines%2520as%2520exceptionally%2520potent%2520aurora%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7392%26epage%3D7416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Park, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, I. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latif, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yun, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chae, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, S. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ha, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yun, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span> </span><span class="NLM_article-title">Novel bis-ortho-alkoxy-para-piperazinesubstituted-2,4-dianilinopyrimidines (KRCA-0008) as potent and selective ALK inhibitors for anticancer treatment</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">6192</span><span class="NLM_x">–</span> <span class="NLM_lpage">6196</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=6192-6196&author=C.+H.+Parkauthor=H.+Choeauthor=I.+Y.+Jangauthor=S.+Y.+Kwonauthor=M.+Latifauthor=H.+K.+Leeauthor=H.+J.+Leeauthor=E.+H.+Yangauthor=J.+I.+Yunauthor=C.+H.+Chaeauthor=S.+Y.+Choauthor=S.+U.+Choiauthor=J.+D.+Haauthor=H.+Jungauthor=H.+R.+Kimauthor=P.+Kimauthor=C.+O.+Leeauthor=C.+S.+Yunauthor=K.+Lee&title=Novel+bis-ortho-alkoxy-para-piperazinesubstituted-2%2C4-dianilinopyrimidines+%28KRCA-0008%29+as+potent+and+selective+ALK+inhibitors+for+anticancer+treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DC.%2BH.%26aulast%3DChoe%26aufirst%3DH.%26aulast%3DJang%26aufirst%3DI.%2BY.%26aulast%3DKwon%26aufirst%3DS.%2BY.%26aulast%3DLatif%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DH.%2BK.%26aulast%3DLee%26aufirst%3DH.%2BJ.%26aulast%3DYang%26aufirst%3DE.%2BH.%26aulast%3DYun%26aufirst%3DJ.%2BI.%26aulast%3DChae%26aufirst%3DC.%2BH.%26aulast%3DCho%26aufirst%3DS.%2BY.%26aulast%3DChoi%26aufirst%3DS.%2BU.%26aulast%3DHa%26aufirst%3DJ.%2BD.%26aulast%3DJung%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DH.%2BR.%26aulast%3DKim%26aufirst%3DP.%26aulast%3DLee%26aufirst%3DC.%2BO.%26aulast%3DYun%26aufirst%3DC.%2BS.%26aulast%3DLee%26aufirst%3DK.%26atitle%3DNovel%2520bis-ortho-alkoxy-para-piperazinesubstituted-2%252C4-dianilinopyrimidines%2520%2528KRCA-0008%2529%2520as%2520potent%2520and%2520selective%2520ALK%2520inhibitors%2520for%2520anticancer%2520treatment%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D6192%26epage%3D6196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerns, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span> </span><span class="NLM_article-title">Development and application of high throughput plasma stability assay for drug discovery</span> <span class="citation_source-journal">Int. J. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">297</span><span class="NLM_x">, </span> <span class="NLM_fpage">110</span><span class="NLM_x">–</span> <span class="NLM_lpage">119</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm501929n&amp;key=10.1016%2Fj.ijpharm.2005.03.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm501929n&amp;key=15876500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm501929n&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkt1ansrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2005&pages=110-119&author=L.+Diauthor=E.+H.+Kernsauthor=Y.+Hongauthor=H.+Chen&title=Development+and+application+of+high+throughput+plasma+stability+assay+for+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Development and application of high throughput plasma stability assay for drug discovery</span></div><div class="casAuthors">Di, Li; Kerns, Edward H.; Hong, Yan; Chen, Hong</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">110-119</span>CODEN:
                <span class="NLM_cas:coden">IJPHDE</span>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Plasma stability plays an important role in drug discovery and development.  Unstable compds. tend to have rapid clearance and short half-life, resulting in poor in vivo performance.  This paper examines the variables that affect the plasma stability assay results, including substrate concn., %DMSO, plasma concn., enzyme activity upon incubation and batch variation.  The results show that plasma stability can accommodate a wide range of exptl. conditions.  Relatively minor differences in results are produced with major differences in conditions.  Significant batch-to-batch variations were obsd. for rat plasma.  We selected the following conditions: 1 μM substrate concn., 2.5% DMSO, and 50% diln. of plasma in pH 7.4 buffer.  Plasma stability can be used as a diagnostic assay when compds. are unexpectedly rapidly cleared, as a special assay when structural classes contain groups that may be susceptible to plasma enzyme hydrolysis, or as general screen for compds. if resources are available.  Plasma stability assay has many applications in drug discovery: to alert teams to labile structural motifs, to prioritize compds. for in vivo studies and to screen prodrugs and antedrugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZUoDVyphu6bVg90H21EOLACvtfcHk0ljrLTrS3PQTmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkt1ansrg%253D&md5=cee758567f2d75838b28817a1040f855</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpharm.2005.03.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpharm.2005.03.022%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DKerns%26aufirst%3DE.%2BH.%26aulast%3DHong%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DH.%26atitle%3DDevelopment%2520and%2520application%2520of%2520high%2520throughput%2520plasma%2520stability%2520assay%2520for%2520drug%2520discovery%26jtitle%3DInt.%2520J.%2520Pharm.%26date%3D2005%26volume%3D297%26spage%3D110%26epage%3D119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Koch-Weser, J.</span><span> </span><span class="NLM_article-title">Clinical application of the pharmacokinetics of procaine amide</span> <span class="citation_source-journal">Cardiovasc. Clin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1974</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">75</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm501929n&amp;key=4613464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm501929n&amp;key=1%3ACAS%3A280%3ADyaE2M%252FnsVWksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1974&pages=63-75&author=J.+Koch-Weser&title=Clinical+application+of+the+pharmacokinetics+of+procaine+amide"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical application of the pharmacokinetics of procaine amide</span></div><div class="casAuthors">Koch-Weser J</div><div class="citationInfo"><span class="NLM_cas:title">Cardiovascular clinics</span>
        (<span class="NLM_cas:date">1974</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">63-75</span>
        ISSN:<span class="NLM_cas:issn">0069-0384</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTb4-aYHwcAyMRAV4D_Ins_fW6udTcc2eaRPM_ntnEGFLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE2M%252FnsVWksA%253D%253D&md5=0e02ddc46a67297748752ab837ebc7ba</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoch-Weser%26aufirst%3DJ.%26atitle%3DClinical%2520application%2520of%2520the%2520pharmacokinetics%2520of%2520procaine%2520amide%26jtitle%3DCardiovasc.%2520Clin.%26date%3D1974%26volume%3D6%26spage%3D63%26epage%3D75" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 18 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vikas  Kumar</span>, <span class="hlFld-ContribAuthor ">Raj  Kumar</span>, <span class="hlFld-ContribAuthor ">Shraddha  Parate</span>, <span class="hlFld-ContribAuthor ">Sanghwa  Yoon</span>, <span class="hlFld-ContribAuthor ">Gihwan  Lee</span>, <span class="hlFld-ContribAuthor ">Donghwan  Kim</span>, <span class="hlFld-ContribAuthor ">Keun Woo  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of ACK1 inhibitors as anticancer agents by using computer-aided drug designing. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2021,</strong> <em>1235 </em>, 130200. <a href="https://doi.org/10.1016/j.molstruc.2021.130200" title="DOI URL">https://doi.org/10.1016/j.molstruc.2021.130200</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2021.130200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2021.130200%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DIdentification%252Bof%252BACK1%252Binhibitors%252Bas%252Banticancer%252Bagents%252Bby%252Busing%252Bcomputer-aided%252Bdrug%252Bdesigning%26aulast%3DKumar%26aufirst%3DVikas%26date%3D2021%26volume%3D1235%26spage%3D130200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiajia  Gu</span>, <span class="hlFld-ContribAuthor ">Luxi  Qian</span>, <span class="hlFld-ContribAuthor ">Guojing  Zhang</span>, <span class="hlFld-ContribAuthor ">Nupam P.  Mahajan</span>, <span class="hlFld-ContribAuthor ">Taofeek K.  Owonikoko</span>, <span class="hlFld-ContribAuthor ">Suresh S.  Ramalingam</span>, <span class="hlFld-ContribAuthor ">Shi-Yong  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of ACK1 delays and overcomes acquired resistance of EGFR mutant NSCLC cells to the third generation EGFR inhibitor, osimertinib. </span><span class="cited-content_cbyCitation_journal-name">Lung Cancer</span><span> <strong>2020,</strong> <em>150 </em>, 26-35. <a href="https://doi.org/10.1016/j.lungcan.2020.09.023" title="DOI URL">https://doi.org/10.1016/j.lungcan.2020.09.023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.lungcan.2020.09.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.lungcan.2020.09.023%26sid%3Dliteratum%253Aachs%26jtitle%3DLung%2520Cancer%26atitle%3DInhibition%252Bof%252BACK1%252Bdelays%252Band%252Bovercomes%252Bacquired%252Bresistance%252Bof%252BEGFR%252Bmutant%252BNSCLC%252Bcells%252Bto%252Bthe%252Bthird%252Bgeneration%252BEGFR%252Binhibitor%25252C%252Bosimertinib%26aulast%3DGu%26aufirst%3DJiajia%26date%3D2020%26volume%3D150%26spage%3D26%26epage%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhengnian  Li</span>, <span class="hlFld-ContribAuthor ">Chelsea E.  Powell</span>, <span class="hlFld-ContribAuthor ">Brian J.  Groendyke</span>, <span class="hlFld-ContribAuthor ">Thomas W.  Gero</span>, <span class="hlFld-ContribAuthor ">Frederic  Feru</span>, <span class="hlFld-ContribAuthor ">John  Feutrill</span>, <span class="hlFld-ContribAuthor ">Bailing  Chen</span>, <span class="hlFld-ContribAuthor ">Bin  Li</span>, <span class="hlFld-ContribAuthor ">Hilary  Szabo</span>, <span class="hlFld-ContribAuthor ">Nathanael S.  Gray</span>, <span class="hlFld-ContribAuthor ">David A.  Scott</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a series of benzopyrimidodiazepinone TNK2 inhibitors via scaffold morphing. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (19)
                                     , 127456. <a href="https://doi.org/10.1016/j.bmcl.2020.127456" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127456</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127456&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127456%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Ba%252Bseries%252Bof%252Bbenzopyrimidodiazepinone%252BTNK2%252Binhibitors%252Bvia%252Bscaffold%252Bmorphing%26aulast%3DLi%26aufirst%3DZhengnian%26date%3D2020%26volume%3D30%26issue%3D19%26spage%3D127456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eric H  Kim</span>, <span class="hlFld-ContribAuthor ">Dengfeng  Cao</span>, <span class="hlFld-ContribAuthor ">Nupam P  Mahajan</span>, <span class="hlFld-ContribAuthor ">Gerald L  Andriole</span>, <span class="hlFld-ContribAuthor ">Kiran  Mahajan</span>. </span><span class="cited-content_cbyCitation_article-title">ACK1–AR and AR–HOXB13 signaling axes: epigenetic regulation of lethal prostate cancers. </span><span class="cited-content_cbyCitation_journal-name">NAR Cancer</span><span> <strong>2020,</strong> <em>2 </em>
                                    (3)
                                     <a href="https://doi.org/10.1093/narcan/zcaa018" title="DOI URL">https://doi.org/10.1093/narcan/zcaa018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/narcan/zcaa018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fnarcan%2Fzcaa018%26sid%3Dliteratum%253Aachs%26jtitle%3DNAR%2520Cancer%26atitle%3DACK1%2525E2%252580%252593AR%252Band%252BAR%2525E2%252580%252593HOXB13%252Bsignaling%252Baxes%25253A%252Bepigenetic%252Bregulation%252Bof%252Blethal%252Bprostate%252Bcancers%26aulast%3DKim%26aufirst%3DEric%2BH%26date%3D2020%26date%3D2020%26volume%3D2%26issue%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brian J.  Groendyke</span>, <span class="hlFld-ContribAuthor ">Chelsea E.  Powell</span>, <span class="hlFld-ContribAuthor ">Frederic  Feru</span>, <span class="hlFld-ContribAuthor ">Thomas W.  Gero</span>, <span class="hlFld-ContribAuthor ">Zhengnian  Li</span>, <span class="hlFld-ContribAuthor ">Hilary  Szabo</span>, <span class="hlFld-ContribAuthor ">Kevin  Pang</span>, <span class="hlFld-ContribAuthor ">John  Feutrill</span>, <span class="hlFld-ContribAuthor ">Bailing  Chen</span>, <span class="hlFld-ContribAuthor ">Bin  Li</span>, <span class="hlFld-ContribAuthor ">Nathanael S.  Gray</span>, <span class="hlFld-ContribAuthor ">David A.  Scott</span>. </span><span class="cited-content_cbyCitation_article-title">Benzopyrimidodiazepinone inhibitors of TNK2. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (4)
                                     , 126948. <a href="https://doi.org/10.1016/j.bmcl.2020.126948" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.126948</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.126948&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.126948%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DBenzopyrimidodiazepinone%252Binhibitors%252Bof%252BTNK2%26aulast%3DGroendyke%26aufirst%3DBrian%2BJ.%26date%3D2020%26volume%3D30%26issue%3D4%26spage%3D126948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing-wei  Liang</span>, <span class="hlFld-ContribAuthor ">Shi-long  Li</span>, <span class="hlFld-ContribAuthor ">Shan  Wang</span>, <span class="hlFld-ContribAuthor ">Wan-qiu  Li</span>, <span class="hlFld-ContribAuthor ">Fan-hao  Meng</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of novel (
              E
              )-
              N'
              -benzylidene hydrazides as novel c-Met inhibitors through fragment based virtual screening. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2020,</strong> <em>35 </em>
                                    (1)
                                     , 468-477. <a href="https://doi.org/10.1080/14756366.2019.1702655" title="DOI URL">https://doi.org/10.1080/14756366.2019.1702655</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2019.1702655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2019.1702655%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252B%252528%252BE%252B%252529-%252BN%252527%252B-benzylidene%252Bhydrazides%252Bas%252Bnovel%252Bc-Met%252Binhibitors%252Bthrough%252Bfragment%252Bbased%252Bvirtual%252Bscreening%26aulast%3DLiang%26aufirst%3DJing-wei%26date%3D2020%26date%3D2020%26volume%3D35%26issue%3D1%26spage%3D468%26epage%3D477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xia  Liu</span>, <span class="hlFld-ContribAuthor ">Xuan  Wang</span>, <span class="hlFld-ContribAuthor ">Lifang  Li</span>, <span class="hlFld-ContribAuthor ">Baolin  Han</span>. </span><span class="cited-content_cbyCitation_article-title">Research Progress of the Functional Role of ACK1 in Breast Cancer. </span><span class="cited-content_cbyCitation_journal-name">BioMed Research International</span><span> <strong>2019,</strong> <em>2019 </em>, 1-6. <a href="https://doi.org/10.1155/2019/1018034" title="DOI URL">https://doi.org/10.1155/2019/1018034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2019/1018034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2019%2F1018034%26sid%3Dliteratum%253Aachs%26jtitle%3DBioMed%2520Research%2520International%26atitle%3DResearch%252BProgress%252Bof%252Bthe%252BFunctional%252BRole%252Bof%252BACK1%252Bin%252BBreast%252BCancer%26aulast%3DLiu%26aufirst%3DXia%26date%3D2019%26volume%3D2019%26spage%3D1%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kyra A.  Gallagher</span>, <span class="hlFld-ContribAuthor ">Austin  Doughty</span>, <span class="hlFld-ContribAuthor ">Elivia  Layton</span>, <span class="hlFld-ContribAuthor ">Sara  Zukerman</span>, <span class="hlFld-ContribAuthor ">Benqing  Zhou</span>, <span class="hlFld-ContribAuthor ">Wei R.  Chen</span>, . </span><span class="cited-content_cbyCitation_article-title">The characterization of graphene-reconstituted low-density lipoproteins and small molecule inhibitor nanoparticles in preparation for use in laser immunotherapy. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 23. <a href="https://doi.org/10.1117/12.2506714" title="DOI URL">https://doi.org/10.1117/12.2506714</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1117/12.2506714&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1117%2F12.2506714%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252Bcharacterization%252Bof%252Bgraphene-reconstituted%252Blow-density%252Blipoproteins%252Band%252Bsmall%252Bmolecule%252Binhibitor%252Bnanoparticles%252Bin%252Bpreparation%252Bfor%252Buse%252Bin%252Blaser%252Bimmunotherapy%26aulast%3DGallagher%26aufirst%3DKyra%2BA.%26date%3D2019%26spage%3D23%26pub%3DSPIE%26atitle%3DBiophotonics%252Band%252BImmune%252BResponses%252BXIV%26date%3D2019%26volume%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohammed A.M.  Massoud</span>, <span class="hlFld-ContribAuthor ">Magda A.  El-Sayed</span>, <span class="hlFld-ContribAuthor ">Waleed A.  Bayoumi</span>, <span class="hlFld-ContribAuthor ">Basem  Mansour</span>. </span><span class="cited-content_cbyCitation_article-title">Cytotoxicity and Molecular Targeting Study of Novel 2-Chloro-3- substituted Quinoline Derivatives as Antitumor Agents. </span><span class="cited-content_cbyCitation_journal-name">Letters in Drug Design & Discovery</span><span> <strong>2019,</strong> <em>16 </em>
                                    (3)
                                     , 273-283. <a href="https://doi.org/10.2174/1570180815666180604090924" title="DOI URL">https://doi.org/10.2174/1570180815666180604090924</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1570180815666180604090924&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1570180815666180604090924%26sid%3Dliteratum%253Aachs%26jtitle%3DLetters%2520in%2520Drug%2520Design%2520%2526%2520Discovery%26atitle%3DCytotoxicity%252Band%252BMolecular%252BTargeting%252BStudy%252Bof%252BNovel%252B2-Chloro-3-%252Bsubstituted%252BQuinoline%252BDerivatives%252Bas%252BAntitumor%252BAgents%26aulast%3DMassoud%26aufirst%3DMohammed%2BA.M.%26date%3D2019%26volume%3D16%26issue%3D3%26spage%3D273%26epage%3D283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nupam P.  Mahajan</span>, <span class="hlFld-ContribAuthor ">Domenico  Coppola</span>, <span class="hlFld-ContribAuthor ">Jongphil  Kim</span>, <span class="hlFld-ContribAuthor ">Harshani R.  Lawrence</span>, <span class="hlFld-ContribAuthor ">Nicholas J.  Lawrence</span>, <span class="hlFld-ContribAuthor ">Kiran  Mahajan</span>. </span><span class="cited-content_cbyCitation_article-title">Blockade of ACK1/TNK2 To Squelch the Survival of Prostate Cancer Stem-like Cells. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2018,</strong> <em>8 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-018-20172-z" title="DOI URL">https://doi.org/10.1038/s41598-018-20172-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-018-20172-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-018-20172-z%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DBlockade%252Bof%252BACK1%25252FTNK2%252BTo%252BSquelch%252Bthe%252BSurvival%252Bof%252BProstate%252BCancer%252BStem-like%252BCells%26aulast%3DMahajan%26aufirst%3DNupam%2BP.%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dongxin  Zhang</span>, <span class="hlFld-ContribAuthor ">Po-Shun  Chuang</span>, <span class="hlFld-ContribAuthor ">Dong  Cao</span>, <span class="hlFld-ContribAuthor ">Yarkali  Krishna</span>, <span class="hlFld-ContribAuthor ">Kola  Shilpa</span>, <span class="hlFld-ContribAuthor ">Fujie  Tanaka</span>. </span><span class="cited-content_cbyCitation_article-title">Detection of enantiomers of chiral primary amines by 1H NMR analysis via enamine formation with an enantiopure γ-position aldol product of a β-keto ester. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2018,</strong> <em>59 </em>
                                    (23)
                                     , 2248-2250. <a href="https://doi.org/10.1016/j.tetlet.2018.04.079" title="DOI URL">https://doi.org/10.1016/j.tetlet.2018.04.079</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2018.04.079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2018.04.079%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DDetection%252Bof%252Benantiomers%252Bof%252Bchiral%252Bprimary%252Bamines%252Bby%252B1H%252BNMR%252Banalysis%252Bvia%252Benamine%252Bformation%252Bwith%252Ban%252Benantiopure%252B%2525CE%2525B3-position%252Baldol%252Bproduct%252Bof%252Ba%252B%2525CE%2525B2-keto%252Bester%26aulast%3DZhang%26aufirst%3DDongxin%26date%3D2018%26volume%3D59%26issue%3D23%26spage%3D2248%26epage%3D2250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kiran  Mahajan</span>, <span class="hlFld-ContribAuthor ">Pavani  Malla</span>, <span class="hlFld-ContribAuthor ">Harshani R.  Lawrence</span>, <span class="hlFld-ContribAuthor ">Zhihua  Chen</span>, <span class="hlFld-ContribAuthor ">Chandan  Kumar-Sinha</span>, <span class="hlFld-ContribAuthor ">Rohit  Malik</span>, <span class="hlFld-ContribAuthor ">Sudhanshu  Shukla</span>, <span class="hlFld-ContribAuthor ">Jongphil  Kim</span>, <span class="hlFld-ContribAuthor ">Domenico  Coppola</span>, <span class="hlFld-ContribAuthor ">Nicholas J.  Lawrence</span>, <span class="hlFld-ContribAuthor ">Nupam P.  Mahajan</span>. </span><span class="cited-content_cbyCitation_article-title">ACK1/TNK2 Regulates Histone H4 Tyr88-phosphorylation and AR Gene Expression in Castration-Resistant Prostate Cancer. </span><span class="cited-content_cbyCitation_journal-name">Cancer Cell</span><span> <strong>2017,</strong> <em>31 </em>
                                    (6)
                                     , 790-803.e8. <a href="https://doi.org/10.1016/j.ccell.2017.05.003" title="DOI URL">https://doi.org/10.1016/j.ccell.2017.05.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ccell.2017.05.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ccell.2017.05.003%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Cell%26atitle%3DACK1%25252FTNK2%252BRegulates%252BHistone%252BH4%252BTyr88-phosphorylation%252Band%252BAR%252BGene%252BExpression%252Bin%252BCastration-Resistant%252BProstate%252BCancer%26aulast%3DMahajan%26aufirst%3DKiran%26date%3D2017%26volume%3D31%26issue%3D6%26spage%3D790%26epage%3D803.e8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Song-Hui  Xu</span>, <span class="hlFld-ContribAuthor ">Jin-Zhou  Huang</span>, <span class="hlFld-ContribAuthor ">Min  Chen</span>, <span class="hlFld-ContribAuthor ">Ming  Zeng</span>, <span class="hlFld-ContribAuthor ">Fei-Yan  Zou</span>, <span class="hlFld-ContribAuthor ">De  Chen</span>, <span class="hlFld-ContribAuthor ">Guang-Rong  Yan</span>. </span><span class="cited-content_cbyCitation_article-title">Amplification of ACK1 promotes gastric tumorigenesis via ECD-dependent p53 ubiquitination degradation. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2017,</strong> <em>8 </em>
                                    (8)
                                     , 12705-12716. <a href="https://doi.org/10.18632/oncotarget.6194" title="DOI URL">https://doi.org/10.18632/oncotarget.6194</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.6194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.6194%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DAmplification%252Bof%252BACK1%252Bpromotes%252Bgastric%252Btumorigenesis%252Bvia%252BECD-dependent%252Bp53%252Bubiquitination%252Bdegradation%26aulast%3DXu%26aufirst%3DSong-Hui%26date%3D2017%26date%3D2015%26volume%3D8%26issue%3D8%26spage%3D12705%26epage%3D12716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xinyan  Wu</span>, <span class="hlFld-ContribAuthor ">Muhammad  Saddiq Zahari</span>, <span class="hlFld-ContribAuthor ">Santosh  Renuse</span>, <span class="hlFld-ContribAuthor ">Dhanashree S.  Kelkar</span>, <span class="hlFld-ContribAuthor ">Mustafa A.  Barbhuiya</span>, <span class="hlFld-ContribAuthor ">Pamela L.  Rojas</span>, <span class="hlFld-ContribAuthor ">Vered  Stearns</span>, <span class="hlFld-ContribAuthor ">Edward  Gabrielson</span>, <span class="hlFld-ContribAuthor ">Pavani  Malla</span>, <span class="hlFld-ContribAuthor ">Saraswati  Sukumar</span>, <span class="hlFld-ContribAuthor ">Nupam P.  Mahajan</span>, <span class="hlFld-ContribAuthor ">Akhilesh  Pandey</span>. </span><span class="cited-content_cbyCitation_article-title">The non-receptor tyrosine kinase TNK2/ACK1 is a novel therapeutic target in triple negative breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2017,</strong> <em>8 </em>
                                    (2)
                                     , 2971-2983. <a href="https://doi.org/10.18632/oncotarget.13579" title="DOI URL">https://doi.org/10.18632/oncotarget.13579</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.13579&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.13579%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DThe%252Bnon-receptor%252Btyrosine%252Bkinase%252BTNK2%25252FACK1%252Bis%252Ba%252Bnovel%252Btherapeutic%252Btarget%252Bin%252Btriple%252Bnegative%252Bbreast%252Bcancer%26aulast%3DWu%26aufirst%3DXinyan%26date%3D2017%26date%3D2016%26volume%3D8%26issue%3D2%26spage%3D2971%26epage%3D2983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Charles M.  Marson</span>. </span><span class="cited-content_cbyCitation_article-title">Saturated Heterocycles with Applications in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 13-33. <a href="https://doi.org/10.1016/bs.aihch.2016.03.004" title="DOI URL">https://doi.org/10.1016/bs.aihch.2016.03.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.aihch.2016.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.aihch.2016.03.004%26sid%3Dliteratum%253Aachs%26atitle%3DSaturated%252BHeterocycles%252Bwith%252BApplications%252Bin%252BMedicinal%252BChemistry%26aulast%3DMarson%26aufirst%3DCharles%2BM.%26date%3D2017%26spage%3D13%26epage%3D33%26pub%3DElsevier%26atitle%3DHeterocyclic%252BChemistry%252Bin%252Bthe%252B21st%252BCentury%252B-%252BA%252BTribute%252Bto%252BAlan%252BKatritzky%26date%3D2017%26volume%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pei-Liang  Zhao</span>, <span class="hlFld-ContribAuthor ">Yan-Hong  Li</span>, <span class="hlFld-ContribAuthor ">Hai-Kui  Yang</span>, <span class="hlFld-ContribAuthor ">Peng  Chen</span>, <span class="hlFld-ContribAuthor ">Bei  Zhang</span>, <span class="hlFld-ContribAuthor ">Qi  Sun</span>, <span class="hlFld-ContribAuthor ">Qiu  Li</span>, <span class="hlFld-ContribAuthor ">Wen-Wei  You</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and antiproliferative activity of novel 5-nitropyrimidine-2,4-diamine derivatives bearing alkyl acetate moiety. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>118 </em>, 161-169. <a href="https://doi.org/10.1016/j.ejmech.2016.04.038" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.04.038</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.04.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.04.038%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bantiproliferative%252Bactivity%252Bof%252Bnovel%252B5-nitropyrimidine-2%25252C4-diamine%252Bderivatives%252Bbearing%252Balkyl%252Bacetate%252Bmoiety%26aulast%3DZhao%26aufirst%3DPei-Liang%26date%3D2016%26volume%3D118%26spage%3D161%26epage%3D169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gervais  Bérubé</span>. </span><span class="cited-content_cbyCitation_article-title">An overview of molecular hybrids in drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2016,</strong> <em>11 </em>
                                    (3)
                                     , 281-305. <a href="https://doi.org/10.1517/17460441.2016.1135125" title="DOI URL">https://doi.org/10.1517/17460441.2016.1135125</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/17460441.2016.1135125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F17460441.2016.1135125%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DAn%252Boverview%252Bof%252Bmolecular%252Bhybrids%252Bin%252Bdrug%252Bdiscovery%26aulast%3DB%25C3%25A9rub%25C3%25A9%26aufirst%3DGervais%26date%3D2016%26date%3D2016%26volume%3D11%26issue%3D3%26spage%3D281%26epage%3D305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Olayinka O.  Ajani</span>, <span class="hlFld-ContribAuthor ">Jessica T.  Isaac</span>, <span class="hlFld-ContribAuthor ">Taiwo F.  Owoeye</span>, <span class="hlFld-ContribAuthor ">Anuoluwa A.  Akinsiku</span>. </span><span class="cited-content_cbyCitation_article-title">Exploration of the Chemistry and Biological Properties of Pyrimidine as a Privilege Pharmacophore in Therapeutics. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Biological Chemistry</span><span> <strong>2015,</strong> <em>9 </em>
                                    (4)
                                     , 148-177. <a href="https://doi.org/10.3923/ijbc.2015.148.177" title="DOI URL">https://doi.org/10.3923/ijbc.2015.148.177</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3923/ijbc.2015.148.177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3923%2Fijbc.2015.148.177%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Biological%2520Chemistry%26atitle%3DExploration%252Bof%252Bthe%252BChemistry%252Band%252BBiological%252BProperties%252Bof%252BPyrimidine%252Bas%252Ba%252BPrivilege%252BPharmacophore%252Bin%252BTherapeutics%26aulast%3DAjani%26aufirst%3DOlayinka%2BO.%26date%3D2015%26volume%3D9%26issue%3D4%26spage%3D148%26epage%3D177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/medium/jm-2014-01929n_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/large/jm-2014-01929n_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501929n&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/medium/jm-2014-01929n_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/large/jm-2014-01929n_0015.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures and activities of representative ACK1 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/large/jm-2014-01929n_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501929n&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/medium/jm-2014-01929n_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/large/jm-2014-01929n_0001.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A–C) Binding modes of known ACK1 inhibitors to ACK1: (A) compound <b>2b</b> taken from its crystal structure with ACK1 (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3EQP">3EQP</a>), (B) compound <b>1b</b> modeled with ACK1, based on similar compounds bound to Lck (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2OF2">2OF2</a>), and (C) compound <b>5</b> (TAE684) modeled with ACK1, based on its crystal structure with ALK (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XB7">2XB7</a>). (D) Bisanilinopyrimidine scaffold <b>6</b> for design of novel ACK1 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/large/jm-2014-01929n_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501929n&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/medium/jm-2014-01929n_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/large/jm-2014-01929n_0006.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Design and Synthesis of Bisanilinopyrimidine Derivatives <b>9a</b>–<b>t</b> with a (±)-Tetrahydrofurfurylamine A-Ring<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/large/jm-2014-01929n_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501929n&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Method a: (±)-tetrahydrofurfurylamine, Et<sub>3</sub>N, MeOH, 0 °C to rt, 2 h. Method b: cat. HCl (4 M) in dioxane, 2-methoxyethanol or ethanol or dioxane, sealed tube, 80–180 °C, 20–30 min, aq NaHCO<sub>3</sub> workup.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/medium/jm-2014-01929n_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/large/jm-2014-01929n_0007.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Design and Synthesis of Bisanilinopyrimidines with Sulfone-Substituted and Sulfide A-Rings<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/large/jm-2014-01929n_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501929n&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>See the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>. Method a: DIPEA, THF, 120 °C, 1 h, 77–90%. Method b: <i>m</i>CPBA, EtOAc, 0 °C to rt, 2 h, 70–96%. Method c: cat. HCl (4 M) in dioxane, microwave heating 180 °C, 30 min, 68–97%. Method d: POCl<sub>3</sub>, 0 °C, PCl<sub>5</sub>, 16 h, 99%. Method e: THF, 15 h, 75%.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/medium/jm-2014-01929n_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/large/jm-2014-01929n_0008.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of (<i>R</i>)-<b>9b</b> and (<i>S</i>)-<b>9b</b> as ACK1 Inhibitors</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/large/jm-2014-01929n_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501929n&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/medium/jm-2014-01929n_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/large/jm-2014-01929n_0002.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effect of ACK1 inhibitors in prostate cancer cells: (a) inhibition of ACK1 autophosphorylation in LAPC4 cells treated with 5 μM (<i>R</i>)-<b>9b</b> and (<i>S</i>)-<b>9b</b>; inhibition of (b) LNCaP, (c) LAPC4, and (d) VCaP cell growth by AIM-100, (<i>R</i>)-<b>9b</b>, and (<i>S</i>)-<b>9b</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/large/jm-2014-01929n_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501929n&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/medium/jm-2014-01929n_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/large/jm-2014-01929n_0003.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Schematic representation of compound (<i>R</i>)-<b>9b</b> (blue) docked to ACK1 (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EWH">4EWH</a>), showing the ACK1 amino acid residues in the hinge (black), hydrophobic pocket (green), and ATP-ribose binding pocket (red). (B) Stick model of (<i>R</i>)-<b>9b</b> (cyan) docked to ACK1 (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EWH">4EWH</a>), showing important ACK1 amino acid residues. (C) Surface model of (<i>R</i>)-<b>9b</b> (cyan) docked to the ATP binding site of ACK1. The surface is colored according to atom type (carbon, green; hydrogen, gray; oxygen, red; nitrogen, blue). The images in panels B and C were rendered using Pymol.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/large/jm-2014-01929n_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501929n&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/medium/jm-2014-01929n_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/large/jm-2014-01929n_0004.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (a) SAR overview. (b) Compounds with an extended carboxylic acid tether as ACK1 inhibitors (inhibition (%) at 10 μM in ELISA is shown).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/large/jm-2014-01929n_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501929n&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/medium/jm-2014-01929n_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/large/jm-2014-01929n_0005.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Plasma stabilities of (<i>R</i>)-<b>9b</b>, (<i>S</i>)-<b>9b</b>, procainamide, and procaine using HPLC: area of the peak (<i>y</i>-axis) plotted against the time (<i>x</i>-axis). Procainamide is reported as stable and procaine unstable in human plasma.<a onclick="showRef(event, 'ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref41 ref42">(41, 42)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501929n/20150320/images/large/jm-2014-01929n_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501929n&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i76">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52447" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52447" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 42 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Mahajan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahajan, N. P.</span><span> </span><span class="NLM_article-title">ACK1 tyrosine kinase: targeted inhibition to block cancer cell proliferation</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">338</span><span class="NLM_x">, </span> <span class="NLM_fpage">185</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm501929n&amp;key=10.1016%2Fj.canlet.2013.04.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm501929n&amp;key=23597703" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm501929n&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmvF2itr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=338&publication_year=2013&pages=185-192&author=K.+Mahajanauthor=N.+P.+Mahajan&title=ACK1+tyrosine+kinase%3A+targeted+inhibition+to+block+cancer+cell+proliferation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">ACK1 tyrosine kinase: Targeted inhibition to block cancer cell proliferation</span></div><div class="casAuthors">Mahajan, Kiran; Mahajan, Nupam P.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">338</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">185-192</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  ACK1 tyrosine kinase, located on chromosome 3q29, is aberrantly activated, amplified or mutated in a wide variety of human cancers.  While the deregulated kinase is oncogenic and its activation correlates with progression to metastatic stage, its inhibition causes cell cycle arrest, sensitizes cells to ionizing radiation and induces apoptosis.  Oncogenicity of ACK1 is not only due to its ability to promote activation of crit. pro-survival kinases and harmone receptors by phosphorylating at distinct tyrosine residues, but also by employing a similar mechanism to eliminate a tumor suppressor from cancer cells.  Despite the substantial data supporting the oncogenic role of ACK1, and the potential clin. benefit of blocking ACK1 in metastatic disease, to date ACK1-specific small mol. inhibitors have not been exploited for cancer therapy.  This review highlights recent advances that elucidate how cancer cells employ ACK1 kinase to their advantage and discusses some of the novel ACK1 inhibitors that have shown promise in pre-clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXKiLC1fojfbVg90H21EOLACvtfcHk0lgeNPRB8Yplpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmvF2itr0%253D&md5=aa2b5b4bb43e73cb00e4c6bad50c869d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2013.04.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2013.04.004%26sid%3Dliteratum%253Aachs%26aulast%3DMahajan%26aufirst%3DK.%26aulast%3DMahajan%26aufirst%3DN.%2BP.%26atitle%3DACK1%2520tyrosine%2520kinase%253A%2520targeted%2520inhibition%2520to%2520block%2520cancer%2520cell%2520proliferation%26jtitle%3DCancer%2520Lett.%26date%3D2013%26volume%3D338%26spage%3D185%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Mahajan, K.; Mahajan, N. P.</span><span> </span><span class="NLM_article-title">ACK1/TNK2 tyrosine kinase: molecular signaling and evolving role in cancers</span>.  <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span>DOI: <span class="refDoi"> DOI: 10.1038/onc.2014.350</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm501929n&amp;key=10.1038%2Fonc.2014.350" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=K.+Mahajan&author=N.+P.+Mahajan&title=ACK1%2FTNK2+tyrosine+kinase%3A+molecular+signaling+and+evolving+role+in+cancers&doi=10.1038%2Fonc.2014.350"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fonc.2014.350&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2014.350%26sid%3Dliteratum%253Aachs%26aulast%3DMahajan%26aufirst%3DK.%26atitle%3DACK1%252FTNK2%2520tyrosine%2520kinase%253A%2520molecular%2520signaling%2520and%2520evolving%2520role%2520in%2520cancers%26jtitle%3DOncogene%26date%3D2014%26doi%3D10.1038%2Fonc.2014.350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Mahajan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahajan, N. P.</span><span> </span><span class="NLM_article-title">Shepherding AKT and androgen receptor by Ack1 tyrosine kinase</span> <span class="citation_source-journal">J. Cell. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">224</span><span class="NLM_x">, </span> <span class="NLM_fpage">327</span><span class="NLM_x">–</span> <span class="NLM_lpage">333</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm501929n&amp;key=10.1002%2Fjcp.22162" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm501929n&amp;key=20432460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm501929n&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmslWiu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=224&publication_year=2010&pages=327-333&author=K.+Mahajanauthor=N.+P.+Mahajan&title=Shepherding+AKT+and+androgen+receptor+by+Ack1+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Shepherding AKT and androgen receptor by Ack1 tyrosine kinase</span></div><div class="casAuthors">Mahajan, Kiran; Mahajan, Nupam P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Physiology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">224</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">327-333</span>CODEN:
                <span class="NLM_cas:coden">JCLLAX</span>;
        ISSN:<span class="NLM_cas:issn">0021-9541</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  Ack1 (also known as ACK, TNK2, or activated Cdc42 kinase) is a structurally unique non-receptor tyrosine kinase that is expressed in diverse cell types.  It integrates signals from plethora of ligand-activated receptor tyrosine kinases (RTKs), for example, MERTK, EGFR, HER2, PDGFR and insulin receptor to initiate intracellular signaling cascades.  Ack1 transduces extracellular signals to cytosolic and nuclear effectors such as the protein kinase AKT/PKB and androgen receptor (AR), to promote cell survival and growth.  While tyrosine phosphorylation of AR at Tyr267 regulates androgen-independent recruitment of AR to the androgen-responsive enhancers and transcription of AR target genes to drive prostate cancer progression, phosphorylation of an evolutionarily conserved Tyrosine 176 in the kinase domain of AKT is essential for mitotic progression and pos. correlates with breast cancer progression.  In contrast to AR and AKT, Ack1-mediated phosphorylation of the tumor suppressor Wwox at Tyr287 lead to rapid Wwox polyubiquitination followed by degrdn.  Thus, by its ability to promote tumor growth by neg. regulating tumor suppressor such as Wwox and pos. regulating pro-survival factors such as AKT and AR, Ack1 is emerging as a crit. player in cancer biol.  In this review, we discuss recent advances in understanding the physiol. functions of Ack1 signaling in normal cells and the consequences of its hyperactivation in various cancers.  J. Cell. Physiol. 224: 327-333, 2010. © 2010 Wiley-Liss, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotDJqD0S9vr7Vg90H21EOLACvtfcHk0lgeNPRB8Yplpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmslWiu7k%253D&md5=520ad1c81b0dc5e6d35a2efdc36af2e9</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1002%2Fjcp.22162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcp.22162%26sid%3Dliteratum%253Aachs%26aulast%3DMahajan%26aufirst%3DK.%26aulast%3DMahajan%26aufirst%3DN.%2BP.%26atitle%3DShepherding%2520AKT%2520and%2520androgen%2520receptor%2520by%2520Ack1%2520tyrosine%2520kinase%26jtitle%3DJ.%2520Cell.%2520Physiol.%26date%3D2010%26volume%3D224%26spage%3D327%26epage%3D333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Mahajan, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majumder, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warren, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohler, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Earp, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whang, Y. E.</span><span> </span><span class="NLM_article-title">Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">8438</span><span class="NLM_x">–</span> <span class="NLM_lpage">8443</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=8438-8443&author=N.+P.+Mahajanauthor=Y.+Liuauthor=S.+Majumderauthor=M.+R.+Warrenauthor=C.+E.+Parkerauthor=J.+L.+Mohlerauthor=H.+S.+Earpauthor=Y.+E.+Whang&title=Activated+Cdc42-associated+kinase+Ack1+promotes+prostate+cancer+progression+via+androgen+receptor+tyrosine+phosphorylation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMahajan%26aufirst%3DN.%2BP.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DMajumder%26aufirst%3DS.%26aulast%3DWarren%26aufirst%3DM.%2BR.%26aulast%3DParker%26aufirst%3DC.%2BE.%26aulast%3DMohler%26aufirst%3DJ.%2BL.%26aulast%3DEarp%26aufirst%3DH.%2BS.%26aulast%3DWhang%26aufirst%3DY.%2BE.%26atitle%3DActivated%2520Cdc42-associated%2520kinase%2520Ack1%2520promotes%2520prostate%2520cancer%2520progression%2520via%2520androgen%2520receptor%2520tyrosine%2520phosphorylation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2007%26volume%3D104%26spage%3D8438%26epage%3D8443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Mahajan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coppola, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rawal, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engelman, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahajan, N. P.</span><span> </span><span class="NLM_article-title">Ack1-mediated androgen receptor phosphorylation modulates radiation resistance in castration-resistant prostate cancer</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">22112</span><span class="NLM_x">–</span> <span class="NLM_lpage">22122</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=22112-22122&author=K.+Mahajanauthor=D.+Coppolaauthor=B.+Rawalauthor=Y.+A.+Chenauthor=H.+R.+Lawrenceauthor=R.+W.+Engelmanauthor=N.+J.+Lawrenceauthor=N.+P.+Mahajan&title=Ack1-mediated+androgen+receptor+phosphorylation+modulates+radiation+resistance+in+castration-resistant+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMahajan%26aufirst%3DK.%26aulast%3DCoppola%26aufirst%3DD.%26aulast%3DRawal%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DY.%2BA.%26aulast%3DLawrence%26aufirst%3DH.%2BR.%26aulast%3DEngelman%26aufirst%3DR.%2BW.%26aulast%3DLawrence%26aufirst%3DN.%2BJ.%26aulast%3DMahajan%26aufirst%3DN.%2BP.%26atitle%3DAck1-mediated%2520androgen%2520receptor%2520phosphorylation%2520modulates%2520radiation%2520resistance%2520in%2520castration-resistant%2520prostate%2520cancer%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D22112%26epage%3D22122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Aqeilan, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croce, C. M.</span><span> </span><span class="NLM_article-title">WWOX in biological control and tumorigenesis</span> <span class="citation_source-journal">J. Cell. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">212</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">310</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm501929n&amp;key=10.1002%2Fjcp.21099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm501929n&amp;key=17458891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm501929n&amp;key=1%3ACAS%3A528%3ADC%252BD2sXntlyqtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=212&publication_year=2007&pages=307-310&author=R.+I.+Aqeilanauthor=C.+M.+Croce&title=WWOX+in+biological+control+and+tumorigenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">WWOX in biological control and tumorigenesis</span></div><div class="casAuthors">Aqeilan, Rami I.; Croce, Carlo M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Physiology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">212</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">307-310</span>CODEN:
                <span class="NLM_cas:coden">JCLLAX</span>;
        ISSN:<span class="NLM_cas:issn">0021-9541</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  The WW domain-contg. oxidoreductase (WWOX) gene is located at 16q23.1-16q23.2, a region that spans the second most common human fragile site, FRA16D.  The WWOX protein contains two N-terminal WW domains and a central short chain oxidoreductase-like domain.  In the last few years, considerable amt. of data have shown inactivation of WWOX in a variety of human malignancies.  Moreover, interacting partners have been identified biochem. that define, at least in part, the mol. mechanism of WWOX action.  Recently, we demonstrated that targeted deletion of the Wwox gene in the mouse led to increased incidence of spontaneous and chem. induced tumor formation, thereby providing the first in vivo evidence that WWOX is a bona fide tumor suppressor.  This review focuses on the most recent progress in understanding WWOX function as a tumor suppressor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlyPpK62RPErVg90H21EOLACvtfcHk0liPiGkOHItJ7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXntlyqtr8%253D&md5=ba1947484f42c8c2d9b0a60359c6984d</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1002%2Fjcp.21099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcp.21099%26sid%3Dliteratum%253Aachs%26aulast%3DAqeilan%26aufirst%3DR.%2BI.%26aulast%3DCroce%26aufirst%3DC.%2BM.%26atitle%3DWWOX%2520in%2520biological%2520control%2520and%2520tumorigenesis%26jtitle%3DJ.%2520Cell.%2520Physiol.%26date%3D2007%26volume%3D212%26spage%3D307%26epage%3D310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Mahajan, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whang, Y. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohler, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Earp, H. S.</span><span> </span><span class="NLM_article-title">Activated tyrosine kinase Ack1 promotes prostate tumorigenesis: role of Ack1 in polyubiquitination of tumor suppressor Wwox</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">10514</span><span class="NLM_x">–</span> <span class="NLM_lpage">10523</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=10514-10523&author=N.+P.+Mahajanauthor=Y.+E.+Whangauthor=J.+L.+Mohlerauthor=H.+S.+Earp&title=Activated+tyrosine+kinase+Ack1+promotes+prostate+tumorigenesis%3A+role+of+Ack1+in+polyubiquitination+of+tumor+suppressor+Wwox"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMahajan%26aufirst%3DN.%2BP.%26aulast%3DWhang%26aufirst%3DY.%2BE.%26aulast%3DMohler%26aufirst%3DJ.%2BL.%26aulast%3DEarp%26aufirst%3DH.%2BS.%26atitle%3DActivated%2520tyrosine%2520kinase%2520Ack1%2520promotes%2520prostate%2520tumorigenesis%253A%2520role%2520of%2520Ack1%2520in%2520polyubiquitination%2520of%2520tumor%2520suppressor%2520Wwox%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D10514%26epage%3D10523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Mahajan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coppola, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Challa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koomen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engelman, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivera, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muraoka-Cook, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schonbrunn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebti, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Earp, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahajan, N. P.</span><span> </span><span class="NLM_article-title">Ack1 mediated AKT/PKB tyrosine 176 phosphorylation regulates its activation</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">e9646</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=e9646&author=K.+Mahajanauthor=D.+Coppolaauthor=S.+Challaauthor=B.+Fangauthor=Y.+A.+Chenauthor=W.+Zhuauthor=A.+S.+Lopezauthor=J.+Koomenauthor=R.+W.+Engelmanauthor=C.+Riveraauthor=R.+S.+Muraoka-Cookauthor=J.+Q.+Chengauthor=E.+Schonbrunnauthor=S.+M.+Sebtiauthor=H.+S.+Earpauthor=N.+P.+Mahajan&title=Ack1+mediated+AKT%2FPKB+tyrosine+176+phosphorylation+regulates+its+activation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMahajan%26aufirst%3DK.%26aulast%3DCoppola%26aufirst%3DD.%26aulast%3DChalla%26aufirst%3DS.%26aulast%3DFang%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DY.%2BA.%26aulast%3DZhu%26aufirst%3DW.%26aulast%3DLopez%26aufirst%3DA.%2BS.%26aulast%3DKoomen%26aufirst%3DJ.%26aulast%3DEngelman%26aufirst%3DR.%2BW.%26aulast%3DRivera%26aufirst%3DC.%26aulast%3DMuraoka-Cook%26aufirst%3DR.%2BS.%26aulast%3DCheng%26aufirst%3DJ.%2BQ.%26aulast%3DSchonbrunn%26aufirst%3DE.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26aulast%3DEarp%26aufirst%3DH.%2BS.%26aulast%3DMahajan%26aufirst%3DN.%2BP.%26atitle%3DAck1%2520mediated%2520AKT%252FPKB%2520tyrosine%2520176%2520phosphorylation%2520regulates%2520its%2520activation%26jtitle%3DPLoS%2520One%26date%3D2010%26volume%3D5%26spage%3De9646" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Franke, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, T. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Datta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazlauskas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsichlis, P. N.</span><span> </span><span class="NLM_article-title">The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">727</span><span class="NLM_x">–</span> <span class="NLM_lpage">736</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1995&pages=727-736&author=T.+F.+Frankeauthor=S.+I.+Yangauthor=T.+O.+Chanauthor=K.+Dattaauthor=A.+Kazlauskasauthor=D.+K.+Morrisonauthor=D.+R.+Kaplanauthor=P.+N.+Tsichlis&title=The+protein+kinase+encoded+by+the+Akt+proto-oncogene+is+a+target+of+the+PDGF-activated+phosphatidylinositol+3-kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFranke%26aufirst%3DT.%2BF.%26aulast%3DYang%26aufirst%3DS.%2BI.%26aulast%3DChan%26aufirst%3DT.%2BO.%26aulast%3DDatta%26aufirst%3DK.%26aulast%3DKazlauskas%26aufirst%3DA.%26aulast%3DMorrison%26aufirst%3DD.%2BK.%26aulast%3DKaplan%26aufirst%3DD.%2BR.%26aulast%3DTsichlis%26aufirst%3DP.%2BN.%26atitle%3DThe%2520protein%2520kinase%2520encoded%2520by%2520the%2520Akt%2520proto-oncogene%2520is%2520a%2520target%2520of%2520the%2520PDGF-activated%2520phosphatidylinositol%25203-kinase%26jtitle%3DCell%26date%3D1995%26volume%3D81%26spage%3D727%26epage%3D736" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Burgering, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coffer, P. J.</span><span> </span><span class="NLM_article-title">Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">376</span><span class="NLM_x">, </span> <span class="NLM_fpage">599</span><span class="NLM_x">–</span> <span class="NLM_lpage">602</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=376&publication_year=1995&pages=599-602&author=B.+M.+Burgeringauthor=P.+J.+Coffer&title=Protein+kinase+B+%28c-Akt%29+in+phosphatidylinositol-3-OH+kinase+signal+transduction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurgering%26aufirst%3DB.%2BM.%26aulast%3DCoffer%26aufirst%3DP.%2BJ.%26atitle%3DProtein%2520kinase%2520B%2520%2528c-Akt%2529%2520in%2520phosphatidylinositol-3-OH%2520kinase%2520signal%2520transduction%26jtitle%3DNature%26date%3D1995%26volume%3D376%26spage%3D599%26epage%3D602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Manning, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span> </span><span class="NLM_article-title">AKT/PKB signaling: navigating downstream</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">1261</span><span class="NLM_x">–</span> <span class="NLM_lpage">1274</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2007&pages=1261-1274&author=B.+D.+Manningauthor=L.+C.+Cantley&title=AKT%2FPKB+signaling%3A+navigating+downstream"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DB.%2BD.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26atitle%3DAKT%252FPKB%2520signaling%253A%2520navigating%2520downstream%26jtitle%3DCell%26date%3D2007%26volume%3D129%26spage%3D1261%26epage%3D1274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Mahajan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coppola, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahajan, N. P.</span><span> </span><span class="NLM_article-title">Ack1 tyrosine kinase activation correlates with pancreatic cancer progression</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">180</span><span class="NLM_x">, </span> <span class="NLM_fpage">1386</span><span class="NLM_x">–</span> <span class="NLM_lpage">1393</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm501929n&amp;key=10.1016%2Fj.ajpath.2011.12.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm501929n&amp;key=22322295" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm501929n&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsFCju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2012&pages=1386-1393&author=K.+Mahajanauthor=D.+Coppolaauthor=Y.+A.+Chenauthor=W.+Zhuauthor=H.+R.+Lawrenceauthor=N.+J.+Lawrenceauthor=N.+P.+Mahajan&title=Ack1+tyrosine+kinase+activation+correlates+with+pancreatic+cancer+progression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Ack1 tyrosine kinase activation correlates with pancreatic cancer progression</span></div><div class="casAuthors">Mahajan, Kiran; Coppola, Domenico; Chen, Y. Ann; Zhu, Weiwei; Lawrence, Harshani R.; Lawrence, Nicholas J.; Mahajan, Nupam P.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">180</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1386-1393</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Pancreatic cancer is a significant cause of cancer mortality worldwide as the disease has advanced significantly in patients before symptoms are evident.  The signal transduction pathways that promote this rapid progression are not well understood.  Ack1 or TNK2, an ubiquitously expressed oncogenic non-receptor tyrosine kinase, integrates signals from ligand-activated receptor tyrosine kinases to modulate intracellular signaling cascades.  In the present study, we investigated the Ack1 activation profile in a pancreatic cancer tumor microarray, and obsd. that expression levels of activated Ack1 and pTyr284-Ack1 pos. correlated with the severity of disease progression and inversely correlated with the survival of patients with pancreatic cancer.  To explore the mechanisms by which Ack1 promotes tumor progression, we investigated the role of AKT/PKB, an oncogene and Ack1-interacting protein.  Ack1 activates AKT directly in pancreatic and other cancer cell lines by phosphorylating AKT at Tyr176 to promote cell survival.  In addn., the Ack1 inhibitor AIM-100 not only inhibited Ack1 activation but also suppressed AKT tyrosine phosphorylation, leading to cell cycle arrest in the G1 phase.  This effect resulted in a significant decrease in the proliferation of pancreatic cancer cells and induction of apoptosis.  Collectively, our data indicate that activated Ack1 could be a prognostic marker for ascertaining early or advanced pancreatic cancer.  Thus, Ack1 inhibitors hold promise for therapeutic intervention to inhibit pancreatic tumor growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_olTwaj3DErVg90H21EOLACvtfcHk0lh1SicD-6Kcog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsFCju7c%253D&md5=de887ab01db229a4d6f6b38d4c6a987a</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.ajpath.2011.12.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajpath.2011.12.028%26sid%3Dliteratum%253Aachs%26aulast%3DMahajan%26aufirst%3DK.%26aulast%3DCoppola%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DY.%2BA.%26aulast%3DZhu%26aufirst%3DW.%26aulast%3DLawrence%26aufirst%3DH.%2BR.%26aulast%3DLawrence%26aufirst%3DN.%2BJ.%26aulast%3DMahajan%26aufirst%3DN.%2BP.%26atitle%3DAck1%2520tyrosine%2520kinase%2520activation%2520correlates%2520with%2520pancreatic%2520cancer%2520progression%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2012%26volume%3D180%26spage%3D1386%26epage%3D1393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Mahajan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahajan, N. P.</span><span> </span><span class="NLM_article-title">ACK1 tyrosine kinase interacts with histone demethylase KDM3A to regulate the mammary tumor oncogene HOXA1</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">28179</span><span class="NLM_x">–</span> <span class="NLM_lpage">28191</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=28179-28191&author=K.+Mahajanauthor=H.+R.+Lawrenceauthor=N.+J.+Lawrenceauthor=N.+P.+Mahajan&title=ACK1+tyrosine+kinase+interacts+with+histone+demethylase+KDM3A+to+regulate+the+mammary+tumor+oncogene+HOXA1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMahajan%26aufirst%3DK.%26aulast%3DLawrence%26aufirst%3DH.%2BR.%26aulast%3DLawrence%26aufirst%3DN.%2BJ.%26aulast%3DMahajan%26aufirst%3DN.%2BP.%26atitle%3DACK1%2520tyrosine%2520kinase%2520interacts%2520with%2520histone%2520demethylase%2520KDM3A%2520to%2520regulate%2520the%2520mammary%2520tumor%2520oncogene%2520HOXA1%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D28179%26epage%3D28191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">DiMauro, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcomb, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunes, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bemis, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boucher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchanan, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckner, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faust, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turci, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span> </span><span class="NLM_article-title">Discovery of 4-amino-5,6-biaryl-furo[2,3-d]pyrimidines as inhibitors of Lck: development of an expedient and divergent synthetic route and preliminary SAR</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2305</span><span class="NLM_x">–</span> <span class="NLM_lpage">2309</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=2305-2309&author=E.+F.+DiMauroauthor=J.+Newcombauthor=J.+J.+Nunesauthor=J.+E.+Bemisauthor=C.+Boucherauthor=J.+L.+Buchananauthor=W.+H.+Bucknerauthor=A.+Chengauthor=T.+Faustauthor=F.+Hsiehauthor=X.+Huangauthor=J.+H.+Leeauthor=T.+L.+Marshallauthor=M.+W.+Martinauthor=D.+C.+McGowanauthor=S.+Schneiderauthor=S.+M.+Turciauthor=R.+D.+Whiteauthor=X.+Zhu&title=Discovery+of+4-amino-5%2C6-biaryl-furo%5B2%2C3-d%5Dpyrimidines+as+inhibitors+of+Lck%3A+development+of+an+expedient+and+divergent+synthetic+route+and+preliminary+SAR"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DNewcomb%26aufirst%3DJ.%26aulast%3DNunes%26aufirst%3DJ.%2BJ.%26aulast%3DBemis%26aufirst%3DJ.%2BE.%26aulast%3DBoucher%26aufirst%3DC.%26aulast%3DBuchanan%26aufirst%3DJ.%2BL.%26aulast%3DBuckner%26aufirst%3DW.%2BH.%26aulast%3DCheng%26aufirst%3DA.%26aulast%3DFaust%26aufirst%3DT.%26aulast%3DHsieh%26aufirst%3DF.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DMarshall%26aufirst%3DT.%2BL.%26aulast%3DMartin%26aufirst%3DM.%2BW.%26aulast%3DMcGowan%26aufirst%3DD.%2BC.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DTurci%26aufirst%3DS.%2BM.%26aulast%3DWhite%26aufirst%3DR.%2BD.%26aulast%3DZhu%26aufirst%3DX.%26atitle%3DDiscovery%2520of%25204-amino-5%252C6-biaryl-furo%255B2%252C3-d%255Dpyrimidines%2520as%2520inhibitors%2520of%2520Lck%253A%2520development%2520of%2520an%2520expedient%2520and%2520divergent%2520synthetic%2520route%2520and%2520preliminary%2520SAR%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D2305%26epage%3D2309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Martin, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcomb, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunes, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bemis, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchanan, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMauro, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boucher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faust, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turci, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span> </span><span class="NLM_article-title">Discovery of novel 2,3-diarylfuro[2,3-<i>b</i>]pyridin-4-amines as potent and selective inhibitors of Lck: synthesis, SAR, and pharmacokinetic properties</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2299</span><span class="NLM_x">–</span> <span class="NLM_lpage">3304</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=2299-3304&author=M.+W.+Martinauthor=J.+Newcombauthor=J.+J.+Nunesauthor=J.+E.+Bemisauthor=D.+C.+McGowanauthor=R.+D.+Whiteauthor=J.+L.+Buchananauthor=E.+F.+DiMauroauthor=C.+Boucherauthor=T.+Faustauthor=F.+Hsiehauthor=X.+Huangauthor=J.+H.+Leeauthor=S.+Schneiderauthor=S.+M.+Turciauthor=X.+Zhu&title=Discovery+of+novel+2%2C3-diarylfuro%5B2%2C3-b%5Dpyridin-4-amines+as+potent+and+selective+inhibitors+of+Lck%3A+synthesis%2C+SAR%2C+and+pharmacokinetic+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DM.%2BW.%26aulast%3DNewcomb%26aufirst%3DJ.%26aulast%3DNunes%26aufirst%3DJ.%2BJ.%26aulast%3DBemis%26aufirst%3DJ.%2BE.%26aulast%3DMcGowan%26aufirst%3DD.%2BC.%26aulast%3DWhite%26aufirst%3DR.%2BD.%26aulast%3DBuchanan%26aufirst%3DJ.%2BL.%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DBoucher%26aufirst%3DC.%26aulast%3DFaust%26aufirst%3DT.%26aulast%3DHsieh%26aufirst%3DF.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DTurci%26aufirst%3DS.%2BM.%26aulast%3DZhu%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520novel%25202%252C3-diarylfuro%255B2%252C3-b%255Dpyridin-4-amines%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520Lck%253A%2520synthesis%252C%2520SAR%252C%2520and%2520pharmacokinetic%2520properties%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D2299%26epage%3D3304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Mahajan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Challa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coppola, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gevariya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahajan, N. P.</span><span> </span><span class="NLM_article-title">Effect of Ack1 tyrosine kinase inhibitor on ligand-independent androgen receptor activity</span> <span class="citation_source-journal">Prostate</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">1274</span><span class="NLM_x">–</span> <span class="NLM_lpage">1285</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=1274-1285&author=K.+Mahajanauthor=S.+Challaauthor=D.+Coppolaauthor=H.+Lawrenceauthor=Y.+Luoauthor=H.+Gevariyaauthor=W.+Zhuauthor=Y.+A.+Chenauthor=N.+J.+Lawrenceauthor=N.+P.+Mahajan&title=Effect+of+Ack1+tyrosine+kinase+inhibitor+on+ligand-independent+androgen+receptor+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMahajan%26aufirst%3DK.%26aulast%3DChalla%26aufirst%3DS.%26aulast%3DCoppola%26aufirst%3DD.%26aulast%3DLawrence%26aufirst%3DH.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DGevariya%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DY.%2BA.%26aulast%3DLawrence%26aufirst%3DN.%2BJ.%26aulast%3DMahajan%26aufirst%3DN.%2BP.%26atitle%3DEffect%2520of%2520Ack1%2520tyrosine%2520kinase%2520inhibitor%2520on%2520ligand-independent%2520androgen%2520receptor%2520activity%26jtitle%3DProstate%26date%3D2010%26volume%3D70%26spage%3D1274%26epage%3D1285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Kopecky, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaen, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardozo, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesche, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrelly, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayser, F.</span><span> </span><span class="NLM_article-title">Identification and optimization of N3,N6-diaryl-1H-pyrazolo[3,4-<i>d</i>]pyrimidine-3,6-diamines as a novel class of ACK1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">6352</span><span class="NLM_x">–</span> <span class="NLM_lpage">6356</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=6352-6356&author=D.+J.+Kopeckyauthor=X.+Haoauthor=Y.+Chenauthor=J.+Fuauthor=X.+Jiaoauthor=J.+C.+Jaenauthor=M.+G.+Cardozoauthor=J.+Liuauthor=Z.+Wangauthor=N.+P.+Walkerauthor=H.+Wescheauthor=S.+Liauthor=E.+Farrellyauthor=S.+H.+Xiaoauthor=F.+Kayser&title=Identification+and+optimization+of+N3%2CN6-diaryl-1H-pyrazolo%5B3%2C4-d%5Dpyrimidine-3%2C6-diamines+as+a+novel+class+of+ACK1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKopecky%26aufirst%3DD.%2BJ.%26aulast%3DHao%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DJiao%26aufirst%3DX.%26aulast%3DJaen%26aufirst%3DJ.%2BC.%26aulast%3DCardozo%26aufirst%3DM.%2BG.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DWalker%26aufirst%3DN.%2BP.%26aulast%3DWesche%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DFarrelly%26aufirst%3DE.%26aulast%3DXiao%26aufirst%3DS.%2BH.%26aulast%3DKayser%26aufirst%3DF.%26atitle%3DIdentification%2520and%2520optimization%2520of%2520N3%252CN6-diaryl-1H-pyrazolo%255B3%252C4-d%255Dpyrimidine-3%252C6-diamines%2520as%2520a%2520novel%2520class%2520of%2520ACK1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D6352%26epage%3D6356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Miduturu, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwiatkowski, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brault, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwaller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">High-throughput kinase profiling: a more efficient approach toward the discovery of new kinase inhibitors</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">868</span><span class="NLM_x">–</span> <span class="NLM_lpage">879</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm501929n&amp;key=10.1016%2Fj.chembiol.2011.05.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm501929n&amp;key=21802008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm501929n&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpsFarurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=868-879&author=C.+V.+Miduturuauthor=X.+Dengauthor=N.+Kwiatkowskiauthor=W.+Yangauthor=L.+Braultauthor=P.+Filippakopoulosauthor=E.+Chungauthor=Q.+Yangauthor=J.+Schwallerauthor=S.+Knappauthor=R.+W.+Kingauthor=J.+D.+Leeauthor=S.+Herrgardauthor=P.+Zarrinkarauthor=N.+S.+Gray&title=High-throughput+kinase+profiling%3A+a+more+efficient+approach+toward+the+discovery+of+new+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">High-Throughput Kinase Profiling: A More Efficient Approach toward the Discovery of New Kinase Inhibitors</span></div><div class="casAuthors">Miduturu, Chandrasekhar V.; Deng, Xianming; Kwiatkowski, Nicholas; Yang, Wannian; Brault, Laurent; Filippakopoulos, Panagis; Chung, Eunah; Yang, Qingkai; Schwaller, Juerg; Knapp, Stefan; King, Randall W.; Lee, Jiing-Dwan; Herrgard, Sanna; Zarrinkar, Patrick; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">868-879</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Selective protein kinase inhibitors have only been developed against a small no. of kinase targets.  Here we demonstrate that "high-throughput kinase profiling" is an efficient method for the discovery of lead compds. for established as well as unexplored kinase targets.  We screened a library of 118 compds. constituting two distinct scaffolds (furan-thiazolidinediones and pyrimido-diazepines) against a panel of 353 kinases.  A distinct kinase selectivity profile was obsd. for each scaffold.  Selective inhibitors were identified with submicromolar cellular activity against PIM1, ERK5, ACK1, MPS1, PLK1-3, and Aurora A,B kinases.  In addn., we identified potent inhibitors for so far unexplored kinases such as DRAK1, HIPK2, and DCAMKL1 that await further evaluation.  This inhibitor-centric approach permits comprehensive assessment of a scaffold of interest and represents an efficient and general strategy for identifying new selective kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKLvN9eLNvybVg90H21EOLACvtfcHk0lgjuzbi3mie9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpsFarurw%253D&md5=d62a4771b1215551f3913b93d6eca7ee</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2011.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2011.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DMiduturu%26aufirst%3DC.%2BV.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DKwiatkowski%26aufirst%3DN.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DBrault%26aufirst%3DL.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DChung%26aufirst%3DE.%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DSchwaller%26aufirst%3DJ.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DKing%26aufirst%3DR.%2BW.%26aulast%3DLee%26aufirst%3DJ.%2BD.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DZarrinkar%26aufirst%3DP.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DHigh-throughput%2520kinase%2520profiling%253A%2520a%2520more%2520efficient%2520approach%2520toward%2520the%2520discovery%2520of%2520new%2520kinase%2520inhibitors%26jtitle%3DChem.%2520Biol.%26date%3D2011%26volume%3D18%26spage%3D868%26epage%3D879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Jin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleinberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadalbajoo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siu, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bittner, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thelemann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhagwat, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulvihill, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rechka, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pachter, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crew, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulvihill, M. J.</span><span> </span><span class="NLM_article-title">Discovery of potent, selective and orally bioavailable imidazo[1,5-<i>a</i>]pyrazine derived ACK1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">979</span><span class="NLM_x">–</span> <span class="NLM_lpage">984</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=979-984&author=M.+Jinauthor=J.+Wangauthor=A.+Kleinbergauthor=M.+Kadalbajooauthor=K.+W.+Siuauthor=A.+Cookeauthor=M.+A.+Bittnerauthor=Y.+Yaoauthor=A.+Thelemannauthor=Q.+Jiauthor=S.+Bhagwatauthor=K.+M.+Mulvihillauthor=J.+A.+Rechkaauthor=J.+A.+Pachterauthor=A.+P.+Crewauthor=D.+Epsteinauthor=M.+J.+Mulvihill&title=Discovery+of+potent%2C+selective+and+orally+bioavailable+imidazo%5B1%2C5-a%5Dpyrazine+derived+ACK1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DKleinberg%26aufirst%3DA.%26aulast%3DKadalbajoo%26aufirst%3DM.%26aulast%3DSiu%26aufirst%3DK.%2BW.%26aulast%3DCooke%26aufirst%3DA.%26aulast%3DBittner%26aufirst%3DM.%2BA.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DThelemann%26aufirst%3DA.%26aulast%3DJi%26aufirst%3DQ.%26aulast%3DBhagwat%26aufirst%3DS.%26aulast%3DMulvihill%26aufirst%3DK.%2BM.%26aulast%3DRechka%26aufirst%3DJ.%2BA.%26aulast%3DPachter%26aufirst%3DJ.%2BA.%26aulast%3DCrew%26aufirst%3DA.%2BP.%26aulast%3DEpstein%26aufirst%3DD.%26aulast%3DMulvihill%26aufirst%3DM.%2BJ.%26atitle%3DDiscovery%2520of%2520potent%252C%2520selective%2520and%2520orally%2520bioavailable%2520imidazo%255B1%252C5-a%255Dpyrazine%2520derived%2520ACK1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D979%26epage%3D984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Golas, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arndt, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Etienne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nardin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frost, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boschelli, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boschelli, F.</span><span> </span><span class="NLM_article-title">SKI-606, a 4-anilino-3-quinolinecarbonitrile dual inhibitor of Src and Abl kinases, is a potent antiproliferative agent against chronic myelogenous leukemia cells in culture and causes regression of K562 xenografts in nude mice</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">375</span><span class="NLM_x">–</span> <span class="NLM_lpage">381</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm501929n&amp;key=12543790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm501929n&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnt1Krsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=375-381&author=J.+M.+Golasauthor=K.+Arndtauthor=C.+Etienneauthor=J.+Lucasauthor=D.+Nardinauthor=J.+Gibbonsauthor=P.+Frostauthor=F.+Yeauthor=D.+H.+Boschelliauthor=F.+Boschelli&title=SKI-606%2C+a+4-anilino-3-quinolinecarbonitrile+dual+inhibitor+of+Src+and+Abl+kinases%2C+is+a+potent+antiproliferative+agent+against+chronic+myelogenous+leukemia+cells+in+culture+and+causes+regression+of+K562+xenografts+in+nude+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">SKI-606, a 4-Anilino-3-quinolinecarbonitrile Dual Inhibitor of Src and Abl Kinases, Is a Potent Antiproliferative Agent against Chronic Myelogenous Leukemia Cells in Culture and Causes Regression of K562 Xenografts in Nude Mice</span></div><div class="casAuthors">Golas, Jennifer M.; Arndt, Kim; Etienne, Carlo; Lucas, Judy; Nardin, Danielle; Gibbons, James; Frost, Philip; Ye, Fei; Boschelli, Diane H.; Boschelli, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">375-381</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Constitutive tyrosine kinase activity of Bcr-Abl promotes proliferation and survival of chronic myelogenous leukemia (CML) cells.  Inhibition of Bcr-Abl tyrosine kinase activity or signaling proteins activated by Bcr-Abl in CML cells blocks proliferation and causes apoptotic cell death.  The selective Abl kinase inhibitor, STI-571 (marketed as Gleevec), is toxic to CML cells in culture, causes regression of CML tumors in nude mice, and is currently used to treat CML patients.  Here we describe a p.o. active, dual Src/Abl kinase inhibitor with potent antiproliferative activity against CML cells in culture.  This 4-anilino-3-quinolinecarbonitrile (SKI-606) ablates tyrosine phosphorylation of Bcr-Abl in CML cells and of v-Abl expressed in fibroblasts.  SKI-606 inhibits phosphorylation of cellular proteins, including STAT5, at concns. that inhibit proliferation in CML cells.  Phosphorylation of the autoactivation site of the Src family kinases Lyn and/or Hck is also reduced by treatment with SKI-606.  Once daily oral administration of this compd. at 100 mg/kg for 5 days causes complete regression of large K562 xenografts in nude mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJ0DM9Z0QjjLVg90H21EOLACvtfcHk0lgjuzbi3mie9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnt1Krsg%253D%253D&md5=e7b5e5ffee0238543dc9c31b7e86b3d2</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGolas%26aufirst%3DJ.%2BM.%26aulast%3DArndt%26aufirst%3DK.%26aulast%3DEtienne%26aufirst%3DC.%26aulast%3DLucas%26aufirst%3DJ.%26aulast%3DNardin%26aufirst%3DD.%26aulast%3DGibbons%26aufirst%3DJ.%26aulast%3DFrost%26aufirst%3DP.%26aulast%3DYe%26aufirst%3DF.%26aulast%3DBoschelli%26aufirst%3DD.%2BH.%26aulast%3DBoschelli%26aufirst%3DF.%26atitle%3DSKI-606%252C%2520a%25204-anilino-3-quinolinecarbonitrile%2520dual%2520inhibitor%2520of%2520Src%2520and%2520Abl%2520kinases%252C%2520is%2520a%2520potent%2520antiproliferative%2520agent%2520against%2520chronic%2520myelogenous%2520leukemia%2520cells%2520in%2520culture%2520and%2520causes%2520regression%2520of%2520K562%2520xenografts%2520in%2520nude%2520mice%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D375%26epage%3D381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Remsing Rix, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rix, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colinge, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hantschel, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stranzl, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumgartner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valent, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augustin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Till, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Superti-Furga, G.</span><span> </span><span class="NLM_article-title">Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">477</span><span class="NLM_x">–</span> <span class="NLM_lpage">485</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm501929n&amp;key=10.1038%2Fleu.2008.334" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm501929n&amp;key=19039322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm501929n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXivVKhu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2009&pages=477-485&author=L.+L.+Remsing+Rixauthor=U.+Rixauthor=J.+Colingeauthor=O.+Hantschelauthor=K.+L.+Bennettauthor=T.+Stranzlauthor=A.+Mullerauthor=C.+Baumgartnerauthor=P.+Valentauthor=M.+Augustinauthor=J.+H.+Tillauthor=G.+Superti-Furga&title=Global+target+profile+of+the+kinase+inhibitor+bosutinib+in+primary+chronic+myeloid+leukemia+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells</span></div><div class="casAuthors">Remsing Rix, L. L.; Rix, U.; Colinge, J.; Hantschel, O.; Bennett, K. L.; Stranzl, T.; Mueller, A.; Baumgartner, C.; Valent, P.; Augustin, M.; Till, J. H.; Superti-Furga, G.</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">477-485</span>CODEN:
                <span class="NLM_cas:coden">LEUKED</span>;
        ISSN:<span class="NLM_cas:issn">0887-6924</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The detailed mol. mechanism of action of second-generation BCR-ABL tyrosine kinase inhibitors, including perturbed targets and pathways, should contribute to rationalized therapy in chronic myeloid leukemia (CML) or in other affected diseases.  Here, we characterized the target profile of the dual SRC/ABL inhibitor bosutinib employing a two-tiered approach using chem. proteomics to identify natural binders in whole cell lysates of primary CML and K562 cells in parallel to in vitro kinase assays against a large recombinant kinase panel.  The combined strategy resulted in a global survey of bosutinib targets comprised of over 45 novel tyrosine and serine/threonine kinases.  We have found clear differences in the target patterns of bosutinib in primary CML cells vs. the K562 cell line.  A comparison of bosutinib with dasatinib across the whole kinase panel revealed overlapping, but distinct, inhibition profiles.  Common among those were the SRC, ABL and TEC family kinases.  Bosutinib did not inhibit KIT or platelet-derived growth factor receptor, but prominently targeted the apoptosis-linked STE20 kinases.  Although in vivo bosutinib is inactive against ABL T315I, we found this clin. important mutant to be enzymically inhibited in the mid-nanomolar range.  Finally, bosutinib is the first kinase inhibitor shown to target CAMK2G, recently implicated in myeloid leukemia cell proliferation.  Leukemia (2009) 23, 477-485; doi:10.1038/leu.2008.334; published online 27 Nov. 2008.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8u0ixFotIMLVg90H21EOLACvtfcHk0lj5ddlHWdfxkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXivVKhu7w%253D&md5=b0d56d468ef66ddc2a6f012d08f8c1a4</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fleu.2008.334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fleu.2008.334%26sid%3Dliteratum%253Aachs%26aulast%3DRemsing%2BRix%26aufirst%3DL.%2BL.%26aulast%3DRix%26aufirst%3DU.%26aulast%3DColinge%26aufirst%3DJ.%26aulast%3DHantschel%26aufirst%3DO.%26aulast%3DBennett%26aufirst%3DK.%2BL.%26aulast%3DStranzl%26aufirst%3DT.%26aulast%3DMuller%26aufirst%3DA.%26aulast%3DBaumgartner%26aufirst%3DC.%26aulast%3DValent%26aufirst%3DP.%26aulast%3DAugustin%26aufirst%3DM.%26aulast%3DTill%26aufirst%3DJ.%2BH.%26aulast%3DSuperti-Furga%26aufirst%3DG.%26atitle%3DGlobal%2520target%2520profile%2520of%2520the%2520kinase%2520inhibitor%2520bosutinib%2520in%2520primary%2520chronic%2520myeloid%2520leukemia%2520cells%26jtitle%3DLeukemia%26date%3D2009%26volume%3D23%26spage%3D477%26epage%3D485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Tan, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haaland, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gan, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tham, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krisna, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thu, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liew, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ullrich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chua, B. T.</span><span> </span><span class="NLM_article-title">Bosutinib inhibits migration and invasion via ACK1 in KRAS mutant non-small cell lung cancer</span> <span class="citation_source-journal">Mol. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm501929n&amp;key=10.1186%2F1476-4598-13-13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm501929n&amp;key=24461128" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm501929n&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivFaksLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=13&author=D.+S.+Tanauthor=B.+Haalandauthor=J.+M.+Ganauthor=S.+C.+Thamauthor=I.+Sinhaauthor=E.+H.+Tanauthor=K.+H.+Limauthor=A.+Takanoauthor=S.+S.+Krisnaauthor=M.+M.+Thuauthor=H.+P.+Liewauthor=A.+Ullrichauthor=W.+T.+Limauthor=B.+T.+Chua&title=Bosutinib+inhibits+migration+and+invasion+via+ACK1+in+KRAS+mutant+non-small+cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Bosutinib inhibits migration and invasion via ack1 in kras mutant non-small cell lung cancer</span></div><div class="casAuthors">Tan, Daniel S. W.; Haaland, Benjamin; Gan, Jia Min; Tham, Su Chin; Sinha, Indrajit; Tan, Eng Huat; Lim, Kiat Hon; Takano, Angela; Krisna, Sai Sakktee; Thu, Minn Minn Myint; Liew, Hoe Peng; Ullrich, Axel; Lim, Wan-Teck; Chua, Boon Tin</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">13/1-13/10, 10 pp.</span>CODEN:
                <span class="NLM_cas:coden">MCOACG</span>;
        ISSN:<span class="NLM_cas:issn">1476-4598</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">The advent of effective targeted therapeutics has led to increasing emphasis on precise biomarkers for accurate patient stratification.  Here, we describe the role of ACK1, a non-receptor tyrosine kinase in abrogating migration and invasion in KRAS mutant lung adenocarcinoma.  Bosutinib, which inhibits ACK1 at 2.7 nM IC50, was found to inhibit cell migration and invasion but not viability in a panel of non-small cell lung cancer (NSCLC) cell lines.  Knockdown of ACK1 abrogated bosutinib-induced inhibition of cell migration and invasion specifically in KRAS mutant cells.  This finding was further confirmed in an in vivo zebrafish metastatic model.  Tissue microarray data on 210 Singaporean lung adenocarcinomas indicate that cytoplasmic ACK1 was significantly over-expressed relative to paired adjacent non-tumor tissue.  Interestingly, ACK1 expression in "normal" tissue adjacent to tumor, but not tumor, was independently assocd. with poor overall and relapse-free survival.  In conclusion, inhibition of ACK1 with bosutinib attenuates migration and invasion in the context of KRAS mutant NSCLC and may fulfil a therapeutic niche through combinatorial treatment approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcHXBxLnO8B7Vg90H21EOLACvtfcHk0lj5ddlHWdfxkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivFaksLc%253D&md5=400cc32d1d67eb1f6c75c197ebebc14e</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1186%2F1476-4598-13-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1476-4598-13-13%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DD.%2BS.%26aulast%3DHaaland%26aufirst%3DB.%26aulast%3DGan%26aufirst%3DJ.%2BM.%26aulast%3DTham%26aufirst%3DS.%2BC.%26aulast%3DSinha%26aufirst%3DI.%26aulast%3DTan%26aufirst%3DE.%2BH.%26aulast%3DLim%26aufirst%3DK.%2BH.%26aulast%3DTakano%26aufirst%3DA.%26aulast%3DKrisna%26aufirst%3DS.%2BS.%26aulast%3DThu%26aufirst%3DM.%2BM.%26aulast%3DLiew%26aufirst%3DH.%2BP.%26aulast%3DUllrich%26aufirst%3DA.%26aulast%3DLim%26aufirst%3DW.%2BT.%26aulast%3DChua%26aufirst%3DB.%2BT.%26atitle%3DBosutinib%2520inhibits%2520migration%2520and%2520invasion%2520via%2520ACK1%2520in%2520KRAS%2520mutant%2520non-small%2520cell%2520lung%2520cancer%26jtitle%3DMol.%2520Cancer%26date%3D2014%26volume%3D13%26spage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Carter, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velasco, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabian, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milanov, Z. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atteridge, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biggs, W. H.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edeen, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grotzfeld, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insko, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyers, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varmus, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, D. J.</span><span> </span><span class="NLM_article-title">Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinases</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">11011</span><span class="NLM_x">–</span> <span class="NLM_lpage">11016</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm501929n&amp;key=10.1073%2Fpnas.0504952102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm501929n&amp;key=16046538" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm501929n&amp;key=1%3ACAS%3A528%3ADC%252BD2MXnvVWjurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=11011-11016&author=T.+A.+Carterauthor=L.+M.+Wodickaauthor=N.+P.+Shahauthor=A.+M.+Velascoauthor=M.+A.+Fabianauthor=D.+K.+Treiberauthor=Z.+V.+Milanovauthor=C.+E.+Atteridgeauthor=W.+H.+Biggsauthor=P.+T.+Edeenauthor=M.+Floydauthor=J.+M.+Fordauthor=R.+M.+Grotzfeldauthor=S.+Herrgardauthor=D.+E.+Inskoauthor=S.+A.+Mehtaauthor=H.+K.+Patelauthor=W.+Paoauthor=C.+L.+Sawyersauthor=H.+Varmusauthor=P.+P.+Zarrinkarauthor=D.+J.+Lockhart&title=Inhibition+of+drug-resistant+mutants+of+ABL%2C+KIT%2C+and+EGF+receptor+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinases</span></div><div class="casAuthors">Carter, Todd A.; Wodicka, Lisa M.; Shah, Neil P.; Velasco, Anne Marie; Fabian, Miles A.; Treiber, Daniel K.; Milanov, Zdravko V.; Atteridge, Corey E.; Biggs, William H., III; Edeen, Philip T.; Floyd, Mark; Ford, Julia M.; Grotzfeld, Robert M.; Herrgard, Sanna; Insko, Darren E.; Mehta, Shamal A.; Patel, Hitesh K.; Pao, William; Sawyers, Charles L.; Varmus, Harold; Zarrinkar, Patrick P.; Lockhart, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">11011-11016</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">To realize the full potential of targeted protein kinase inhibitors for the treatment of cancer, it is important to address the emergence of drug resistance in treated patients.  Mutant forms of BCR-ABL, KIT, and the EGF receptor (EGFR) have been found that confer resistance to the drugs imatinib, gefitinib, and erlotinib.  The mutations weaken or prevent drug binding, and interestingly, one of the most common sites of mutation in all three kinases is a highly conserved "gatekeeper" threonine residue near the kinase active site.  We have identified existing clin. compds. that bind and inhibit drug-resistant mutant variants of ABL, KIT, and EGFR.  We found that the Aurora kinase inhibitor VX-680 and the p38 inhibitor BIRB-796 inhibit the imatinib- and BMS-354825-resistant ABL(T315I) kinase.  The KIT/FLT3 inhibitor SU-11248 potently inhibits the imatinib-resistant KIT(V559D/T670I) kinase, consistent with the clin. efficacy of SU-11248 against imatinib-resistant gastrointestinal tumors, and the EGFR inhibitors EKB-569 and Cl-1033, but not GW-572016 and ZD-6474, potently inhibit the gefitinib- and erlotinib-resistant EGFR(L858R/T790M) kinase.  EKB-569 and Cl-1033 are already in clin. trials, and our results suggest that they should be considered for testing in the treatment of gefitinib/erlotinib-resistant non-small cell lung cancer.  The results highlight the strategy of screening existing clin. compds. against newly identified drug-resistant mutant variants to find compds. that may serve as starting points for the development of next-generation drugs, or that could be used directly to treat patients that have acquired resistance to first-generation targeted therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdgFgcC03tybVg90H21EOLACvtfcHk0ljH8cPwxvZpQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXnvVWjurg%253D&md5=448c95c51b0cf9b5035df4065cd8f62c</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0504952102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0504952102%26sid%3Dliteratum%253Aachs%26aulast%3DCarter%26aufirst%3DT.%2BA.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DShah%26aufirst%3DN.%2BP.%26aulast%3DVelasco%26aufirst%3DA.%2BM.%26aulast%3DFabian%26aufirst%3DM.%2BA.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DBiggs%26aufirst%3DW.%2BH.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DFord%26aufirst%3DJ.%2BM.%26aulast%3DGrotzfeld%26aufirst%3DR.%2BM.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DInsko%26aufirst%3DD.%2BE.%26aulast%3DMehta%26aufirst%3DS.%2BA.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DPao%26aufirst%3DW.%26aulast%3DSawyers%26aufirst%3DC.%2BL.%26aulast%3DVarmus%26aufirst%3DH.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26atitle%3DInhibition%2520of%2520drug-resistant%2520mutants%2520of%2520ABL%252C%2520KIT%252C%2520and%2520EGF%2520receptor%2520kinases%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D11011%26epage%3D11016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karaca, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gioeli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Earp, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whang, Y. E.</span><span> </span><span class="NLM_article-title">Dasatinib inhibits site-specific tyrosine phosphorylation of androgen receptor by Ack1 and Src kinases</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">3208</span><span class="NLM_x">–</span> <span class="NLM_lpage">3216</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2010&pages=3208-3216&author=Y.+Liuauthor=M.+Karacaauthor=Z.+Zhangauthor=D.+Gioeliauthor=H.+S.+Earpauthor=Y.+E.+Whang&title=Dasatinib+inhibits+site-specific+tyrosine+phosphorylation+of+androgen+receptor+by+Ack1+and+Src+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DKaraca%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DGioeli%26aufirst%3DD.%26aulast%3DEarp%26aufirst%3DH.%2BS.%26aulast%3DWhang%26aufirst%3DY.%2BE.%26atitle%3DDasatinib%2520inhibits%2520site-specific%2520tyrosine%2520phosphorylation%2520of%2520androgen%2520receptor%2520by%2520Ack1%2520and%2520Src%2520kinases%26jtitle%3DOncogene%26date%3D2010%26volume%3D29%26spage%3D3208%26epage%3D3216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rix, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colinge, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eschrich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Superti-Furga, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koomen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haura, E. B.</span><span> </span><span class="NLM_article-title">A chemical and phosphoproteomic characterization of dasatinib action in lung cancer</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="NLM_x">–</span> <span class="NLM_lpage">299</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm501929n&amp;key=10.1038%2Fnchembio.332" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm501929n&amp;key=20190765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm501929n&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFeksbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=291-299&author=J.+Liauthor=U.+Rixauthor=B.+Fangauthor=Y.+Baiauthor=A.+Edwardsauthor=J.+Colingeauthor=K.+L.+Bennettauthor=J.+Gaoauthor=L.+Songauthor=S.+Eschrichauthor=G.+Superti-Furgaauthor=J.+Koomenauthor=E.+B.+Haura&title=A+chemical+and+phosphoproteomic+characterization+of+dasatinib+action+in+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">A chemical and phosphoproteomic characterization of dasatinib action in lung cancer</span></div><div class="casAuthors">Li, Jiannong; Rix, Uwe; Fang, Bin; Bai, Yun; Edwards, Arthur; Colinge, Jacques; Bennett, Keiryn L.; Gao, Jingchun; Song, Lanxi; Eschrich, Steven; Superti-Furga, Giulio; Koomen, John; Haura, Eric B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">291-299</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We describe a strategy for comprehending signaling pathways that are active in lung cancer cells and that are targeted by dasatinib using chem. proteomics to identify direct interacting proteins combined with immunoaffinity purifn. of tyrosine-phosphorylated peptides corresponding to activated tyrosine kinases.  We identified nearly 40 different kinase targets of dasatinib.  These include SRC-family kinase (SFK) members (LYN, SRC, FYN, LCK and YES), nonreceptor tyrosine kinases (FRK, BRK and ACK) and receptor tyrosine kinases (Ephrin receptors, DDR1 and EGFR).  Using quant. phosphoproteomics, we identified peptides corresponding to autophosphorylation sites of these tyrosine kinases that are inhibited in a concn.-dependent manner by dasatinib.  Using drug-resistant gatekeeper mutants, we show that SFKs (particularly SRC and FYN), as well as EGFR, are relevant targets for dasatinib action.  The combined mass spectrometry-based approach described here provides a system-level view of dasatinib action in cancer cells and suggests both functional targets and a rationale for combinatorial therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqww7cetmkYebVg90H21EOLACvtfcHk0ljH8cPwxvZpQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFeksbw%253D&md5=6118751b40473b407f1cb45b785c7028</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.332%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DRix%26aufirst%3DU.%26aulast%3DFang%26aufirst%3DB.%26aulast%3DBai%26aufirst%3DY.%26aulast%3DEdwards%26aufirst%3DA.%26aulast%3DColinge%26aufirst%3DJ.%26aulast%3DBennett%26aufirst%3DK.%2BL.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DSong%26aufirst%3DL.%26aulast%3DEschrich%26aufirst%3DS.%26aulast%3DSuperti-Furga%26aufirst%3DG.%26aulast%3DKoomen%26aufirst%3DJ.%26aulast%3DHaura%26aufirst%3DE.%2BB.%26atitle%3DA%2520chemical%2520and%2520phosphoproteomic%2520characterization%2520of%2520dasatinib%2520action%2520in%2520lung%2520cancer%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D6%26spage%3D291%26epage%3D299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Galkin, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melnick, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steensma, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopiuk, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warmuth, M.</span><span> </span><span class="NLM_article-title">Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">270</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=270-275&author=A.+V.+Galkinauthor=J.+S.+Melnickauthor=S.+Kimauthor=T.+L.+Hoodauthor=N.+Liauthor=L.+Liauthor=G.+Xiaauthor=R.+Steensmaauthor=G.+Chopiukauthor=J.+Jiangauthor=Y.+Wanauthor=P.+Dingauthor=Y.+Liuauthor=F.+Sunauthor=P.+G.+Schultzauthor=N.+S.+Grayauthor=M.+Warmuth&title=Identification+of+NVP-TAE684%2C+a+potent%2C+selective%2C+and+efficacious+inhibitor+of+NPM-ALK"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGalkin%26aufirst%3DA.%2BV.%26aulast%3DMelnick%26aufirst%3DJ.%2BS.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DHood%26aufirst%3DT.%2BL.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DXia%26aufirst%3DG.%26aulast%3DSteensma%26aufirst%3DR.%26aulast%3DChopiuk%26aufirst%3DG.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DWan%26aufirst%3DY.%26aulast%3DDing%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DF.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DWarmuth%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520NVP-TAE684%252C%2520a%2520potent%252C%2520selective%252C%2520and%2520efficacious%2520inhibitor%2520of%2520NPM-ALK%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2007%26volume%3D104%26spage%3D270%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Davis, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallares, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hocker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span> </span><span class="NLM_article-title">Comprehensive analysis of kinase inhibitor selectivity</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1046</span><span class="NLM_x">–</span> <span class="NLM_lpage">1051</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm501929n&amp;key=10.1038%2Fnbt.1990" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm501929n&amp;key=22037378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm501929n&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyisrrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=1046-1051&author=M.+I.+Davisauthor=J.+P.+Huntauthor=S.+Herrgardauthor=P.+Ciceriauthor=L.+M.+Wodickaauthor=G.+Pallaresauthor=M.+Hockerauthor=D.+K.+Treiberauthor=P.+P.+Zarrinkar&title=Comprehensive+analysis+of+kinase+inhibitor+selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive analysis of kinase inhibitor selectivity</span></div><div class="casAuthors">Davis, Mindy I.; Hunt, Jeremy P.; Herrgard, Sanna; Ciceri, Pietro; Wodicka, Lisa M.; Pallares, Gabriel; Hocker, Michael; Treiber, Daniel K.; Zarrinkar, Patrick P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1046-1051</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We tested the interaction of 72 kinase inhibitors with 442 kinases covering >80% of the human catalytic protein kinome.  Our data show that, as a class, type II inhibitors are more selective than type I inhibitors, but that there are important exceptions to this trend.  The data further illustrate that selective inhibitors have been developed against the majority of kinases targeted by the compds. tested.  Anal. of the interaction patterns reveals a class of 'group-selective' inhibitors broadly active against a single subfamily of kinases, but selective outside that subfamily.  The data set suggests compds. to use as tools to study kinases for which no dedicated inhibitors exist.  It also provides a foundation for further exploring kinase inhibitor biol. and toxicity, as well as for studying the structural basis of the obsd. interaction patterns.  Our findings will help to realize the direct enabling potential of genomics for drug development and basic research about cellular signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEZnKVs6Xt5rVg90H21EOLACvtfcHk0ljC6XYGThJd1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyisrrK&md5=67639f702cb48ffb2c60e9a250f0df5e</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fnbt.1990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.1990%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DM.%2BI.%26aulast%3DHunt%26aufirst%3DJ.%2BP.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DPallares%26aufirst%3DG.%26aulast%3DHocker%26aufirst%3DM.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26atitle%3DComprehensive%2520analysis%2520of%2520kinase%2520inhibitor%2520selectivity%26jtitle%3DNat.%2520Biotechnol.%26date%3D2011%26volume%3D29%26spage%3D1046%26epage%3D1051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Metz, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soni, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merta, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kifle, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajduk, P. J.</span><span> </span><span class="NLM_article-title">Navigating the kinome</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">200</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm501929n&amp;key=10.1038%2Fnchembio.530" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm501929n&amp;key=21336281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm501929n&amp;key=1%3ACAS%3A528%3ADC%252BC3MXit1aitrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=200-202&author=J.+T.+Metzauthor=E.+F.+Johnsonauthor=N.+B.+Soniauthor=P.+J.+Mertaauthor=L.+Kifleauthor=P.+J.+Hajduk&title=Navigating+the+kinome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Navigating the kinome</span></div><div class="casAuthors">Metz, James T.; Johnson, Eric F.; Soni, Niru B.; Merta, Philip J.; Kifle, Lemma; Hajduk, Philip J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">200-202</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Although it is increasingly being recognized that drug-target interaction networks can be powerful tools for the interrogation of systems biol. and the rational design of multitargeted drugs, there is no generalized, statistically validated approach to harmonizing sequence-dependent and pharmacol.-dependent networks.  Here we demonstrate the creation of a comprehensive kinome interaction network based not only on sequence comparisons but also on multiple pharmacol. parameters derived from activity profiling data.  The framework described for statistical interpretation of these network connections also enables rigorous investigation of chemotype-specific interaction networks, which is crit. for multitargeted drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOgzF9Q0eH87Vg90H21EOLACvtfcHk0ljC6XYGThJd1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXit1aitrc%253D&md5=09234ec451a4918e5aca6d65e0b65aee</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.530&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.530%26sid%3Dliteratum%253Aachs%26aulast%3DMetz%26aufirst%3DJ.%2BT.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DSoni%26aufirst%3DN.%2BB.%26aulast%3DMerta%26aufirst%3DP.%2BJ.%26aulast%3DKifle%26aufirst%3DL.%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26atitle%3DNavigating%2520the%2520kinome%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2011%26volume%3D7%26spage%3D200%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Jiao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopecky, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaen, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardozo, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesche, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrelly, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayser, F.</span><span> </span><span class="NLM_article-title">Synthesis and optimization of substituted furo[2,3-<i>d</i>]-pyrimidin-4-amines and 7H-pyrrolo[2,3-<i>d</i>]pyrimidin-4-amines as ACK1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">6212</span><span class="NLM_x">–</span> <span class="NLM_lpage">6217</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=6212-6217&author=X.+Jiaoauthor=D.+J.+Kopeckyauthor=J.+Liuauthor=J.+C.+Jaenauthor=M.+G.+Cardozoauthor=R.+Sharmaauthor=N.+Walkerauthor=H.+Wescheauthor=S.+Liauthor=E.+Farrellyauthor=S.+H.+Xiaoauthor=Z.+Wangauthor=F.+Kayser&title=Synthesis+and+optimization+of+substituted+furo%5B2%2C3-d%5D-pyrimidin-4-amines+and+7H-pyrrolo%5B2%2C3-d%5Dpyrimidin-4-amines+as+ACK1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJiao%26aufirst%3DX.%26aulast%3DKopecky%26aufirst%3DD.%2BJ.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DJaen%26aufirst%3DJ.%2BC.%26aulast%3DCardozo%26aufirst%3DM.%2BG.%26aulast%3DSharma%26aufirst%3DR.%26aulast%3DWalker%26aufirst%3DN.%26aulast%3DWesche%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DFarrelly%26aufirst%3DE.%26aulast%3DXiao%26aufirst%3DS.%2BH.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DKayser%26aufirst%3DF.%26atitle%3DSynthesis%2520and%2520optimization%2520of%2520substituted%2520furo%255B2%252C3-d%255D-pyrimidin-4-amines%2520and%25207H-pyrrolo%255B2%252C3-d%255Dpyrimidin-4-amines%2520as%2520ACK1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D6212%26epage%3D6217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Bossi, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saccardo, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ardini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menichincheri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusconi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnaghi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orsini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avanzi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgia, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nesi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bandiera, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogliatto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, J. A.</span><span> </span><span class="NLM_article-title">Crystal structures of anaplastic lymphoma kinase in complex with ATP competitive inhibitors</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6813</span><span class="NLM_x">–</span> <span class="NLM_lpage">6825</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi1005514" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm501929n&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpt1Clsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=6813-6825&author=R.+T.+Bossiauthor=M.+B.+Saccardoauthor=E.+Ardiniauthor=M.+Menichincheriauthor=L.+Rusconiauthor=P.+Magnaghiauthor=P.+Orsiniauthor=N.+Avanziauthor=A.+L.+Borgiaauthor=M.+Nesiauthor=T.+Bandieraauthor=G.+Fogliattoauthor=J.+A.+Bertrand&title=Crystal+structures+of+anaplastic+lymphoma+kinase+in+complex+with+ATP+competitive+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structures of Anaplastic Lymphoma Kinase in Complex with ATP Competitive Inhibitors</span></div><div class="casAuthors">Bossi, Roberto T.; Saccardo, M. Beatrice; Ardini, Elena; Menichincheri, Maria; Rusconi, Luisa; Magnaghi, Paola; Orsini, Paolo; Avanzi, Nilla; Borgia, Andrea Lombardi; Nesi, Marcella; Bandiera, Tiziano; Fogliatto, Gianpaolo; Bertrand, Jay A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">6813-6825</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase involved in the development of several human cancers and, as a result, is a recognized target for the development of small-mol. inhibitors for the treatment of ALK-pos. malignancies.  Here, the crystal structures of the unphosphorylated human ALK kinase domain in complex with the ATP competitive ligands PHA-E429 and NVP-TAE684 are presented.  Anal. of these structures provides valuable information concerning the specific characteristics of the ALK active site as well as giving indications about how to obtain selective ALK inhibitors.  In addn., the ALK-KD-PHA-E429 structure led to the identification of a potential regulatory mechanism involving a link made between a short helical segment immediately following the DFG motif and an N-terminal two-stranded β-sheet.  Finally, mapping of the activating mutations assocd. with neuroblastoma onto the structures may explain the roles these residues have in the activation process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2b8yuzTuAYbVg90H21EOLACvtfcHk0ljC6XYGThJd1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpt1Clsbs%253D&md5=e8e9e3fde63a196a15c874300c995342</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fbi1005514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi1005514%26sid%3Dliteratum%253Aachs%26aulast%3DBossi%26aufirst%3DR.%2BT.%26aulast%3DSaccardo%26aufirst%3DM.%2BB.%26aulast%3DArdini%26aufirst%3DE.%26aulast%3DMenichincheri%26aufirst%3DM.%26aulast%3DRusconi%26aufirst%3DL.%26aulast%3DMagnaghi%26aufirst%3DP.%26aulast%3DOrsini%26aufirst%3DP.%26aulast%3DAvanzi%26aufirst%3DN.%26aulast%3DBorgia%26aufirst%3DA.%2BL.%26aulast%3DNesi%26aufirst%3DM.%26aulast%3DBandiera%26aufirst%3DT.%26aulast%3DFogliatto%26aufirst%3DG.%26aulast%3DBertrand%26aufirst%3DJ.%2BA.%26atitle%3DCrystal%2520structures%2520of%2520anaplastic%2520lymphoma%2520kinase%2520in%2520complex%2520with%2520ATP%2520competitive%2520inhibitors%26jtitle%3DBiochemistry%26date%3D2010%26volume%3D49%26spage%3D6813%26epage%3D6825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Bernhart, C.; Bouaboula, M.; Casellas, P.; Jegham, S.; Arigon, J.; Combet, R.; Hilairet, S.; Fraisse, P.</span><span> </span><span class="NLM_article-title">Nicotinamide derivatives, preparation thereof and therapeutic use thereof</span>. US20100222319A1,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=C.+Bernhart&author=M.+Bouaboula&author=P.+Casellas&author=S.+Jegham&author=J.+Arigon&author=R.+Combet&author=S.+Hilairet&author=P.+Fraisse&title=Nicotinamide+derivatives%2C+preparation+thereof+and+therapeutic+use+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBernhart%26aufirst%3DC.%26atitle%3DNicotinamide%2520derivatives%252C%2520preparation%2520thereof%2520and%2520therapeutic%2520use%2520thereof%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Martin, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pireddu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alam, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozcan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebti, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schonbrunn, E.</span><span> </span><span class="NLM_article-title">A novel mechanism by which small molecule inhibitors induce the DFG flip in Aurora A</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">698</span><span class="NLM_x">–</span> <span class="NLM_lpage">706</span></span><div class="citationLinks">[<a href="/doi/10.1021/cb200508b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=698-706&author=M.+P.+Martinauthor=J.+Y.+Zhuauthor=H.+R.+Lawrenceauthor=R.+Piredduauthor=Y.+Luoauthor=R.+Alamauthor=S.+Ozcanauthor=S.+M.+Sebtiauthor=N.+J.+Lawrenceauthor=E.+Schonbrunn&title=A+novel+mechanism+by+which+small+molecule+inhibitors+induce+the+DFG+flip+in+Aurora+A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fcb200508b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb200508b%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DM.%2BP.%26aulast%3DZhu%26aufirst%3DJ.%2BY.%26aulast%3DLawrence%26aufirst%3DH.%2BR.%26aulast%3DPireddu%26aufirst%3DR.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DAlam%26aufirst%3DR.%26aulast%3DOzcan%26aufirst%3DS.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26aulast%3DLawrence%26aufirst%3DN.%2BJ.%26aulast%3DSchonbrunn%26aufirst%3DE.%26atitle%3DA%2520novel%2520mechanism%2520by%2520which%2520small%2520molecule%2520inhibitors%2520induce%2520the%2520DFG%2520flip%2520in%2520Aurora%2520A%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2012%26volume%3D7%26spage%3D698%26epage%3D706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gevariya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rix, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schonbrunn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebti, S. M.</span><span> </span><span class="NLM_article-title">Dual Aurora A and JAK2 kinase blockade effectively suppresses malignant transformation</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">2947</span><span class="NLM_x">–</span> <span class="NLM_lpage">2961</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=2947-2961&author=H.+Yangauthor=H.+R.+Lawrenceauthor=A.+Kaziauthor=H.+Gevariyaauthor=R.+Patelauthor=Y.+Luoauthor=U.+Rixauthor=E.+Schonbrunnauthor=N.+J.+Lawrenceauthor=S.+M.+Sebti&title=Dual+Aurora+A+and+JAK2+kinase+blockade+effectively+suppresses+malignant+transformation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DH.%26aulast%3DLawrence%26aufirst%3DH.%2BR.%26aulast%3DKazi%26aufirst%3DA.%26aulast%3DGevariya%26aufirst%3DH.%26aulast%3DPatel%26aufirst%3DR.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DRix%26aufirst%3DU.%26aulast%3DSchonbrunn%26aufirst%3DE.%26aulast%3DLawrence%26aufirst%3DN.%2BJ.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26atitle%3DDual%2520Aurora%2520A%2520and%2520JAK2%2520kinase%2520blockade%2520effectively%2520suppresses%2520malignant%2520transformation%26jtitle%3DOncotarget%26date%3D2014%26volume%3D5%26spage%3D2947%26epage%3D2961" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Cooper, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walborsky, H. M.</span><span> </span><span class="NLM_article-title">Alkali metals dissolved in optically active solvents</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">2110</span><span class="NLM_x">–</span> <span class="NLM_lpage">2116</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00323a026" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1981&pages=2110-2116&author=K.+D.+Cooperauthor=H.+M.+Walborsky&title=Alkali+metals+dissolved+in+optically+active+solvents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjo00323a026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00323a026%26sid%3Dliteratum%253Aachs%26aulast%3DCooper%26aufirst%3DK.%2BD.%26aulast%3DWalborsky%26aufirst%3DH.%2BM.%26atitle%3DAlkali%2520metals%2520dissolved%2520in%2520optically%2520active%2520solvents%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1981%26volume%3D46%26spage%3D2110%26epage%3D2116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Jones, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willett, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glen, R. C.</span><span> </span><span class="NLM_article-title">Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">245</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm501929n&amp;key=10.1016%2FS0022-2836%2895%2980037-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm501929n&amp;key=7823319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm501929n&amp;key=1%3ACAS%3A528%3ADyaK2MXjtVKlsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=245&publication_year=1995&pages=43-53&author=G.+Jonesauthor=P.+Willettauthor=R.+C.+Glen&title=Molecular+recognition+of+receptor+sites+using+a+genetic+algorithm+with+a+description+of+desolvation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular recognition of a receptor sites using a genetic algorithm with a description of desolvation</span></div><div class="casAuthors">Jones, Gareth; Willett, Peter; Glen, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">245</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-53</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Understanding the principles whereby macromol. biol. receptors can recognize small mol. substrates or inhibitors is the subject of a major effort.  This is of paramount importance in rational drug design where the receptor structure is known (the "docking" problem).  Current theor. approaches utilize models of the steric and electrostatic interaction of bound ligands and recently conformational flexibility has been incorporated.  The authors report results based on software using a genetic algorithm that uses an evolutionary strategy in exploring the full conformational flexibility of the ligand with partial flexibility of the protein, and which satisfies the fundamental requirement that the ligand must displace loosely bound water on binding.  Results are reported on five test systems showing excellent agreement with exptl. data.  The design of the algorithm offers insight into the mol. recognition mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7Xcn7nQyVRLVg90H21EOLACvtfcHk0lhmLXI5W2QypA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjtVKlsbc%253D&md5=bf45edafb986a73c7c1d0ac55e070f28</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2FS0022-2836%2895%2980037-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-2836%252895%252980037-9%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DG.%26aulast%3DWillett%26aufirst%3DP.%26aulast%3DGlen%26aufirst%3DR.%2BC.%26atitle%3DMolecular%2520recognition%2520of%2520receptor%2520sites%2520using%2520a%2520genetic%2520algorithm%2520with%2520a%2520description%2520of%2520desolvation%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1995%26volume%3D245%26spage%3D43%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Verdonk, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartshorn, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, R. D.</span><span> </span><span class="NLM_article-title">Improved protein–ligand docking using GOLD</span> <span class="citation_source-journal">Proteins: Struct., Funct., Bioinf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">609</span><span class="NLM_x">–</span> <span class="NLM_lpage">623</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2003&pages=609-623&author=M.+L.+Verdonkauthor=J.+C.+Coleauthor=M.+J.+Hartshornauthor=C.+W.+Murrayauthor=R.+D.+Taylor&title=Improved+protein%E2%80%93ligand+docking+using+GOLD"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVerdonk%26aufirst%3DM.%2BL.%26aulast%3DCole%26aufirst%3DJ.%2BC.%26aulast%3DHartshorn%26aufirst%3DM.%2BJ.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DTaylor%26aufirst%3DR.%2BD.%26atitle%3DImproved%2520protein%25E2%2580%2593ligand%2520docking%2520using%2520GOLD%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Bioinf.%26date%3D2003%26volume%3D52%26spage%3D609%26epage%3D623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Targeting cancer with small molecule kinase inhibitors</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm501929n&amp;key=10.1038%2Fnrc2559" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm501929n&amp;key=19104514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm501929n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1yg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=28-39&author=J.+Zhangauthor=P.+L.+Yangauthor=N.+S.+Gray&title=Targeting+cancer+with+small+molecule+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting cancer with small molecule kinase inhibitors</span></div><div class="casAuthors">Zhang, Jianming; Yang, Priscilla L.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">28-39</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Deregulation of kinase activity has emerged as a major mechanism by which cancer cells evade normal physiol. constraints on growth and survival.  To date, 11 kinase inhibitors have received US Food and Drug Administration approval as cancer treatments, and there are considerable efforts to develop selective small mol. inhibitors for a host of other kinases that are implicated in cancer and other diseases.  Herein we discuss the current challenges in the field, such as designing selective inhibitors and developing strategies to overcome resistance mutations.  This Review provides a broad overview of some of the approaches currently used to discover and characterize new kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriSM3BN_uEz7Vg90H21EOLACvtfcHk0lhNJLgsMiWd0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1yg&md5=35bc38f414cd21eef5e61ce181b580fb</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1038%2Fnrc2559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2559%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DP.%2BL.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DTargeting%2520cancer%2520with%2520small%2520molecule%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2009%26volume%3D9%26spage%3D28%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Hartman, D. A.</span><span> </span><span class="NLM_article-title">Determination of the stability of drugs in plasma</span>.  <span class="citation_source-book">Current Protocols in Pharmacology</span>; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2003</span><span class="NLM_x">; </span>Chapter 7, Unit 7.6.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm501929n&amp;key=10.1002%2F0471141755.ph0706s19" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=D.+A.+Hartman&title=Current+Protocols+in+Pharmacology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1002%2F0471141755.ph0706s19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F0471141755.ph0706s19%26sid%3Dliteratum%253Aachs%26aulast%3DHartman%26aufirst%3DD.%2BA.%26atitle%3DDetermination%2520of%2520the%2520stability%2520of%2520drugs%2520in%2520plasma%26btitle%3DCurrent%2520Protocols%2520in%2520Pharmacology%26pub%3DWiley%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Lawrence, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pireddu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gevariya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozcan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kendig, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elias, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebti, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schonbrunn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, N. J.</span><span> </span><span class="NLM_article-title">Development of <i>o</i>-chlorophenyl substituted pyrimidines as exceptionally potent aurora kinase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">7392</span><span class="NLM_x">–</span> <span class="NLM_lpage">7416</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300334d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm501929n&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVGhsrfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7392-7416&author=H.+R.+Lawrenceauthor=M.+P.+Martinauthor=Y.+Luoauthor=R.+Piredduauthor=H.+Yangauthor=H.+Gevariyaauthor=S.+Ozcanauthor=J.+Y.+Zhuauthor=R.+Kendigauthor=M.+Rodriguezauthor=R.+Eliasauthor=J.+Q.+Chengauthor=S.+M.+Sebtiauthor=E.+Schonbrunnauthor=N.+J.+Lawrence&title=Development+of+o-chlorophenyl+substituted+pyrimidines+as+exceptionally+potent+aurora+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Development of o-Chlorophenyl Substituted Pyrimidines as Exceptionally Potent Aurora Kinase Inhibitors</span></div><div class="casAuthors">Lawrence, Harshani R.; Martin, Mathew P.; Luo, Yunting; Pireddu, Roberta; Yang, Hua; Gevariya, Harsukh; Ozcan, Sevil; Zhu, Jin-Yi; Kendig, Robert; Rodriguez, Mercedes; Elias, Roy; Cheng, Jin Q.; Sebti, Said M.; Schonbrunn, Ernst; Lawrence, Nicholas J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7392-7416</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The o-carboxylic acid substituted bisanilinopyrimidine I was identified as a potent hit (Aurora A IC50 = 6.1 ± 1.0 nM) from inhouse screening.  Detailed structure-activity relationship (SAR) studies indicated that polar substituents at the para position of the B-ring are crit. for potent activity.  X-ray crystallog. studies revealed that compd. I is a type I inhibitor that binds the Aurora kinase active site in a DFG-in conformation.  Structure-activity guided replacement of the A-ring carboxylic acid with halogens and incorporation of fluorine at the pyrimidine 5-position led to highly potent inhibitors of Aurora A that bind in a DFG-out conformation.  B-Ring modifications were undertaken to improve the soly. and cell permeability.  Compds. such as II with water-solubilizing moieties at the para position of the B-ring inhibited the autophosphorylation of Aurora A in MDA-MB-468 breast cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeJbI5uTT-4bVg90H21EOLACvtfcHk0lh49SUQwhpsKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVGhsrfN&md5=8158e18d9d2a26dfce7a831a353f333c</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm300334d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300334d%26sid%3Dliteratum%253Aachs%26aulast%3DLawrence%26aufirst%3DH.%2BR.%26aulast%3DMartin%26aufirst%3DM.%2BP.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DPireddu%26aufirst%3DR.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DGevariya%26aufirst%3DH.%26aulast%3DOzcan%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DJ.%2BY.%26aulast%3DKendig%26aufirst%3DR.%26aulast%3DRodriguez%26aufirst%3DM.%26aulast%3DElias%26aufirst%3DR.%26aulast%3DCheng%26aufirst%3DJ.%2BQ.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26aulast%3DSchonbrunn%26aufirst%3DE.%26aulast%3DLawrence%26aufirst%3DN.%2BJ.%26atitle%3DDevelopment%2520of%2520o-chlorophenyl%2520substituted%2520pyrimidines%2520as%2520exceptionally%2520potent%2520aurora%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7392%26epage%3D7416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Park, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, I. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latif, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yun, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chae, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, S. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ha, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yun, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span> </span><span class="NLM_article-title">Novel bis-ortho-alkoxy-para-piperazinesubstituted-2,4-dianilinopyrimidines (KRCA-0008) as potent and selective ALK inhibitors for anticancer treatment</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">6192</span><span class="NLM_x">–</span> <span class="NLM_lpage">6196</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=6192-6196&author=C.+H.+Parkauthor=H.+Choeauthor=I.+Y.+Jangauthor=S.+Y.+Kwonauthor=M.+Latifauthor=H.+K.+Leeauthor=H.+J.+Leeauthor=E.+H.+Yangauthor=J.+I.+Yunauthor=C.+H.+Chaeauthor=S.+Y.+Choauthor=S.+U.+Choiauthor=J.+D.+Haauthor=H.+Jungauthor=H.+R.+Kimauthor=P.+Kimauthor=C.+O.+Leeauthor=C.+S.+Yunauthor=K.+Lee&title=Novel+bis-ortho-alkoxy-para-piperazinesubstituted-2%2C4-dianilinopyrimidines+%28KRCA-0008%29+as+potent+and+selective+ALK+inhibitors+for+anticancer+treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DC.%2BH.%26aulast%3DChoe%26aufirst%3DH.%26aulast%3DJang%26aufirst%3DI.%2BY.%26aulast%3DKwon%26aufirst%3DS.%2BY.%26aulast%3DLatif%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DH.%2BK.%26aulast%3DLee%26aufirst%3DH.%2BJ.%26aulast%3DYang%26aufirst%3DE.%2BH.%26aulast%3DYun%26aufirst%3DJ.%2BI.%26aulast%3DChae%26aufirst%3DC.%2BH.%26aulast%3DCho%26aufirst%3DS.%2BY.%26aulast%3DChoi%26aufirst%3DS.%2BU.%26aulast%3DHa%26aufirst%3DJ.%2BD.%26aulast%3DJung%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DH.%2BR.%26aulast%3DKim%26aufirst%3DP.%26aulast%3DLee%26aufirst%3DC.%2BO.%26aulast%3DYun%26aufirst%3DC.%2BS.%26aulast%3DLee%26aufirst%3DK.%26atitle%3DNovel%2520bis-ortho-alkoxy-para-piperazinesubstituted-2%252C4-dianilinopyrimidines%2520%2528KRCA-0008%2529%2520as%2520potent%2520and%2520selective%2520ALK%2520inhibitors%2520for%2520anticancer%2520treatment%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D6192%26epage%3D6196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerns, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span> </span><span class="NLM_article-title">Development and application of high throughput plasma stability assay for drug discovery</span> <span class="citation_source-journal">Int. J. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">297</span><span class="NLM_x">, </span> <span class="NLM_fpage">110</span><span class="NLM_x">–</span> <span class="NLM_lpage">119</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm501929n&amp;key=10.1016%2Fj.ijpharm.2005.03.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm501929n&amp;key=15876500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm501929n&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkt1ansrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2005&pages=110-119&author=L.+Diauthor=E.+H.+Kernsauthor=Y.+Hongauthor=H.+Chen&title=Development+and+application+of+high+throughput+plasma+stability+assay+for+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Development and application of high throughput plasma stability assay for drug discovery</span></div><div class="casAuthors">Di, Li; Kerns, Edward H.; Hong, Yan; Chen, Hong</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">110-119</span>CODEN:
                <span class="NLM_cas:coden">IJPHDE</span>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Plasma stability plays an important role in drug discovery and development.  Unstable compds. tend to have rapid clearance and short half-life, resulting in poor in vivo performance.  This paper examines the variables that affect the plasma stability assay results, including substrate concn., %DMSO, plasma concn., enzyme activity upon incubation and batch variation.  The results show that plasma stability can accommodate a wide range of exptl. conditions.  Relatively minor differences in results are produced with major differences in conditions.  Significant batch-to-batch variations were obsd. for rat plasma.  We selected the following conditions: 1 μM substrate concn., 2.5% DMSO, and 50% diln. of plasma in pH 7.4 buffer.  Plasma stability can be used as a diagnostic assay when compds. are unexpectedly rapidly cleared, as a special assay when structural classes contain groups that may be susceptible to plasma enzyme hydrolysis, or as general screen for compds. if resources are available.  Plasma stability assay has many applications in drug discovery: to alert teams to labile structural motifs, to prioritize compds. for in vivo studies and to screen prodrugs and antedrugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZUoDVyphu6bVg90H21EOLACvtfcHk0lh49SUQwhpsKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkt1ansrg%253D&md5=cee758567f2d75838b28817a1040f855</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpharm.2005.03.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpharm.2005.03.022%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DKerns%26aufirst%3DE.%2BH.%26aulast%3DHong%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DH.%26atitle%3DDevelopment%2520and%2520application%2520of%2520high%2520throughput%2520plasma%2520stability%2520assay%2520for%2520drug%2520discovery%26jtitle%3DInt.%2520J.%2520Pharm.%26date%3D2005%26volume%3D297%26spage%3D110%26epage%3D119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Koch-Weser, J.</span><span> </span><span class="NLM_article-title">Clinical application of the pharmacokinetics of procaine amide</span> <span class="citation_source-journal">Cardiovasc. Clin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1974</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">75</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm501929n&amp;key=4613464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm501929n&amp;key=1%3ACAS%3A280%3ADyaE2M%252FnsVWksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1974&pages=63-75&author=J.+Koch-Weser&title=Clinical+application+of+the+pharmacokinetics+of+procaine+amide"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical application of the pharmacokinetics of procaine amide</span></div><div class="casAuthors">Koch-Weser J</div><div class="citationInfo"><span class="NLM_cas:title">Cardiovascular clinics</span>
        (<span class="NLM_cas:date">1974</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">63-75</span>
        ISSN:<span class="NLM_cas:issn">0069-0384</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTb4-aYHwcAyMRAV4D_Ins_fW6udTcc2eYPvMh2bDa6Ubntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE2M%252FnsVWksA%253D%253D&md5=0e02ddc46a67297748752ab837ebc7ba</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoch-Weser%26aufirst%3DJ.%26atitle%3DClinical%2520application%2520of%2520the%2520pharmacokinetics%2520of%2520procaine%2520amide%26jtitle%3DCardiovasc.%2520Clin.%26date%3D1974%26volume%3D6%26spage%3D63%26epage%3D75" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3EQR" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3EQR','PDB','3EQR'); return false;">PDB: 3EQR</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EWH" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EWH','PDB','4EWH'); return false;">PDB: 4EWH</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XB7" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XB7','PDB','2XB7'); return false;">PDB: 2XB7</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3EQP" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3EQP','PDB','3EQP'); return false;">PDB: 3EQP</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2OF2" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2OF2','PDB','2OF2'); return false;">PDB: 2OF2</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i72"><a href="/doi/suppl/10.1021/jm501929n">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_23085"></div></div></div></div></div><hr /></hr><p class="last">Synthetic protocols for preparation of sulfides <b>10a</b>–<b>d</b>, sulfones <b>11a</b>–<b>d</b>, sulfides and sulfones <b>12a</b>–<b>r</b>, and compounds <b>23</b>–<b>42</b> and Figures S1 and S2 showing (<i>R</i>)-<b>9b</b> superposed in JAK2 and ALK. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm501929n/suppl_file/jm501929n_si_001.pdf">jm501929n_si_001.pdf (617.22 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm501929n&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm501929n%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2015.58.issue-6%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm501929n" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677b615e9fa5d932","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
